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CHAPTER 1
INTRODUCTION
Breast cancer is the most common type of cancer among women in North
America, accounting for approximately 1 in 3 cancers diagnosed in US women. In 2013,
it is estimated that approximately 230,000 women will be diagnosed with invasive breast
cancer in the US and that 39,500 women will die from breast cancer1. Currently, a
woman living in the US has a 12.15%, or about 1 in 8 chance of being diagnosed with
breast cancer in their lifetime. Fortunately, breast cancer death rates have decreased
2.2% per year between from 1999 to 2007 due to a combination of improvements in
breast cancer treatment and early detection. Early detection is accomplished through the
use of breast cancer risk models and screening mammography.
1.1 Breast Cancer Risk Models
Breast cancer typically produces no symptoms when the tumor is small and most
treatable, so early detection of the disease is critical. Gail et. al2 developed a model for
estimating the risk of developing breast cancer in women who had no evidence of cancer
at the time of their initial screening mammogram. The model was developed from casecontrol data from the Breast Cancer Detection Demonstration Project (BCDDP) in which
more than 280,000 women volunteered to have their annual breast cancer screenings
monitored for 5 years3. The Gail model used risk factors known at the time to predict the
relative risk. These factors included current age, age at menarche, age at birth of first
child, number of first-degree relatives with a family history of breast cancer and number
of previous breast biopsy examinations.

The model was modified to use during

recruitment for the Breast Cancer Prevention Trial using Surveillance Epidemiology End
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Results (SEER) data to update the underlying incidence rates4. The Gail model is useful
to describe breast cancer risk in large populations, but it does not discriminate very well
between individual women who will and will not develop cancer. As such, the primary
use of these models is to develop power calculations for prevention trials.
However, asymptomatic women who are aware of any elevated risk factors they
may possess may be more inclined to seek breast cancer screening. Screening takes on
different forms for women depending on their age. For women aged 20-39, the American
Cancer Society suggests a clinical breast examination every 3 years and optional breast
self-examinations as a guideline for early detection of breast cancer. For women aged 40
and over, in addition to optional breast self-examinations and annual clinical breast
examinations, the ACS also suggests annual screening mammograms5. For women with
the highest lifetime risk of cancer (~20% - 25% or greater), an annual screening MRI is
also suggested5. Yet, despite their actual level of risk, women tend to overestimate their
risk of developing and dying of breast cancer6, 7. It is therefore important to not only
create strong predictive models of breast cancer risk, but to also inform women of the
true nature of their risk to assuage their fears.
1.1.1 Breast Density and Cancer Risk
The ability to predict future occurrences of disease in individuals allows for
improvements in the development of preventative strategies as well as improved clinical
decision making. Yet, predictions of breast cancer risk are less well developed than risk
predictions for many other diseases. The Gail model was an initial attempt to quantify a
woman’s risk of developing breast cancer, but it was limited by the choice of risk factors.
Since the release of the Gail model, studies have shown there are other factors associated
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with breast cancer risk. These include the use of hormone therapy, high body mass index
(BMI), the result of previous mammographic examinations and mammographic breast
density, among many other factors listed by the ACS (Table 1-15).

In fact,

mammographic breast density is one of the strongest predictors of breast cancer risk.
Women with the densest breasts are at a four- to six-fold greater risk of breast cancer
when compared to women with less dense breasts. Attempts to incorporate breast density
into these predictive models have shown modest improvements in risk prediction
estimates8-10. However, these studies excluded young women that would benefit most
from predictive models, used incomplete covariate information and qualitative measures
of breast density11. Despite these limitations, the studies indicate that the inclusion of
breast density is an important risk factor to consider when designing a predictive model.
Table 1-1 – Factors Associated with an Increased Risk of Breast Cancer in Women5
Relative
Risk

Factor

Relative
Risk

Age

>4.0

High socioeconomic status
Late age at first full-term pregnancy (>30
years)

Mammographically dense breasts

Late menopause (>55 years)

Personal history of breast cancer

Never breastfed a child

High bone density (postmenopausal)
High-dose radiation to the chest
Two first-degree relatives with breast
cancer
1.1-2.0

Height (Tall)

Biopsy-confirmed atypical
hyperplasia
Certain inherited genetic mutations
(BRCA1 and/or BRCA2)

High estrogen or testosterone levels
2.1-4.0

Factor

Alcohol consumption
Early menarche (<12 years)

1.1-2.0

No full-term pregnancies
Obesity (postmenopausal)/adult weight
gain
One first-degree relative with breast
cancer
Personal history of endometrium, ovary
or colon cancer
Recent and long-term use of menopausal
hormone therapy
Recent oral contraceptive use

4
The effect breast density has, not just on predictive models, but on the actual
breast cancer risk has been studied extensively and is quite strong. McCormack and dos
Santos Silva12 conducted a systematic analysis of the association between percent
mammographic density and risk of breast cancer. Their data included more than 14,000
women with cancer and 226,000 women without cancer from 42 studies. They found that
extensive percent mammographic density was consistently associated with an increased
risk of breast cancer. Associations were stronger in studies that were conducted in
general populations rather than for symptomatic women.

Associations were also

apparent when using both qualitative methods, such as Wolfe’s parenchymal patterns or
the Breast Imaging Reporting and Data System (BI-RADS) categories, and for
quantitative methods, such as computer-assisted methods like Cumulus13. However, the
associations were stronger for the quantitative measurements as opposed to the
qualitative ones. The risk associated with mammographic density did not differ by age,
menopausal status or ethnicity.
Many other studies have also shown that breast density is consistently associated
with breast cancer risk. Boyd et al has investigated this relationship thoroughly over
many years14-19. Density was primarily assessed as a percent density on mammograms
through the use of a computer-assisted method. It was determined that, when compared
to women with lower densities, women with the highest densities showed an increased
risk of breast cancer of 4 to 6-fold. This elevated risk also persisted for at least 8 years
after entry into the study and the risk due to density was greater in younger women
compared to older women. In fact, for young women with more than 50% dense tissue
on their mammograms, 26% of all breast cancers and 50% of cancers detected less than
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12 months after a negative screening exam were attributable to their mammographic
density16. Other studies done by Byrne et al20, Byng et al21, 22, Wolfe et al23, Saftlas et
al24, Sala et al25, Harvey et al26 and Vachon et al27 further highlight that no matter how
mammographic breast density is measured, its presence is a strong indicator of breast
cancer risk. Breast density is a risk factor that strongly correlates to breast cancer risk
and may in fact account for a substantial number of breast cancers. However, of the
breast cancer factors that present the greatest risk (Table 1-1), breast density is of special
importance. It is a factor that can be easily influenced and altered through intervention.
Breast density is therefore a key factor that can easily be monitored and modified to aid
in the fight against cancer.
1.1.2 Factors That Affect Breast Density
Since breast density is a strong predictor of breast cancer risk, it is no surprise that
many of the factors that affect breast cancer risk also have an effect on breast density.
The average mammographic percent density (MPD) in the population decreases with
increasing age18, 20, 24, 26, 28-32. This should lower the risk of developing breast cancer. Yet
breast cancer incidence increases with age. This apparent paradox can be explained by a
model of cancer incidence proposed by Pike et al33. The Pike model introduces the
concept of “breast tissue aging” which is the exposure of breast tissue to hormones and
growth factors. It also includes the effects that menarche, pregnancy and menopause
have on these factors. Exposure is highest at the time of menarche and decreases at the
time of pregnancy. It is further reduced during the perimenopausal period and is lowest
after menopause. It is the cumulative effect of this aging which describes the age-
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incidence for breast cancer. Women with higher exposure levels are more likely to
develop breast cancer.
In a model developed by Boyd et al18, the average exposure to mammographically
dense tissue resembles Pike’s concept of breast tissue aging. We therefore expect that
any factor that increases or decreases cumulative exposure to breast cancer risk will have
a similar effect on breast density. Early menarche, late age at first pregnancy, nulliparity
and late menopause are factors that should increase exposure to dense tissue. Late
menarche, early age at first pregnancy, multiple pregnancies and early menopause are
factors that should decrease cumulative exposure to mammographic density. Studies
have shown that women who have given birth and women with a large number of live
births show decreased density while women whose age at the birth of their first child was
older have shown increased density26,

28, 29, 32

. As women pass through menopause,

density has been shown to decline34-36.
There are many other factors that affect breast density that are not related to the
concept of exposure. Higher densities have been associated with women who have a
family history of breast cancer37. Breast density has intrauterine roots, as reflected by
increasing adult breast density with increasing birth weight and head circumference38.
Density has shown an inverse association with body weight and body mass index
(BMI)26, 31, 34, 39-41 despite obesity being a known risk factor for breast cancer. Therefore,
obese women with dense breasts may be at higher risk. Diet, a modifiable risk factor, has
shown some correlations with breast density26. In particular, a low-fat, high-carbohydrate
diet has shown to decrease percent density and dense area in the breast34, 42. Vitamin D
intake was inversely associated with breast density43,

44

while intakes of protein and
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animal protein were associated with higher breast densities44, 45. High alcohol intake is
positively correlated with breast density46. Women with benign breast disease show
higher density as well47. The associations between race and ethnicity with breast density
are conflicting and limited when comparing between African-American (AA) and white
women. Some studies48 showed that AA women have higher mammographic densities,
while others49, 50 have shown lower densities for the AA group.
Hormonal factors can also affect breast density and breast cancer risk.
Menopausal hormone therapy (MHT) slows normal breast involution51-53 and causes an
increase in MPD in 17%-73% of women53-58. The increase is most commonly diffuse,
but breast density does appear to be very responsive to MHT. The breast responds
rapidly to the treatment and the greatest change in density occurs during the 1st year of
use59. Upon the stopping of treatment, density reverts to baseline levels in as quickly as 2
to 3 weeks60,

61

.

Examples of MHT include the use of estrogen, progesterone and

progestin. Selective estrogen receptor modulators (SERM) decrease MPD presumably
due to their antiestrogen effect on the breast. They are also associated with decreased
breast cancer risk26.

Examples of SERM drugs include tamoxifen and raloxifene.

Tamoxifen has been shown to reduce breast density in 44% of women and reduce breast
cancer risk by half in high-risk women62. Since women with higher breast densities have
an increased risk of breast cancer, women who experience a change in their density from
either MHT or SERMs may in fact be respectively increasing or reducing their risk. It is
unknown whether these risk factors that affect breast density and breast cancer risk act
independent of each other or with similar mechanisms. Table 1-2 summarizes each factor
described here with its effect on breast density.
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1.2 Screening Mammography
Mammography is a low-dose x-ray procedure that allows visualization of the
internal anatomy of the breast.

Dedicated mammography devices are capable of

producing high quality images with low x-ray doses. Digital systems appear to be more
accurate for women under 50 with dense breasts63, 64. The ACS suggests that women
receive regular and annual screening mammograms beginning at age 401. Screening has
been shown to reduce breast cancer mortality65 in randomized trials and population-based
screening evaluations. It also leads to a greater range of treatment options that include
less-aggressive surgeries and therapies. A typical mammogram is shown below in Figure
1-1.
Table 1-2 – List of Factors that Affect the Breast Density of Women
Factor
Age
Age at Menarche
Parity

Effect on Breast Density
Increased age correlates to decreased density
Late age at menarche is associated with increased density
Nulliparity increases density; Multiparity decreases density

Age at First Birth Increased age at first birth correlates to increased density
Menopause
Family History
Birth Weight
Head Size

Menopause correlates to a decrease in density
Family history of breast cancer correlates to increased density
Increasing birth weight correlates to increased density
Increasing head circumference at birth correlates to increased density

Weight

Increasing weight and BMI correlate to decreased density

Alcohol

High alcohol intake correlates to increased density

Diet
Benign Disease

Vitamin D intake associated with decreased density;
Protein correlates with increased density
Benign breast diseases correlates with increased density

MHT

Menopausal hormone therapy correlates with increased density

SERM

The selective estrogen receptor modulator tamoxifen correlates with
decreased density
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Figure 1-1 - An example of a screening mammogram. Dense breast anatomy appears as regions of white
on the mammogram, while fatty tissue appears as darker regions.

1.2.1 Qualitative Mammographic Breast Density Measurements
The radiographic appearance of the breast on mammography varies among
women and reflects variations in breast tissue composition and the different x-ray
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attenuation characteristics of these tissues. Fibroglandular tissue in the breast attenuates
more x-rays than fat and therefore appears bright on a mammogram. Breast density is
therefore a measure of these mammographic parenchymal patterns. John Wolfe was the
first to propose a relationship between these patterns and breast cancer risk23. Four
classifications were used to separate women into groups according to their relative risk of
developing breast cancer.

Since the release of this work, many other studies have

assessed the risk of breast cancer according to Wolfe’s classifications66.

Figure 1-2 - Examples of the BI-RADS categories for density measurements made on mammography.

Currently, the Wolfe classifications have been replaced in the literature by the
American College of Radiology Breast Imaging Reporting and Data System (BI-RADS)
density score67. BI-RADS is a density estimation technique that typically involves a
radiologist’s visual assessment of the mammogram. It is routinely included for a large
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proportion of mammograms in the United States and also uses four classifications: 1
(predominately fat), 2 (scattered densities), 3 (heterogeneously dense) and 4 (extremely
dense) (Figure 1-2). However, due to the subjective nature of these classifications,
considerable inter- and intra- rater variability exists68, 69. Federal regulations70 dictate that
a report of the results of any mammography exam must be prepared by the facility where
the mammogram occurred and must be sent to the patient’s physician. Also, a lay
summary of the results is required to be sent to the patient as well. The reporting of
breast density in these reports is not yet mandated. However, several states have recently
passed legislation and a bill calling for federal law has been introduced that requires the
reporting of breast density in these reports71. The American College of Radiology72
supports the practice of patient education but warns of the possible harms this additional
information can cause, including confusion, a false sense of security, undue anxiety or a
loss of faith in mammography.
1.2.2 Quantitative Mammographic Breast Density Measurements
A quantitative method to measure breast density involves the use of computerassisted programs that are based on interactive thresholding and segmentation.

An

example of such a program is Cumulus13. An observer places thresholds at the edge of
the breast and at the edge of the density and the subsequent areas defined on the
mammogram are recorded by the computer. Mammographic percent density can then be
easily calculated by finding the ratio of fibroglandular to total breast areas. It can then be
treated as either a continuous or categorical variable in subsequent analysis. Density
measured in this way requires the use of trained observers and digitized film images, but
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reliability between readers has been shown to be high. Observers using Cumulus have
achieved an ICC of 0.9 or greater16, 73.
1.3 Limitations of Density Measurements Made by Mammography
Mammography screening has been shown to reduce the mortality rate in multiple
screening trials65. However, despite being the current gold standard for breast imaging,
mammography does pose some shortcomings for both cancer detection and breast density
measurement. Mammographic percent density is related more towards the attenuation
and absorption characteristics of the breast tissues rather than the direct density of the
breast. Because of a masking bias74, it is also the least effective for women with the
densest breasts and therefore the highest risk of developing breast cancer.

It uses

ionizing radiation which limits its screening capabilities and can in fact lead to an
increased risk of developing breast cancer75. Diagnostic mammography also generates
many abnormal findings not related to cancer which leads to costly and unnecessary
procedures and biopsies76. A mammographic image is also a two-dimensional (2D)
projection of three-dimensional (3D) volume.

This does not provide an accurate

volumetric analysis of the density due to the variable breast thickness.
Breast density calculated by the use of mammography is dependent on the
variations in breast tissue composition along with the x-ray attenuation properties of
those tissues and the methods used to generate the images.

Film and digital

mammography interact differently with x-rays. Film has a sigmoidal response to x-rays
and regions of the breast where little radiation passes through tend to be uniformly white
because they fall in the flat portion of the characteristic curve. Digital mammography has
a linear x-ray response and a wider dynamic range (Figure 1-3)77, so these regions are

13
viewed with more shades of grey. Therefore, when using Cumulus, regions that would
have appeared white on film and therefore considered dense tissue, may actually lie
below the cutoff and not be counted as “density” on digital mammograms. The image
processing that is applied to digital images to maximize contrast may also accentuate this
effect.

While this helps in detecting relevant signs of cancers, it can distort the

calculation of density. Digital image processing algorithms ultimately function to spread
the image more uniformly among all the possible grey levels, while film mammography
tends to render most of the image towards the black or white levels with few pixels
occupying the intermediate grey levels.

The use of higher energy x-rays in

mammography tends to flatten the grey scale and produce less contrast in the finished
images.

The differences between manufacturers in the production of the processed

mammographic images means that image quality may vary from institution to institution.
Also, the focus for mammography is on advancing the technology to better improve
cancer detection, and not necessarily to improve density measurements. This means that
density measurements made on mammographic equipment will be a dynamic and
constantly changing endeavor.
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Figure 1-3 - X-ray characteristic curves showing differences in x-ray response of film and digital
detectors77. Film detectors have a sigmoidal response, while digital detectors show a linear response over
many orders of magnitude.

Despite breast density being a known risk factor for developing breast cancer,
women with high breast densities may not benefit as much from mammography due to a
masking bias. As Egan and Mosteller hypothesized74, a masking phenomenon exists that
underestimates the number of cancers in dense breasts compared to fatty breasts.
Because of this masking, tumors may in fact be present in a mammogram, but are
obscured by the dense tissue in the breast. They will then manifest themselves as cancer
in later years and lead to an increase in breast cancer incidence. Since early detection of
breast cancer is key to successfully treating the disease, this masking of potential tumors
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can have potentially harmful effects on the treatment.
mammography was shown to exist in individual trials66,

78

This masking bias of

, and in general population

trials12. The masking bias only affects the identification of tumors, not the underlying
breast cancer risk. The relationship between breast density and breast cancer risk is
calculated after correcting for the masking bias.
In addition to this masking bias, mammography may not be the ideal imaging
modality to screen women with high densities due to the carcinogenic effects of the
radiation used. Since asymptomatic women with an elevated cancer risk due to increased
density may wish to be monitored more frequently, the increased radiation dose from the
additional examination may in fact further harm these women. It is estimated that for
every million screening mammograms performed, up to 8 women may develop cancer
from the radiation75. Although radiation dose is kept as low as reasonably achievable in
mammography, its mere presence is a limiting factor in how frequently screening can
occur for those most at risk.
Also, not all breast cancers can be detected by the use of mammography and some
cancers that are detected still may have poor prognosis.

Observations made in

mammography can lead to follow up examinations, including biopsies, which are
determined not to be cancer. This is referred to as a false-positive test result and can
cause unnecessary pain, anxiety and inconveniences to the patient. It is estimated that
after 10 years of annual mammographic screening, approximately 50% of women will
receive at least one false-positive recall76. Biennial screening reduces this probability to
approximately 1 out of 379. Mammograms are based on the projected area of the breast
tissue and not the volume, as thickness is not considered. No allowance for the technique
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of the mammogram is made nor is any variation in film development of breast
compression accounted for. Mammograms are performed by a trained observer and
therefore have a degree of subjectivity.

However, despite these limitations,

mammography is the single most effective method of early detection in clinical practice
since it can identify cancer several years before physical symptoms develop.
1.4 Volume Estimation Using Mammography
Breast density measurements using mammography are typically based on the 2dimensional projected area of the breast instead of examining the entire 3-dimensional
volume. For mammographic density measurements, each pixel is simply assumed to
represent either completely dense or completely fatty tissue.

In reality, each pixel

represents the x-ray absorption and attenuation characteristics of both fibroglandular and
fatty tissues combined.

It is therefore possible that two women may show similar

projected areas of dense tissue yet may have different volumes of dense tissue80. Efforts
have been made to estimate the volume of dense tissue based on these mammographic
measurements. These efforts generally involve the use of algorithms or physics models
that use the imaging acquisition parameters (tube voltage, film exposure time, anodefilter combination, breast thickness) to convert the mammographic pixel values into
estimates of the thickness of the fibroglandular tissue81, 82.
Highnam et al83, 84 have developed a fully automated physics model for screenfilm mammography known as the standard mammographic form (SMF) to extract the
thickness of fibroglandular tissue. This method can not only be applied prospectively,
but also retrospectively to mammograms taken in the past.

Van Engeland et al85

described a simple physical model to calculate the volumetric density for full field digital
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mammography (FFDM).

Shepherd et al86,

87

and Maskarinec et al88 have defined

fibroglandular volume using similar fully automated technique called single x-ray
absorptiometry (SXA) and dual energy x-ray absorptiometry (DXA) respectively.
Pawluczyk et al89 and Kaufhold et al90 have developed methods relating the transmitted
signal measured to breast equivalent calibration objects with known thicknesses and have
applied this relationship to estimate the volume.
For any method that attempts to quantify the mammographic density from
projection images, it is first necessary to test the accuracy of the method. All the methods
described above produced volumetric measurements that correlated well with the
standard area mammographic measurements.

Of all the different volumetric

measurements of density, volumetric percent density measurements showed the weakest,
yet still relatively strong correlations with traditional mammographic area percent density
measurements. These correlations ranged from r2 = 0.59 for the SXA measurements86, a
Pearson coefficient of rp = 0.76 for the FFDM measurement91 and Spearman coefficients
of rs = 0.68 for the SMF method92 and rs = 0.76 for the DXA method88. Correlations
relating volume of dense tissue and area of dense tissue on the mammogram tended to be
much stronger for all methods, with correlations greater than 0.9.
Despite these correlations to mammography, the attempts to measure the
volumetric density in mammography have not improved risk prediction compared to the
measurement of the projected area91-93. The different volume and area measures had
different distributions but did show similar associations with age and other risk factors
for breast cancer. Yet, most volumetric data have yielded weaker gradients in breast
cancer risk than the standard area measurements, although not all volumetric
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measurements86. This appears to be counterintuitive as the entire breast volume should
logically contain more information than the projected area. The most likely explanation
for why the area measurements appear to provide better risk prediction is due to the
sensitivity of the volume measurements to errors in the measurements of breast thickness.
Most of the algorithms require knowledge of the breast thickness and the calculated
volumes are sensitive to small changes in the measured value. Compression paddles that
are not parallel can cause small uncertainties in the measured thickness and even
perfectly parallel paddles do not guarantee dependable thickness measurements. These
small errors can lead to inaccurate estimations of volume of dense and non-dense tissue
which can explain their poorer performance in risk prediction.
1.5 Alternatives to Mammography
In current practice, mammography is used for both breast cancer detection and
breast density measurements. This is because it is less expensive and more efficient for
one device to perform several different functions. Ideally, each of these individual tasks,
cancer detection and density measurement, should be done with a device that is best
suited for it. This is a common approach with measurements that are made in other
medical fields. Since mammography is the only screening method that has been shown
to reduce mortality from breast cancer65, it is likely that it will remain as the principle
method of breast cancer detection.

Digital mammography is replacing film

mammography as it improves the detection of breast cancer, yet it is not optimal for the
measurement of breast density.

Potential alternatives to mammography for breast

imaging and breast density measurements include magnetic resonance (MR)94-98, double
x-ray absorption (DEXA)81, 82, 88, 93, 99-103 , dedicated breast CT104-107, positron emission
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mammography (PEM)108-114 and ultrasound tomography (UST)115-123. All these options
are volumetric methods that do not obtain their volumetric information based on two
dimensional projection mammograms.
Magnetic resonance imaging has been demonstrated to have superior sensitivity in
assessing breast composition compared to mammography in younger, high-risk women98.
Correlations have been demonstrated between mammographic percent density and two
MRI parameters: T2 relaxation time and relative water content94 and estimation of fat and
parenchyma in breast tissue is feasible using T1 times96. The images produced from MR
imaging are tomographic, with virtual slices showing the three dimensional anatomy.
The benefit of these images is that the overlying and underlying tissue can be removed
when viewing individual slices, which overcomes the superposition problems from
projection mammography. Figure 1-4 shows a breast MRI image. However, while MR
is useful as a research tool, its limited access and high expense make it impractical for
widespread use. Furthermore, the image acquisition process for MR takes much longer
than mammography. This means that a small fraction (~15%) of the general population
will be unable to tolerate the process due to claustrophobia.
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Figure 1-4 - Coronal (Top) and transverse (Bottom) breast MRI images.
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Breast CT was initially investigated many years ago as a method of breast cancer
screening124 but was largely dismissed as impractical due to concerns about radiation
dose and cost-effectiveness125.

Dose concerns arose because early studies used

conventional CT units where images were acquired transversely. This caused the x-ray
beam to penetrate the thoracic cavity which unnecessarily exposed a great deal of nonbreast tissue to radiation. This geometry can also potentially reduce image quality due to
cardiac and respiratory motion. More recent attempts to study breast CT have used a
dedicated and specially designed scanner to obtain the three dimensional tomographic
images104-106. The dose delivered using the system was found to be comparable to or
even lower than the doses delivered at routine mammography104.

Compared to

mammography, the image quality of breast CT varied depending on exactly what
structures were being imaged. For imaging breast lesions, image quality was similar
between the modalities, while CT provided superior image quality for the visualization of
masses and mammography was better for visualization of microcalcifications106.
However, despite this, the limited and costly machinery limits the widespread
implementation of breast CT.

Still, further investigation is needed into clinical

applications of breast CT. An example of the images obtained using a dedicated breast
CT scanner are shown below in Figure 1-5.
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Figure 1-5 - (Top) Transverse, (Middle) coronal and (Bottom) sagittal breast CT scans of a breast that
show a speculated mass106.
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Dual-energy x-ray absorptiometry (DXA) has been commonly used for many
years to measure bone mass and density in the diagnosis of osteoporosis and whole body
soft tissue composition expressed as percent fat mass99, 100. It has recently been applied
to the measurement of breast density81,

82, 101

due to its clinical success in the fields

previously listed. By using two different x-ray beams with different effective energies,
the volume of two different irradiated tissues can be calculated. In the breast, these two
tissues are fibroglandular and fatty tissue. DXA is a low dose imaging system, with
doses up to 10 times lower than that of mammography100. Due to this low dose level,
DXA has been used to measure breast density in adolescent girls102, 103 as well as adult
women88.

Yet, methods not involving the use of ionizing radiation would still be

preferable for these younger patients as well as for women at higher risk of developing
breast cancer. This is because susceptibility to the carcinogenic effects of radiation are
greatest at this time and repeated measurements might also be required. Also, most DXA
measurements are made using devices designed for measuring bone density. Although
these devices are common and do not require compression, a unit specially designed for
imaging women’s breasts would be preferred. Figure 1-6 shows the images obtained
using a DXA device.
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Figure 1-6 - Breast images by DXA (left) and conventional mammography (right)88.
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Positron emission mammography (PEM) is an imaging modality that can be used
to screen for malignant tumors111,

113, 114

. It is a functional imaging method where

physiologic changes, rather than structural changes, are observed. Figure 1-7 shows an
example of several images obtained by using this modality. Through the use of FDG
(18F-fluordeoxyglucose), a positron-emitting glucose analog, metabolic activity in the
breast can be monitored. Because localized increases in metabolic activity may indicate
the presence of a neoplasm before mammography can indicate the morphological
changes, PEM characterization of palpable breast masses is highly accurate108,

110, 112

.

Few studies have examined the relationship between breast density and FDG uptake in
the breast. Vranjesevic et al109 found that average peak standardized uptake values
(SUV) correlated with breast density (P < 0.01) while Berg et al112 found that increasing
FDG uptake correlated strongly with density, as measured using the BIRADS categories
(Spearman coefficient rs = 0.76). However, despite its ability to depict primary breast
cancer, PEM is not a widespread imaging modality and there exist many hurdles to
overcome to achieve implementation as a practical density assessment tool.
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Figure 1-7 - (a) Transverse FDG PEM image demonstrating two abnormalities. Lesion 1 represents
invasive carcinoma that was depicted at conventional mammography while lesion 2 represents a
noninvasive papillary carcinoma, which was not visible at conventional mammography. (b) Transverse
PEM image of the left breast depicts a single focus of increased FDG activity (arrows) at the site of the
mass110.

Ultrasound (US) imaging has traditionally complemented mammographic
imaging by helping to differentiate cysts from solid masses. It has also become the
dominant mode for guiding needle biopsy.

Standard ultrasound has demonstrated

effectiveness in detecting breast cancers of smaller sizes and earlier stages for women
with dense breasts126. Efforts to improve the diagnostic accuracy of US have been
carried out on two fronts.

The first has been to improve current US devices and
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techniques that rely on reflection, or B-mode, imaging127-129 while the other characterizes
masses using transmission imaging.
In 1976, Greenleaf et al made the observation that acoustic measurements made
with transmission US could characterize breast tissue130.

Using the transmission

parameters of sound speed and attenuation they concluded that differentiation between
benign masses and cancers was possible. In vitro samples of tissue were used to obtain
plots of sound speed as a function of attenuation and it was observed that benign and
malignant masses were well separated. This result led to the development of many
different US transmission scanners in an attempt to measure the transmission parameters
in vivo131-135. Ultrasound tomography (UST) is one example of this type of ultrasound
scanner. The breast UST scanner developed by Duric et al provides several advantages
as a breast density assessment tool115-123.
compression to create images.

UST does not use ionizing radiation or

UST examinations take on the order of minutes to

perform and the costs for the machine are expected to be low. Therefore, UST can be
used for risk assessment in conjunction with mammographic screening for breast cancer
and will add little in terms of cost and time.
Previous work done by Glide et al.119, 120 examined the preliminary relationship
between UST density measurements and mammography density measurements.

An

anthropomorphic breast phantom was imaged using UST and CT. It was found that
sound speed correlated strongly with the known mass densities (Pearson correlation
coefficient rp = 0.87) and CT numbers (Pearson correlation coefficient rp = 0.87) of the
different regions in the phantom. These phantom results lead to the investigation of UST
in vivo. Comparing the measured sound speed in UST to film MPD measurements also
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gave strong correlations (rp ranged from 0.72-0.75). However, the correlations improved
as the order of fit increased (rp ranged from 0.81-0.88 for the higher order fits). Finally, a
volumetric estimation of percent density (USPD) also showed strong correlations with
MPD (rp ranged from 0.75-0.84). These results all showed that ultrasound tomography is
an imaging modality that could be used to accurately measure material density and that it
has similar capabilities to mammography in determining breast density.
1.6 Dissertation Outline
The aim of this work is to evaluate ultrasound tomography (UST) of the breast as
a novel method of measuring the breast tissue characteristic known as “breast density”
(BD). There are many studies that have found that mammographic breast density is
strongly associated with risk of breast cancer. This study of UST is a continuation of the
work done by Duric et al and Glide et al on a clinical prototype located at the Karmanos
Cancer Institute in Detroit, Michigan115,

116, 119

. Currently, mammography is the gold

standard for the measurement of breast density.

However, measurements of breast

density by UST could be at least as strongly associated with breast cancer risk as the
projected area of breast density measured by mammography.
An overview of the prototype itself and the algorithms used to create the images
will be discussed. UST presents the density of the breast in terms of a new measurement
known as the volume averaged sound speed (VASS). The method of extracting this
information from the UST images will be explained.
Next, the results of a study involving approximately 250 patients who underwent
both mammography and UST exams will be presented. These results will show the
strong associations between densities as measured by the two different imaging
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modalities which will allow us to pursue further investigation into finding a direct link
between UST measurements and breast cancer risk. Relationships between the UST
density measurements and other common breast cancer risk factors will also be shown.
Continuing, preliminary results are presented from a study that aims to track
changes in breast density using UST measurement for patients undergoing treatment with
tamoxifen. Tamoxifen is a SERM that is known to reduce the risk of breast cancer and
reduce breast density. Changes in mammographic density associated with tamoxifen
have been studied elsewhere and the preliminary data presented here shows promising
early results that align with those outcomes.
The overall goal of this work is to show the ability of the UST imaging system to
measure breast density. By showing its effectiveness at assessing density, UST may one
day be a safe and cost-effective alternative in the field of breast density measurement and
breast cancer risk prediction.
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CHAPTER 2
ULTRASOUND TOMOGRAPHY
Ultrasound tomography (UST) has the potential to overcome many of the
shortcomings present with mammography in the measurement of breast density. It uses
non-ionizing ultrasonic waves to create images and poses no radiation risk to the patient
allowing for essentially unlimited repeats of exams. It creates coronal slices of the whole
breast anatomy and can therefore extract diagnostic information from the entire threedimensional volume of the breast. It is also less expensive to implement than other three
dimensional imaging modalities, such as MRI.
2.1 Measuring Breast Density Using UST
UST uses whole-breast acoustic velocity as an indicator of breast density. In
breast tissue, the speed of sound (v) has the following relationship to the elastic constant
(c) and material density (ρ):
v=

c

ρ

Eq. 1

Studies have shown that in human tissues, the elastic constant scales proportionally to the
cube of density ( c ∝ ρ 3 )136-138. Substitution into this equation reveals that in human
breast tissue, the sound speed is directly proportional to the density. Therefore, the
average density of the breast can be measured by calculating the volume averaged sound
speed (VASS) of the breast. This measurement represents an absolute scale that can
easily be replicated between current and future machines without the need for phantom
calibrations.
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Figure 2-1 - UST sound speed images showing rough estimates of the BI-RADS density categories. Top
Left – Category 1; Top Right – Category 2; Bottom Left – Category 3; Bottom Right – Category 4.

Breast sound speed images can be classified in many ways. Sound speed images
are a quantitative way of determining density, as will be discussed later. Visualizing the
sound speed images can also be used as a quick method of breast density estimation in
much the same way it is performed in mammography. The same general BI-RADS
categories can be applied to sound speed images to group breasts of similar densities
(Figure 2-1). Since BI-RADS was designed for use with the two dimensional projection
mammography images, applying the terminology to the three dimensional volumetric
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images of UST is not necessarily expected to be compatible. The distribution of dense
and fatty regions in mammography can appear very different to the distribution of dense
and fatty regions in UST. However, the general principle holds, in that an image with
more white regions is an image of a denser breast.
2.2 The UST Prototype
Figure 2-2 shows the system workstation and prototype patient bed for the UST
scanner. It depicts a patient setup that is different than that for mammography and
conventional ultrasound.

The CURE, or Computerized Ultrasound Risk Evaluation,

device was located at the Karmanos Cancer Institute (KCI) in Detroit, MI and has been
used clinically for several clinical research studies. The patient climbs a few steps onto
the bed and is positioned prone with the breast situated in a hole in the tensioned sailcloth
bedding. The breast is suspended in the water tank located below. The water acts as a
coupling medium and allows the breast to maintain its natural shape without deformation
or tissue displacement.
Also inside the tank is the 20-cm diameter ring transducer. It operates at a central
frequency of 2 MHz and is composed of 256 elements.

The ultrasound signal is

sequentially transmitted by each element and subsequently received by the rest of the
elements. Data acquisition time for each slice is approximately 0.03 seconds which
reduces intra-slice motion artifacts. A motorized gantry translates the ring away from the
chest wall towards the nipple in 1 mm intervals. Depending on the size of the breast, this
creates anywhere from 40 to 100 tomographic images of the breast and the entire exam
takes about 1 minute to perform (Figure 2-3).
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Figure 2-2 - (Top) Schematic diagram of the UST prototype showing patient positioning (Bottom) Actual
UST prototype at the Karmanos Cancer Institute in Detroit, MI.
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Figure 2-3 - Schematic showing the translation of the rind transducer to create UST image slices.

2.3 The Ultrasound Sound Speed Tomography Algorithm
There are several advantages for ultrasound transmission imaging (tomography)
when compared to conventional B-mode imaging. Transmission images are quantitative
and they provide sound-speed imaging of the whole breast. Transmission measurements
are independent of echo images and encode different information about the whole
anatomy of the breast.

The measurements are also relatively easy to analyze

mathematically. There are two basic types of UST methods, one based on ray theory and
the second which applies inverse scattering principles. Using ray theory is fast and
stable, while the inverse scattering principle method is more time consuming but gives
higher resolutions133, 139-141
The ray theory method used here uses the time-of-flight measurements of the
transmission US signals to reproduce the sound-speed distribution in the breast. Based
on Fermat’s Principle and Snell’s Law, the ultrasound ray path in an inhomogeneous
medium (such as breast tissue) is not straight. This makes the inverse problem non-linear
and it limited early applications of bent-ray algorithms to numerical simulations and
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phantom studies142-144. Since most abnormal breast lesions have higher sound speed than
normal breast tissue145, a robust UST algorithm is critical to accurately and efficiently
produce images of breast sound speed based on the ultrasound signals that are reflected
by and transmitted through the breast tissue. Here, an iterative bent-ray UST method is
used to extract sound speed information from in vivo ultrasound breast data. To solve the
bent-ray ultrasound tomography problem, a rectangular grid model, whose boundaries
enclose the transducer ring, was created on the image plane. During each iteration, both
the forward and inverse problems were solved.

The model was then updated for

successive iterations. The details of the algorithm are described below.
2.3.1 Forward Modeling
Two-dimensional (2-D) ultrasound wave propagation is governed by the eikonal
equation

(∇E )2 = (∂T

2

2

2

(

∂x ) + (∂T ∂y ) = (1 v ) = s x2 + s y2

)

Eq. 2

where T is the travel time, v is the sound speed and (s x , s y ) is the slowness vector of the
wave, defined as the inverse of sound speed.

The “wavefronts” are described by

E = const. and the orthogonal trajectories of these wavefronts are defined as the “rays”.
This equation was solved with Klimes’s method146 which has been proven to be both
accurate and fast. The method calculates the slowness vector, (s x , s y ) and travel time, T
at the center point of each grid cell simultaneously with at least second order accuracy
(relative to the grid size). The slowness vector and travel time, (s x , s y ) and T, were
interpolated by a 2-D fourth order Lagrange interpolation at an arbitrary point within the
grid model.
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By assuming the slowness is constant within each grid cell, the bent ray path can
be traced back from the receiver to the transmitter fairly accurately. The method to do
this is:
1. Starting from the receiver location

(

(x r , y r ) ,

trace the ray segment along the

)

direction G = − s xr ,− s yr until it intercepts the breast boundary at point ( xi , y i ) ;
2. Set a new value for G to be the negative slowness vector of the intercept point,

(

)

G = − s xi ,− s yi . Trace the ray segment along this vector to the next adjacent cell;
3. Repeat step 2 until the current ray arrives at the transmitter within a certain
tolerance.
An illustration of the grid model and the backpropagation is shown below in Figure 2-4.

Figure 2-4 – An example of the grid model used for the forward modeling. Rays are traced from the
receiver to the transmitter121.
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2.3.2 The Inverse Problem
The inverse problem can be described as
M

∑l

ij

∆s j = ∆t i

Eq. 3

j

where ∆ti is the difference between the ith picked time-of-flight (TOF) for the ultrasound
data and the ith calculated TOF for the sound speed model, ∆s j is the slowness
perturbation for the jth grid cell (which needs to be inverted), and l ij is the ray length of
the ith ray within the jth cell. This equation can be expressed in matrix form as
Eq. 4

L∆S = ∆T

Due to ray bending, this is a nonlinear problem. The objective function for the inverse
problem can be described as

(

f = argmin L∆S λ − ∆T
∆S

2

)

+ λTV (∆S λ )

Eq. 5

and
2

TV (∆S λ ) = ∫ ∇(∆S λ ) dxdy

Eq. 6

However, a small positive constant value is added to the equation because TV (∆S λ ) is
not differentiable at zero. Eq. 6 now becomes
2

TV (∆S λ ) = ∫ ∇(∆S λ ) + β 2 dxdy
The quantity

Eq. 7

2

∇(∆S λ ) + β 2 is known as the gradient magnitude and this provides us

with the information about the discontinuities in the image. The λ is the regularization
parameter that balances the roughness of the inverted results and the fit to the data.
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The quasi-Newton algorithm–L-BFGS method was applied to iteratively solve the
nonlinear problem in Eq. 5 for ∆S . This method avoided the direct computation of
Hessian matrices and was proven to be both time and memory efficient. After each
iteration, the updated model was obtained by adding the solution ∆S to the initial
homogeneous sound speed model. Rays were traced on the updated model using the
same method ass in the forward modeling section. The TOF data was updated at the
same time as well. The iteration continued until the TOF misfit ∆T was not significantly
improved from the previous iteration. This signified that the solution had converged.
The regularization parameter, λ , was determined using the L-curve technique147.

2.4 UST Image Reconstruction
Because of its circular shape, the CURE device captures most of the scattered and
reflected fields (Figure 2-5). This additional information allows for the creation of both
reflection and transmission images.

Figure 2-5 - The difference in how reflection (Rx) and transmission (Tx) ultrasound signals are collected
between UST (left) and conventional ultrasound (right).
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A signal generator is used to define a pulse shape, Ψ0(t), which in this case was a onecycle sinusoid. The transmitting transducer elements are sequentially driven with that
pulse to produce transmitting pulses, AiΨ0(t-ti) for {i = 1,….,256). For each transmitted
pulse, there is a set of received pulses, characterized by different shapes, amplitudes and
arrival times and given by: AijΦij(t-ti-τij) for {j = 1,….,256), where Φij(t) is defined to be a
normalized, time varying waveform so that the amplitude Aij is the received amplitude
and τij is the propagation time delay for each transmit-receive pair (i,j). Therefore, the
known quantities are the transmitted amplitudes Ai and transmit times ti. The measured
values are the matrices of the received amplitudes Aij and the propagation time delays τij.
Measurements of the amplitudes and time delays of the first signals to arrive at the
receiving elements are used to construct the transmission images (attenuation and sound
speed), while measurements of the amplitudes and time delays of the later signals to
arrive are used to construct the reflection images. For N elements, there are N(N+1)/2
independent transmit-receive pairs, so for a ring with N = 256, there are nearly 33,000
such pairs.

2.4.1 Sound Speed Images
It is possible to perform a computed tomography-(CT-) like reconstruction of the
sound speed based on the signals that are transmitted through the breast tissue to the other
side of the ring array. When compared to a homogeneous medium, in an inhomogeneous
medium such as the breast, the arrival times will deviate because the acoustic velocity
varies spatially within the medium. The deviations in arrival can be inverted to obtain
information about the sound speed changes in the isonofied plane and then used to create
maps of the sound-speed distribution.

The propagation speed of a sound wave is
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determined by the density of the medium that it is traveling through. So a map of the
sound-speed distribution is also a map of the density distribution throughout the breast

2.5 Measuring Average Sound Speed
Analysis of the sound speed images was done primarily with the public domain
software ImageJ, a package developed with support from the National Institutes of
Health148. The stack of sound speed images created by the CURE device was converted
into ASCII images to preserve the measurements and units (km/s). The UST exams
require that the subject’s breast be placed in a body-temperature water bath, which has a
sound speed of ~1.52 km/s. Unfortunately, this value falls within the range of breast
tissue, being higher than fatty tissue and lower than dense glandular tissue. This means
that the breast tissue cannot be segmented from the background image via simple
thresholding. A more robust method that separates the breast from the water bath was
used.

A script was written for ImageJ that uses a semi-automated elliptical

approximation of the breast to create a mask for each image slice.
The first step involved in using this script is to identify the slice where the nipple
ends and the slice where the chest wall begins. Slices beyond the nipple contain only the
water bath, so they must be discarded. In practice, determining the last slice with the
nipple is complicated as a clear boundary around the breast is not always visible.
Fortunately, selecting the nipple is not a critical step as the area on the slice is very small
and will have a very small impact on the overall volume average. Figure 2-6 shows the
selection of the last slice containing a nipple.

41

Figure 2-6 - An example of choosing the first slice that contains the nipple. Slice C was chosen to be the
first slice with the nipple present. Slices A, B and C were therefore included in the final image stack.

Determining the slice where the chest wall appears is more critical.

If the

transducer is placed high enough up on the patient’s chest wall at the beginning of the
scan, the anatomy that is actually being imaged may include more than just the breast. It
is important to exclude this anatomy from any measurements of VASS. As the images
approach the chest wall, the clear borders surrounding the breast begin to blur.
Sometimes, sections of the chest wall tissue were overhanging down below and next to
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the breast. In both of these cases, the chest wall created very apparent artifacts on the
image that signaled its presence. By removing any slice before these artifacts appeared,
only the breast anatomy would be analyzed. Figure 2-7 shows the selection of the last
slice without a chest wall. However, this is not a necessary step for every patient as some
images will not include the chest wall.

Figure 2-7 - An example of choosing the slice to remove the chest wall from the final sound speed image.
Slice C was chosen to be the first slice without any chest wall present. Slices C and D will be included in
the final sound speed image stack.
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Once the slices containing the breast anatomy were chosen, segmentation of the
breast from the background water bath could begin. For each slice, the script involved
choosing 10 points to approximate the breast-water boundary. The points were chosen to
equally surround the breast in all directions, as shown in Figure 2-8. The script would
then use a built-in feature of ImageJ to approximate an ellipse based on the hand-picked
points. The breast does not form a perfect ellipse in each slice, so in some instances the
ellipse included a small volume of the surrounding water bath and in other slices the
ellipse did not cover the entire volume of the breast. However, over the entire stack,
these offsetting errors partially compensated for each other.

Figure 2-8 - The breast segmentation algorithm working on a sound speed image. Left: The breast/water
bath interface is manually selected using 10 points Right: An ellipse is fit to the chosen points to
approximate the shape of the breast in the current slice.
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Figure 2-9 - Left: The original sound speed image before the masking algorithm was applied. Right: the
masked sound speed image. Bottom: The histogram obtained from the masked images showing the
distribution of sound speed within the entire image stack.

The best fitting ellipse was then used to create a mask of the breast. All pixels
that lie inside the mask had a value of 1, while all pixels that lie outside the mask had a
value of 0. In ImageJ, two images can be multiplied pixel by pixel. Taking the mask and
the sound speed image and multiplying them resulted in an image where all pixels that
correspond to the surrounding water bath now had a value of 0 and all pixels
corresponding to the breast tissue had an unchanged pixel value. This image was known
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as the masked sound speed image and it was also saved. Using the built in mathematical
features of ImageJ, the mean, standard deviation, number of counts or volume and the
standard error of the mean were calculated from the masked sound speed image.
Histogram data was also collected. Figure 2-9 shows the final masked sound speed
image in comparison with the original sound speed image and the calculated histogram
from the entire volume.
Since an image stack corresponds to the entire breast volume, the histograms
represent the statistical distribution of all sound speed voxels within the breast. The
volume averaged sound speed (VASS) of the breast could be calculated very easily from
the images in this form. The volume of the breast, V, can be calculated by a direct count
of all voxels:
Nx , Ny , Nz

V =

∑δ

x, y, z

∆x∆y∆z

Eq. 8

x, y, z

where δ is a voxel located at position (x,y,z), ∆x, ∆y and ∆z are the dimensions of the
voxels (typically 1 mm3 for this device) and Nx, Ny and Nz are the dimensions of the
sound speed image stack (typically 221 x 221 x 75 pixels). For most images, the total
number of voxels can range from 50,000 to more than 2 million which corresponds to
breast volumes of 50 to 2000 cm3. The VASS can then be calculated by using the
formula:

VASS =

1
V

∑ s ( x, y , z )

Eq. 9

x, y, z

where s(x,y,z) is the sound speed value of the voxel located at position (x,y,z). The net
result, the VASS, is a single-valued estimate of the average sound speed that is
representative of the whole breast. It is this value that can be used as a quantitative
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estimate of the average density of the breast. Additional counting statistics can also be
obtained very easily from the distribution of sound speed within the breast.

2.6 K-means Clustering
The sound speed images were also analyzed through the use of a k-means
clustering routine.

This approach segments images via grouping gray-level pixels

according to their proximity to randomly initialized centroid values. Here, the two
clusters chosen correspond to volumes of dense and fatty tissue. This allows for the
calculation of the total volume of dense and fatty tissues in the breast and, due to the
quantitative nature of the sound speed images, the average sound speed of the dense and
fatty volumes. The ultrasound percent density (USTPD) can then be calculated in a
similar fashion to the mammographic percent density. The USTPD is simply the ratio of
the volume of segmented dense tissue to the entire volume of the breast.

2.7 Statistical Analysis
A wide variety of statistical tests were used to analyze the results. The value of
each voxel in the reconstructed UST image is assumed to represent a sound speed value
that is normally distributed around the average sound speed, µ, with variance σ2.
However, the volume averaged sound speed that is measured using the methods
described above is actually the sample mean, x . The distribution of the sound speed
values of the voxels in the masked UST image is also assumed to be normally distributed.
The standard deviation, σ, describes the distribution of the values of the voxels relative to
the sample mean. The best measure of the uncertainty of the sample mean relative to the
actual mean is through the use of the standard error ( SE x ), defined as:
SE x =

σ
N

Eq. 10
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where N is the voxel count of the image. Using the standard error alongside the sample
mean gives the best estimation of the volume averaged sound speed and its uncertainty.
Correlations between sound speed and patient characteristics were assessed using
the Spearman’s rank correlation coefficient (rs). The Spearman correlation coefficient is
a non-parametric measure of statistical dependence between two variables. It assesses
how well the relationship between these two variables can be described using a
monotonic function. A positive Spearman correlation corresponds to an increasing trend
between the variables while a negative Spearman correlation corresponds to a decreasing
trend.

The Spearman coefficient was chosen instead of the Pearson correlation

coefficient because the Spearman coefficient is less sensitive to strong outliers. Also, the
Spearman coefficient is able to compare two variables related by any monotonic function,
not just linear functions as with the Pearson coefficient.

Figure 2-10 shows the

differences between the two correlation coefficients on hypothetical sample data.

Figure 2-10 - Two examples using hypothetical data to highlight the difference between Spearman and
Pearson coefficients149. Left: The Spearman coefficient is less sensitive to outliers in the data. Right:
Spearman coefficients are even useful on data that follows a non-linear but predictable pattern.

48
To test the repeatability of the sound speed measurements between different users,
intra-class correlation coefficients (ICC) were calculated. The measurements on each
scan by different raters were placed into groups and the ICC is a measure of how strongly
these units resemble each other. Since the true mean sound speed is not known, the
similarity of the sample means calculated by the different raters is measured. However,
the ICC will not be able to differentiate between inter-observer and intra-observer
variability. The ICC used here is usually attributed to Harris150 and is described as:
N
K
ICC =
⋅
K −1

−1

∑ (x
N

n =1

s

2

n

− x)

2

−

1
K −1

Eq. 11

where K is the number of raters, N is the number of scans being compared, x is the
sample mean of all measurements, xn is the sample mean of the nth group and s2 is the
average variance of all measurements.
To test results between different groups, the Student’s t-test was used.

The

independent sample t-test was used to compare two separate sets of independent and
identically distributed samples. For example, when examining a cohort of patients,
differences in the average breast density between pre- and post-menopausal women can
be determined by using the independent sample t-test. A paired sample t-test was used to
test samples of matched pairs and units that were tested twice in order to examine the
effect of a specific treatment. For example, testing the effect of tamoxifen treatment on
breast density was accomplished through the use of a paired sample t-test by comparing
measurements made before treatment began with those made after treatment began.
These t-tests are able to reject or fail to reject the null hypothesis of no change in breast
density.
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The asymmetry of the distribution of the patient data was also measured by
respectively calculating the skewness. This is a descriptor commonly used to describe
the shape of a probability distribution. The skewness of a random variable, X, is the third
standardized moment denoted by γ1 and defined by:

γ1 =

µ3
σ3

Eq. 12

where µ3 is the third moment about the mean and σ is the standard deviation.

A

distribution that is positively skewed is one with a longer right tail with relatively few
high values. A negatively skewed distribution has a longer left tail with relatively few
low values. Figure 2-11 shows examples of hypothetical sample data that is negatively
and positively skewed.

Figure 2-11 – Examples showing negatively skewed (Left) and positively skewed (Right) data using
hypothetical data151.

The data was mostly organized and analyzed using Microsoft Excel.

This

spreadsheet software allowed for easy organization of the data, a wide variety of simple
statistical calculations and the ability to easily create plots. Further analysis using the
data was performed using the open-source statistical software program SOFA Statistics
version 1.2.2. It allowed for the calculation of the Spearman correlation coefficient, the
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calculation of both the independent and paired sample t-tests and the calculation of
skewness.
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CHAPTER 3
VASS VERSUS MPD STUDY
3.1 Patient Recruitment for VASS versus MPD Study
Patient data were acquired from patients recruited into ongoing studies in accord
with a Karmanos Cancer Institute (KCI) and Wayne State University approved protocol.
A population of 251 patients was examined with both the UST device to create sound
speed images of the breast and with either digital or film mammography. The UST
images were analyzed according to the methods described earlier to measure both the
sound speed and cluster results.

The mammograms were digitized and the

mammographic percent density of each patient was analyzed by one reader (NFB) using
the CUMULUS 4 Software. This software allowed for measurements of dense and total
breast area which was then used to calculate the percent density and non-dense areas.
The patient characteristics of the entire group were analyzed and the results are shown
below in Table 3-1.
The patient data could also be sorted into specific groups in order to compare any
potential differences or biases between the groups. These groups are either logical
separation points or known breast cancer risk factors or factors that affect breast density.
These groups are:
1. The type of mammogram received – Digital or Film
2. Menopausal status – Post-menopause or Pre-menopause
3. Race – African-American or White
4. Family history – A first degree relative with breast cancer or no
5. Parity – Nulliparous or Parous
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Table 3-1 – Average Patient Characteristics
Average
Value

Standard
Error

# of
Women

1.4428

0.0016

251

USTPD

17.8

0.6

247

Volume of Dense Tissue (cm3)

478

21

247

Volume of Non-Dense Tissue (cm3)

2737

116

247

Total Volume of Breast Tissue (cm3)

3214

124

247

Average SS of Dense Tissue (km/s)

1.4954

0.0015

247

Average SS of Non-Dense Tissue (km/s)

1.4358

0.0019

247

Mammography Related Characteristics

Average
Value

Standard
Error

# of
Women

MPD

28.0

1.1

251

Dense Area on Mammogram (cm2)

46.2

1.9

249

Fat Area on Mammogram (cm2)

143.2

5.8

251

Total Area on Mammogram (cm2)

189.0

5.8

251

Patient Related Characteristics

Average
Value

Standard
Error

# of
Women

Age of Patient (years)

46.4

0.7

251

Weight of Patient (kg)

79.1

1.1

244

Height of Patient (cm)

163.1

0.4

235

Body Mass Index (kg/m2)

29.7

0.4

233

Age at Menarche (years)

12.6

0.1

211

Age at Birth of First Child (years)

21.5

0.5

171

Age at Menopause (years)

43.9

0.9
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UST Related Characteristics
VASS (km/s)

3.1.1 Patient Characteristics – Type of Mammogram Received
Of the 251 patients that were examined, 85 received a digital mammogram while
166 received a film mammogram that was then digitized. The different mammogram
types used are a result of a transition in mammography hardware at KCI that occurred
during the patient enrollment period.

Table 3-2 summarizes and compares the
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characteristics of the data sets collected from patients that received digital and film
mammography. It enumerates the number of patients in each specific group by category.
It includes mammographic imaging characteristics such as MPD, the total area of dense
tissue as measured on the mammogram, the non-dense area as measured on a
mammogram and the total breast area as measured on the mammogram, UST imaging
characteristics such as the VASS,
volumes.

USTPD and dense, non-dense and total breast

It also includes patient information such as age, weight, height, age at

menarche and menopausal status among others. Chi-squared and independent t-tests
were performed on the data to test for any discrepancies between the categories. Any
differences in the patient characteristics between these two groups should be coincidental
not indicative of any causal relationship.

3.1.2 Patient Characteristics – Menopausal Status
When grouping by menopausal status, 154 women were pre-menopausal, 86 were
post-menopausal and the menopausal status of the remaining 11 women was unknown.
Menopause has a well-known influence on breast density and breast cancer risk, so
mammography and UST-related characteristics could differ by menopausal status. Chisquared and independent t-tests were performed on the data to test for differences by
menopausal status. Table 3-3 summarizes the collected statistics between the pre- and
post-menopausal women. Since the pre-menopausal women obviously have not begun
menopause, their age at menopause could not be calculated and the comparison could not
be completed for this category. The women whose menopausal status was unknown were
also not included in this analysis.

54
Table 3-2 – Patient Characteristics – Type of Mammogram
Count (%) or Mean (SEM)
Digital (n = 85)
Film (n = 166)
26 (31 %)
60 (36 %)
57 (67 %)
97 (58 %)
2 (2 %)
9 (5 %)

Menopausal Status
Post
Pre
Unknown
Race
African-American
55 (65 %)
Unknown/Other
14 (17 %)
White
16 (19 %)
Family History of Cancer
No
63 (74 %)
Unknown
1 (1 %)
Yes
21 (25 %)
Parity
Nulliparous
23 (27 %)
Parous
59 (69 %)
Unknown
3 (3 %)
Mammography Related Characteristics
MPD
25.0 (1.7)
2
Total Area (cm )
192.0 (12.5)
Dense Area (cm2), n=84, 165
38.8 (2.5)
2
Non-Dense Area (cm )
153.7 (12.4)
UST Related Characteristics
VASS (km/s)
1.448 (0.003)
Dense SS (km/s), n=84, 163
1.495 (0.003)
Non-Dense SS (km/s) , n=84, 163
1.438 (0.003)
USTPD, n=84, 163
18.0 (1.1)
3
Total Volume (cm ), n=84, 163
3084 (219)
3
Dense Volume (cm ), n=84, 163
428 (32)
Non-Dense Volume (cm3), n=84, 163
2656 (206)
Patient Related Characteristics
Age (years)
44.5 (1.2)
Height (m), n=82, 153
1.63 (0.01)
Weight (kg), n=84, 160
74.4 (1.8)
BMI, n=82, 152
28.3 (0.7)
Age at Menarche (years), n=79, 132
12.3 (0.2)
Age at First Birth (years), n=59, 112
21.6 (0.7)
Age at Menopause (years), n=17, 35
42.8 (1.7)
a

Pa
0.302

106 (64 %)
29 (18 %)
31 (19 %)

0.980

106 (64 %)
29 (18 %)
31 (19 %)

< 0.001

22 (13 %)
113 (68 %)
31 (19 %)

< 0.001

29.5 (1.3)
187.5 (6.0)
49.9 (2.5)
137.9 (6.0)

0.043
0.713
0.006
0.197

1.440 (0.002)
1.496 (0.002)
1.435 (0.003)
17.7 (0.7)
3281 (151)
503 (27)
2778 (139)

0.210
0.693
0.417
0.778
0.453
0.088
0.617

47.4 (0.8)
1.63 (0.01)
81.6 (1.3)
30.3 (0.5)
12.7 (0.2)
21.4 (0.6)
44.4 (1.1)

0.036
0.471
0.001
0.024
0.127
0.885
0.428

P is a p-value from the chi-squared test for menopausal status, race, family history and parity; two sample
independent t-test for all Mammography, UST and Patient related characteristics.
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Table 3-3 – Patient Characteristics – Menopausal Status

a

Mammogram
Digital
Film
Race
African-American
Unknown/Other
White
Family History of Cancer
No
Unknown
Yes
Parity
Nulliparous
Parous
Unknown
Mammography Related Characteristics
MPD
Total Area (cm2)
Dense Area (cm2), n=84, 154
Non-Dense Area (cm2)
UST Related Characteristics
VASS (km/s)
Dense SS (km/s), n=85, 151
Non-Dense SS (km/s) , n=85, 151
USTPD, n=85, 151
Total Volume (cm3), n=85, 151
Dense Volume (cm3), n=85, 151
Non-Dense Volume (cm3), n=85, 151
Patient Related Characteristics
Age (years)
Height (m), n=82, 146
Weight (kg), n=85, 150
BMI, n=82, 145
Age at Menarche (years), n=78, 130
Age at First Birth (years), n=66, 101
Age at Menopause (years)

Count (%) or Mean (SEM)
Pa
Post (n = 86)
Pre (n = 154)
26 (30 %)
57 (37 %)
0.290
60 (70 %)
97 (63 %)
54 (63 %)
15 (17 %)
17 (20 %)

102 (66 %)
26 (17 %)
26 (17 %)

0.832

64 (74%)
7 (8 %)
15 (17 %)

102 (66 %)
16 (10 %)
36 (23 %)

0.419

10 (12 %)
66 (77 %)
10 (12 %)

34 (22 %)
102 (66 %)
18 (12 %)

0.125

23.8 (1.8)
204.3 (10.8)
42.3 (3.2)
163.0 (11.0)

30.1 (1.4)
181.2 (6.9)
48.0 (2.5)
133.2 (6.8)

0.005
0.062
0.165
0.016

1.435 (0.002)
1.490 (0.003)
1.429 (0.003)
15.7 (1.0)
3558 (229)
468 (38)
3091 (212)

1.447 (0.002)
1.498 (0.002)
1.439 (0.002)
18.6 (0.8)
3065 (152)
477 (24)
2588 (141)

< 0.001
0.016
0.012
0.025
0.064
0.828
0.042

56.0 (1.0)
1.62 (0.01)
78.5 (1.8)
29.8 (0.6)
12.5 (0.2)
20.6 (0.6)
N/A

40.9 (0.6)
1.63 (0.01)
79.3 (1.4)
29.5 (0.6)
12.6 (0.2)
21.8 (0.6)
N/A

< 0.001
0.320
0.735
0.794
0.562
0.196
N/A

P is a p-value from the chi-squared test for mammogram, race, family history and parity; two sample
independent t-test for all Mammography, UST and Patient related characteristics.
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3.1.3 Patient Characteristics – Race
The race statistics of the cohort reflect those of the local general population. The
metropolitan Detroit area in southeast Michigan is a predominantly African-American
region and this is reflected in the enrollment. Of the 251 patients, there were 161
African-Americans, 47 White and 43 women who were another race or whose race was
unknown. This last group of women was excluded in this section of the analysis. Table
3-4 shows the statistical breakdown by race and several important mammographic and
UST-related statistics along with the results of chi-squared and independent t-tests. The
use of UST could be useful in clarifying the uncertain relationship between race and
breast density.

3.1.4 Patient Characteristics – Family History of Breast Cancer
Family history of breast cancer is another well-known breast cancer risk factor.
Of the 251 patients, 169 had no family history of the disease while 52 patients had a first
degree relative with breast cancer. A further 30 patients were unaware if they had a
family member with cancer and they were excluded in this analysis. The mammography
and UST results are shown below in Table 3-5. Since family history is a breast cancer
risk factor, breast density should be greater for women with a family history of breast
cancer. An increase in density could be a factor that causes an increased risk of breast
cancer for those with a family history.
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Table 3-4 – Patient Characteristics – Race

Mammogram
Digital
Film
Menopausal Status
Post
Pre
Unknown
Family History of Cancer
No
Unknown
Yes
Parity
Nulliparous
Parous
Unknown
Mammography Related Characteristics
MPD
Total Area (cm2)
Dense Area (cm2), n=160, 47
Non-Dense Area (cm2)
UST Related Characteristics
VASS (km/s)
Dense SS (km/s), n=157, 47
Non-Dense SS (km/s) , n=157, 47
USTPD, n=157, 47
Total Volume (cm3), n=157, 47
Dense Volume (cm3), n=157, 47
Non-Dense Volume (cm3), n=157, 47
Patient Related Characteristics
Age (years)
Height (m), n=151, 44
Weight (kg), n=159, 44
BMI, n=151, 43
Age at Menarche (years), n=131, 41
Age at First Birth (years), n=106, 33
Age at Menopause (years), n=32, 11
a

Count (%) or Mean (SEM)
AA (n = 161)
White (n = 47)
Pa
55 (34 %)
16 (34 %)
0.988
106 (66 %)
31 (66 %)
54 (34 %)
102 (63 %)
5 (3 %)

17 (36 %)
26 (55 %)
4 (9 %)

0.233

104 (65 %)
23 (14 %)
34 (21 %)

31 (66 %)
5 (11 %)
11 (23 %)

0.795

27 (17 %)
106 (66 %)
28 (17 %)

10 (21 %)
33 (70 %)
4 (9 %)

0.304

29.2 (1.4)
197.9 (7.6)
50.5 (2.6)
147.7 (7.6)

25.1 (2.1)
174.5 (12.4)
37.4 (2.9)
137.1 (12.4)

0.154
0.134
0.011
0.497

1.444 (0.002)
1.496 (0.002)
1.437 (0.002)
18.3 (0.8)
3463 (163)
527 (29)
2936 (152)

1.438 (0.003)
1.491 (0.003)
1.432 (0.003)
16.1 (1.2)
2587 (234)
339 (25)
2248 (223)

0.187
0.198
0.274
0.188
0.008
< 0.001
0.025

46.1 (0.8)
1.63 (0.01)
80.0 (1.3)
30.0 (0.5)
12.4 (0.2)
20.6 (0.6)
43.8 (1.1)

46.3 (1.7)
1.63 (0.01)
79.5 (2.9)
29.7 (1.0)
12.7 (0.3)
24.0 (0.9)
43.4 (2.4)

0.873
0.910
0.858
0.790
0.375
0.003
0.836

P is a p-value from the chi-squared test for mammogram, menopause status, family history and parity; two
sample independent t-test for all Mammography, UST and Patient related characteristics.
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Table 3-5 – Patient Characteristics – Family History of Breast Cancer

Mammogram
Digital
Film
Menopausal Status
Post
Pre
Unknown
Race
African-American
Unknown/Other
White
Parity
Nulliparous
Parous
Unknown
Mammography Related Characteristics
MPD
Total Area (cm2)
Dense Area (cm2), n=169, 50
Non-Dense Area (cm2)
UST Related Characteristics
VASS (km/s)
Dense SS (km/s), n=166, 51
Non-Dense SS (km/s), n=166, 51
USTPD, n=166, 51
Total Volume (cm3), n=166, 51
Dense Volume (cm3), n=166, 51
Non-Dense Volume (cm3), n=166, 51
Patient Related Characteristics
Age (years)
Height (m), n=165, 51
Weight (kg), n=166, 51
BMI, n=164, 50
Age at Menarche (years), n=158, 51
Age at First Birth (years), n=127, 41
Age at Menopause (years), n=38, 10
a

Count (%) or Mean (SEM)
Positive Family
No History (n = 169)
History (n = 52)
63 (37 %)
21 (40 %)
106 (63 %)
31 (60 %)

Pa
0.687

64 (38 %)
102 (60 %)
3 (2 %)

15 (29 %)
36 (69 %)
1 (2%)

0.494

104 (62 %)
34 (20 %)
31 (18 %)

34 (65 %)
7 (14 %)
11 (21 %)

0.546

34 (20 %)
128 (76 %)
7 (4 %)

11 (21 %)
41 (79 %)
0 (0 %)

0.329

27.3 (1.3)
188.5 (7.4)
43.0 (2.0)
145.6 (7.5)

29.8 (2.4)
179.8 (10.9)
49.1 (4.1)
132.6 (11.1)

0.347
0.554
0.152
0.383

1.444 (0.002)
1.496 (0.002)
1.438 (0.002)
17.2 (0.7)
3155 (152)
438 (23)
2718 (144)

1.445 (0.004)
1.500 (0.003)
1.438 (0.005)
19.8 (1.3)
3070 (290)
509 (44)
2561 (265)

0.824
0.279
0.962
0.101
0.789
0.139
0.600

46.7 (0.8)
1.63 (0.01)
77.7 (1.3)
29.4 (0.5)
12.6 (0.2)
21.4 (0.5)
44.4 (1.1)

45.5 (1.4)
1.63 (0.01)
80.0 (2.6)
30.1 (1.0)
12.4 (0.3)
21.6 (0.8)
42.1 (2.1)

0.481
0.778
0.401
0.471
0.403
0.811
0.315

P is a p-value from the chi-squared test for mammogram, menopause status, race and parity; two sample
independent t-test for all Mammography, UST and Patient related characteristics.
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Table 3-6 – Patient Characteristics – Parity

a

Mammogram
Digital
Film
Menopausal Status
Post
Pre
Unknown
Race
African-American
Unknown/Other
White
Family History of Cancer
No
Unknown
Yes
Mammography Related Characteristics
MPD
Total Area (cm2)
Dense Area (cm2), n=45, 170
Non-Dense Area (cm2)
UST Related Characteristics
VASS (km/s)
Dense SS (km/s), n=45, 168
Non-Dense SS (km/s), n=45, 168
USTPD, n=45, 168
Total Volume (cm3), n=45, 168
Dense Volume (cm3), n=45, 168
Non-Dense Volume (cm3), n=45, 168
Patient Related Characteristics
Age (years)
Height (m), n=45, 168
Weight (kg), n=45, 168
BMI, n=45, 166
Age at Menarche (years), n=43, 166
Age at First Birth (years)
Age at Menopause (years), n=6, 42

Count (%) or Mean (SEM)
Nulliparous (n = 45)
Parous (n = 172)
23 (51 %)
59 (34 %)
22 (49 %)
113 (66 %)

Pa
0.038

10 (22 %)
34 (76 %)
1 (2 %)

66 (38 %)
102 (59 %)
4 (2 %)

0.125

27 (60 %)
8 (18 %)
10 (22 %)

106 (62 %)
33 (19 %)
33 (19 %)

0.896

34 (76 %)
0 (0 %)
11 (24 %)

128 (74 %)
3 (2 %)
41 (24 %)

0.671

29.9 (2.5)
180.5 (17.5)
42.3 (3.6)
137.8 (17.3)

27.3 (1.3)
188.2 (6.6)
44.6 (2.1)
144.1 (6.7)

0.345
0.622
0.668
0.691

1.449 (0.004)
1.500 (0.004)
1.441 (0.005)
19.6 (1.5)
2778 (301)
413 (34)
2365 (285)

1.443 (0.002)
1.495 (0.002)
1.437 (0.002)
17.4 (0.7)
3203 (150)
463 (25)
2739 (140)

0.138
0.185
0.333
0.166
0.198
0.328
0.226

42.4 (1.6)
1.62 (0.01)
77.0 (2.9)
29.5 (1.1)
11.7 (0.2)
N/A
46.0 (1.9)

47.1 (0.8)
1.63 (0.01)
79.3 (1.3)
29.8 (0.5)
12.8 (0.2)
N/A
43.7 (1.0)

0.008
0.273
0.438
0.766
0.002
N/A
0.417

P is a p-value from the chi-squared test for mammogram, menopause status, race and family history; two
sample independent t-test for all Mammography, UST and Patient related characteristics.
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3.1.5 Patient Characteristics – Parity
Parity is a factor in women that affects their hormonal levels and therefore could
potentially have an effect on their breast densities. Of the 251 patients, 45 women were
nulliparous (gave birth to no children) while 172 were parous (gave birth to at least one
child). The parity of the final 34 women was not known and their results were not
included in this analysis. Table 3-6 shows the mammographic and UST image analysis
along with other patient characteristics. The nulliparous women have not given birth to a
child, so calculating their age at first birth is obviously impossible. This category was
therefore omitted from the analysis as well.

3.2 Distribution of Density Measurements
The frequency distributions for density measurements by both imaging modalities
were also calculated and shown below in Figure 3-1. Each plot also includes a normal
distribution overlaid on the measured data that uses the calculated mean and standard
deviation. To examine the effect that the mammogram type had, they were separated
accordingly. VASS and MPD are both positively skewed, but sound speed measurements
are more strongly skewed than MPD measurements. The VASS is more sharply peaked
around a value of 1.43-1.44 km/s while the MPD distribution is more uniformly spread
out but still biased towards lower densities.

3.2.1 Distribution of Mammographic Imaging Characteristics
Figure 3-2 shows the frequency distributions for many other imaging
characteristics related to mammography. It shows the distribution of dense area, nondense area and total area separated by mammogram type. Once again, on each plot, a
normal distribution is overlaid on top of the data that was created using the calculated
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mean and standard deviation for each value.

Like the overall MPD and VASS

measurements, the mammography characteristics are positively skewed.

All values

appear to be peaked more towards the lower values. The digital data appears to be more
skewed than the film data.
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Figure 3-1 - Frequency distributions for the sound speed (VASS) and MPD measurements grouped by
mammography type (bars). A normal distribution using the measured mean and standard deviation is
overlayed on top of the data. For film distributions (Left), n = 166; for digital distributions (Right), n = 85.
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Figure 3-2 - Frequency distributions showing mammographic area measurements separated by
mammogram type. A normal distribution is overlaid on each plot that was created by using the calculated
mean and standard deviation. For film distributions (Left), n = 166; for digital distributions (Right), n = 85.
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3.2.2 Distribution of UST Imaging Characteristics
Frequency distributions for the UST imaging characteristics were calculated and
are plotted below in Figure 3-3. Since the UST characteristics were not dependent on the
type of mammogram, the distributions were calculated for the entire population, n = 247.
All distributions were positively skewed, with lower values being more common. The
volume of dense tissue was the most heavily skewed, with the other volume measures
and USTPD being skewed roughly the same amount. In all plots, a normal distribution
was also fit using the measured mean and standard deviations.
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Figure 3-3 - Frequency distributions for the UST imaging characteristics for all patients with a normal
distribution created by using the calculated mean and standard deviation. For all distributions, n = 247.
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3.3 Correlations of VASS and MPD
Correlations involving the sound speed measurements and mammographic
percent density were also completed using the Spearman correlation coefficient. The two
different methods of calculating density, VASS and MPD, were related to many of the
patient factors that were discussed above. Table 3-7 shows these correlations for the
entire patient data grouped together. Grouping the data according to the groups listed
before (mammogram type, menopausal status, race, family history of breast cancer and
parity) was also done to see if the sub-groups showed stronger or weaker trends than the
overall groups. Although there are a total of 251 patients, not all categories have data for
all patients.
The strongest correlations exist between both the density measurements and many
of the imaging characteristics. Strong and positive correlations are found for both VASS
and MPD with USTPD, average speed of both dense and non-dense tissue and the
mammographic area of dense tissue. Strong and negative correlations are found for both
VASS and MPD with non-dense and total breast volume and mammographic area. There
was no strong correlation found between the density measurements and total dense tissue
volume however. All other patient characteristics showed weaker correlations. Age,
weight and BMI were found to be moderately and negatively correlated with both density
measurements, although the correlation between age and MPD was the weakest. All
other characteristics were found to have no strong correlation or were not statistically
significant.
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Table 3-7 – VASS and MPD Correlations for All Patients
Spearman Coefficient (p-value)
VASS Correlated
With:

MPD Correlated
With:

MPD, n=251

0.726 (<0.001)

N/A

USTPD, n=247

0.647 (<0.001)

0.648 (<0.001)

Volume of Dense Tissue (cm3) , n=247

0.070 (0.273)

0.085 (0.185)

Volume of Non-Dense Tissue (cm3), n=247

-0.553 (<0.001)

-0.568 (<0.001)

Total Volume of Breast Tissue (cm3), n=247

-0.497 (<0.001)

-0.509 (<0.001)

Average SS of Dense Tissue (km/s), n=247

0.765 (<0.001)

0.651 (<0.001)

Average SS of Non-Dense Tissue (km/s), n=247

0.837 (<0.001)

0.642 (<0.001)

Dense Area on Mammogram (cm2), n=249

0.431 (<0.001)

0.731 (<0.001)

Fat Area on Mammogram (cm2), n=251

-0.649 (<0.001)

-0.757 (<0.001)

Total Area on Mammogram (cm2), n=251

-0.472 (<0.001)

-0.477 (<0.001)

Age of Patient (years), n=251

-0.314 (<0.001)

-0.167 (0.008)

Weight of Patient (kg), n=244

-0.440 (<0.001)

-0.402 (<0.001)

Height of Patient (cm), n=235

-0.052 (0.425)

-0.066 (0.311)

Body Mass Index (BMI), n=233

-0.441 (<0.001)

-0.382 (<0.001)

Age at Menarche (years), n=211

0.111 (0.106)

0.161 (0.020)

Age at Birth of First Child (years), n=171

0.013 (0.863)

0.104 (0.176)

Age at Menopause (years), n=52

0.056 (0.691)

0.118 (0.405)

A direct comparison between the two different imaging modalities is the
comparison of the VASS and MPD. Both these values are representations of the same
quantity, breast density, but expressed in two different methods. VASS is a volumetric
and quantitative analysis of the density, while MPD is the standard method, but a twodimensional assessment. The plot of VASS versus MPD for all the patients is shown
below in Figure 3-4. The Spearman correlation coefficient between these two values was
found to be rs = 0.726 (p-value < 0.001). This is a strong correlation and it suggests that
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measurement of breast density using the VASS and UST is comparable to the
measurement of density using mammography and MPD.
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Figure 3-4 - Plot of volume averaged sound speed (VASS) as measured by UST compared to the
mammographic percent density (MPD) as measured by mammography for all patients, n = 251.

3.3.1 Correlations of VASS and MPD – Type of Mammogram
The data were once again separated into groups and the correlations between both
VASS and MPD were recalculated. Table 3-8 shows these correlations for patients
grouped by the type of mammogram that was received. These correlations could show
whether or not there is any systematic difference between digital and film
mammography. Any differences between the types of mammogram are likely to only be
evident when comparing the correlations involving the MPD. The type of image receptor
used may affect the measurement of the percent density, so only the correlations
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involving MPD are considered.

Of the 251 patients enrolled, 166 received a film

mammogram and 85 received a digital mammogram.
Table 3-8 – MPD Correlations – Type of Mammogram
Spearman Correlation Coefficient
(p-value)
MPD Correlated With:

Film

Digital

VASS, n=166, 85

0.794 (< 0.001)

0.706 (< 0.001)

USTPD, n=163, 84

0.608 (< 0.001)

0.747 (< 0.001)

0.064 (0.416)

0.104 (0.346)

Volume of Non-Dense Tissue (cm3), n=163, 84

-0.549 (< 0.001)

-0.642 (< 0.001)

Total Breast Volume (cm3), n=163, 84

-0.485 (< 0.001)

-0.585 (< 0.001)

SS of Dense Tissue (km/s), n=163, 84

0.662 (< 0.001)

0.624 (< 0.001)

SS of Non-Dense Tissue (km/s), n=163,84

0.687 (< 0.001)

0.607 (< 0.001)

Area of Dense Tissue (cm2), n=165, 84

0.755 (< 0.001)

0.612 (< 0.001)

Area of Non-Dense Tissue (cm2), n=166, 85

-0.774 (< 0.001)

-0.764 (< 0.001)

Total Breast Area (cm2), n=166, 85

-0.436 (< 0.001)

-0.576 (< 0.001)

Age (years), n=166, 85

-0.253 (< 0.001)

-0.057 (0.605)

Weight (kg), n=160, 84

-0.393 (< 0.001)

-0.529 (< 0.001)

Height (cm), n=153, 82

-0.134 (0.099)

0.055 (0.624)

-0.344 (< 0.001)

-0.567 (< 0.001)

Age at Start of Menarche (years), n=132, 79

0.116 (0.186)

0.191 (0.091)

Age at Birth of First Child (years), n=112, 59

0.136 (0.154)

0.033 (0.807)

Age at Start of Menopause (years), n=35, 17

0.104 (0.554)

0.178 (0.495)

Volume of Dense Tissue (cm3), n=163, 84

Body Mass Index (BMI), n=151, 82

When separating by mammogram group, the same general trends hold overall.
The strongest correlations once again are between the density measurements and the
different imaging characteristics with the exception of the volume of dense tissue. Most
of the correlations are of similar strength between the two different types of
mammography, with a few small exceptions. Digital MPD had a stronger correlation
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with USTPD when compared to the film measurements (rs of 0.747 compared to rs of
0.608). Dense area correlated to MPD more strongly on film than on digital images (rs of
0.755 compared to rs of 0.612). Most of the non-imaging characteristics showed weak or
statistically insignificant results. Age, weight and BMI all showed negative and moderate
correlations with density measurements made by both types of mammography once
again.
The plot of VASS versus MPD for patients receiving film and digital
mammograms is shown in Figure 3-5. The Spearman correlation coefficients for the
plots are 0.794 for patients that received a film mammogram and 0.706 for patients that
received a digital mammogram. This indicates that a strong and positive correlation
between VASS and MPD exists.

The correlation is slightly stronger for film

mammography than it is for digital mammography. The relationship between VASS and
MPD appears to be more curvilinear for the film mammograms than it is for the digital
mammograms. This may be due to the x-ray response of the detector being used. Film
detectors show a sigmoidal response to x-rays while digital detectors have a linear
response.
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Figure 3-5 - Plots of the UST measured sound speed versus the mammographic percent density grouped
according to the type of mammogram received. Top: Film, n = 166; Bottom: Digital, n = 85
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Some studies152 have also suggested that the relationship between a volumetric(VASS) and area-based (MPD) density measurement may in fact be curvilinear. This
was tested here by performing both linear and non-linear regression on the data. A
slightly stronger fit was observed when using a 2nd degree polynomial compared to a
linear fit. For patients receiving digital mammograms, the R2 value increased to 0.640
from 0.630 when moving to a 2nd degree polynomial from a linear fit, while the R2 value
increased to 0.606 from 0.542 for patients that received a film mammogram. The effect
was stronger for patients that received a film mammogram, which suggests that the x-ray
response of film may be the reason. For film mammograms, the sound speed shows a
narrow range for patients with low MPD’s. For patients with an MPD of less than ~35%,
the sound speed has a range of about 1.42 to 1.44 km/s. The range is much wider for
MPD’s greater than 35%, ranging from 1.44 km/s to 1.52 km/s. The digital response is
much more linear, so this further suggests the detector x-ray response is responsible for
the shape of the curve.

3.3.2 Correlations of VASS and MPD – Menopausal Status
The data were grouped according to menopausal status and correlations were then
performed. Since menopausal status is known to affect breast density and breast cancer
risk, it may also affect the strength of the correlations. Of the 251 patients enrolled, 86
were post-menopausal and 154 were pre-menopausal. The menopausal status of the
remaining women was not known and was not included in this analysis. Table 3-9 shows
the correlations between the patient characteristics and both density measurements
grouped by menopausal status.

Since pre-menopausal women have obviously not

reached menopause, the correlation with age at menopause could not be calculated.
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Table 3-9 – VASS and MPD Correlations – Menopausal Status

VASS Correlated With:
MPD, n=86, 154
USTPD, n=85, 151
Volume of Dense Tissue (cm3), n=85, 151
Volume of Non-Dense Tissue (cm3), n=85, 151
Total Breast Volume (cm3), n=85, 151
SS of Dense Tissue (km/s), n=85, 151
SS of Non-Dense Tissue (km/s), n=85, 151
Area of Dense Tissue (cm2), n=84, 154
Area of Non-Dense Tissue (cm2), n=86, 154
Total Breast Area (cm2), n=86, 154
Age (years), n=86, 154
Weight (kg), n=85, 150
Height (cm), n=82, 146
Body Mass Index (BMI), n=82, 144
Age at Menarche (years), n=78, 130
Age at Birth of First Child (years), n=66, 101
Age at Menopause (years), n=52
MPD Correlated With:
USTPD, n=85, 151
Volume of Dense Tissue (cm3), n=85, 151
Volume of Non-Dense Tissue (cm3), n=85, 151
Total Breast Volume (cm3), n=85, 151
SS of Dense Tissue (km/s), n=85, 151
SS of Non-Dense Tissue (km/s), n=85, 151
Area of Dense Tissue (cm2), n=84, 154
Area of Non-Dense Tissue (cm2), n=86, 154
Total Breast Area (cm2), n=86, 154
Age (years), n=86, 154
Weight (kg), n=85, 150
Height (cm), n=82, 146
Body Mass Index (BMI), n=82, 144
Age at Menarche (years), n=78, 130
Age at Birth of First Child (years), n=66, 101
Age at Menopause (years), n=52

Spearman Correlation Coefficient
(p-value)
Post
Pre
0.669 (< 0.001)
0.727 (< 0.001)
0.612 (< 0.001)
0.682 (< 0.001)
0.142 (0.196)
-0.036 (0.661)
-0.499 (< 0.001)
-0.629 (< 0.001)
-0.430 (< 0.001)
-0.581 (< 0.001)
0.665 (< 0.001)
0.779 (< 0.001)
0.689 (< 0.001)
0.898 (< 0.001)
0.464 (< 0.001)
0.387 (< 0.001)
-0.585 (< 0.001)
-0.686 (< 0.001)
-0.410 (< 0.001)
-0.514 (< 0.001)
-0.140 (0.198)
-0.110 (0.174)
-0.295 (0.006)
-0.562 (< 0.001)
-0.007 (0.951)
-0.118 (0.156)
-0.303 (0.006)
-0.536 (< 0.001)
0.134 (0.242)
0.106 (0.230)
-0.070 (0.578)
0.045 (0.653)
0.056 (0.691)
N/A
0.638 (< 0.001)
0.076 (0.490)
-0.571 (< 0.001)
-0.508 (< 0.001)
0.576 (< 0.001)
0.560 (< 0.001)
0.800 (< 0.001)
-0.758 (< 0.001)
-0.495 (< 0.001)
-0.178 (0.101)
-0.315 (0.003)
-0.008 (0.946)
-0.323 (0.003)
0.226 (0.047)
0.135 (0.279)
0.118 (0.405)

0.616 (< 0.001)
0.029 (0.724)
-0.571 (< 0.001)
-0.522 (< 0.001)
0.670 (< 0.001)
0.673 (< 0.001)
0.688 (< 0.001)
-0.755 (< 0.001)
-0.466 (< 0.001)
0.020 (0.801)
-0.459 (< 0.001)
-0.125 (0.134)
-0.404 (< 0.001)
0.123 (0.163)
0.046 (0.646)
N/A
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Figure 3-6 - Plot of sound speed versus mammographic density grouped by menopause status. Top: Postmenopausal women, n = 86; Bottom: Pre-menopausal women, n = 154.
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The same general trends remain the same for these groups.

The strongest

correlations exist between both density measurements and the imaging characteristics
with the exception of the volume of dense tissue, which shows a statistically irrelevant
correlation. Of the patient-specific characteristics, age, weight and BMI show moderate
correlations with all other factors either showing no relation or are statistically uncertain.
When comparing the two groups, most of the correlations involving the VASS are
stronger for the pre-menopausal women. For the correlations involving MPD, both
groups tend to show correlations of similar strength. The plot of the VASS versus the
MPD is shown below in Figure 3-6 for both groups. Both groups are mixed with patients
who received film and digital mammograms; the plot relating the two density
measurements is not linear.

3.3.3 Correlations of VASS and MPD – Race
The data were then grouped according to race and the correlations were
performed once again on both density measurements. Table 3-10 shows the results of
these correlations for African-American and white patients. The same trends that existed
for all the data show themselves when grouped by race. Strong correlations between the
density measurements and imaging characteristics exist while moderate correlations exist
with the same patient related characteristics. There is little to no difference in the
strength of the correlations between races. Figure 3-7 shows the correlation between
VASS and MPD grouped by race.
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Table 3-10 – VASS and MPD Correlations – Race

VASS Correlated With:
MPD, n=161, 47
USTPD, n=157, 47
Volume of Dense Tissue (cm3), n=157, 47
Volume of Non-Dense Tissue (cm3), n=157, 47
Total Breast Volume (cm3), n=157, 47
SS of Dense Tissue (km/s), n=157, 47
SS of Non-Dense Tissue (km/s), n=157, 47
Area of Dense Tissue (cm2), n=160, 47
Area of Non-Dense Tissue (cm2), n=161, 47
Total Breast Area (cm2), n=161, 47
Age (years), n=161, 47
Weight (kg), n=159, 44
Height (cm), n=151, 44
Body Mass Index (BMI), n=151, 43
Age at Menarche (years), n=131, 41
Age at Birth of First Child (years), n=106, 33
Age at Menopause (years), n=32, 11
MPD Correlated With:
USTPD, n=157, 47
Volume of Dense Tissue (cm3), n=157, 47
Volume of Non-Dense Tissue (cm3), n=157, 47
Total Breast Volume (cm3), n=157, 47
SS of Dense Tissue (km/s), n=157, 47
SS of Non-Dense Tissue (km/s), n=157, 47
Area of Dense Tissue (cm2), n=160, 47
Area of Non-Dense Tissue (cm2), n=161, 47
Total Breast Area (cm2), n=161, 47
Age (years), n=161, 47
Weight (kg), n=159, 44
Height (cm), n=151, 44
Body Mass Index (BMI), n=151, 43
Age at Menarche (years), n=131, 41
Age at Birth of First Child (years), n=106, 33
Age at Menopause (years), n=32, 11

Spearman Correlation Coefficient
(p-value)
African-American
White
0.720 (< 0.001)
0.706 (< 0.001)
0.673 (< 0.001)
0.517 (< 0.001)
0.057 (0.481)
0.131 (0.379)
-0.578 (< 0.001)
-0.435 (0.002)
-0.521 (< 0.001)
-0.411 (0.004)
0.759 (< 0.001)
0.782 (< 0.001)
0.842 (< 0.001)
0.814 (< 0.001)
0.400 (< 0.001)
0.460 (0.001)
-0.678 (< 0.001)
-0.567 (< 0.001)
-0.500 (< 0.001)
-0.391 (0.007)
-0.296 (< 0.001)
-0.236 (0.110)
-0.453 (< 0.001)
-0.445 (0.002)
-0.018 (0.823)
-0.128 (0.406)
-0.447 (< 0.001)
-0.453 (0.002)
0.087 (0.323)
0.291 (0.065)
-0.085 (0.386)
0.376 (0.031)
0.035 (0.849)
-0.350 (0.291)
0.665 (< 0.001)
0.097 (0.228)
-0.566 (< 0.001)
-0.503 (< 0.001)
0.647 (< 0.001)
0.644 (< 0.001)
0.734 (< 0.001)
-0.749 (< 0.001)
-0.441 (< 0.001)
-0.157 (0.046)
-0.409 (< 0.001)
-0.015 (0.856)
-0.387 (< 0.001)
0.158 (0.071)
0.028 (0.774)
0.118 (0.521)

0.535 (< 0.001)
0.098 (0.513)
-0.494 (< 0.001)
-0.476 (< 0.001)
0.569 (< 0.001)
0.603 (< 0.001)
0.706 (< 0.001)
-0.770 (< 0.001)
-0.559 (< 0.001)
0.047 (0.752)
-0.480 (< 0.001)
-0.088 (0.572)
-0.511 (< 0.001)
0.214 (0.179)
0.454 (0.008)
-0.198 (0.560)
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Figure 3-7 - Sound speed versus mammographic density as grouped by race. Top: African-American, n =
161; Bottom: White, n = 47
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3.3.4 Correlations of VASS and MPD – Family History of Breast Cancer
Family history of breast cancer is a known risk factor for breast cancer and it is
included in the Gail model. Examining the effect of family history was accomplished by
calculating the correlations between the density measurements and the various imaging
and patient characteristics while grouping patients with a family history and those
without. Table 3-11 shows these results. The same overall trends exist once again. The
strongest correlations involve the density measurements with the imaging characteristics
while the select patient characteristics show moderate correlations. However, patients
with a family history of breast cancer tend to show weaker correlations than those
without a family history, especially for measurements made with UST. Figure 3-8 shows
the plot of the VASS versus MPD grouped by family history.

3.3.5 Correlations of VASS and MPD – Parity
When a woman carries a pregnancy to full term, the hormones associated with
this event can affect breast density and breast cancer risk. To see if this change is evident
when measuring density, the correlations were performed but grouped according to the
parity. Table 3-12 shows these results. The trends involving the imaging and patient
characteristics generally behave as before. However, correlations between VASS and the
various UST imaging characteristics tended to be stronger for the women who have not
given birth (nulliparous). Figure 3-9 shows the plots of the VASS versus the MPD
grouped by parity.
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Table 3-11 – VASS and MPD Correlations – Family History of Breast Cancer

VASS Correlated With:
MPD, n=52, 169
USTPD, n=51, 166
Volume of Dense Tissue (cm3), n=51, 166
Volume of Non-Dense Tissue (cm3), n=51, 166
Total Breast Volume (cm3), n=51, 166
SS of Dense Tissue (km/s), n=51, 166
SS of Non-Dense Tissue (km/s), n=51, 166
Area of Dense Tissue (cm2), n=50, 169
Area of Non-Dense Tissue (cm2), n=52, 169
Total Breast Area (cm2), n=52, 169
Age (years), n=52, 169
Weight (kg), n=51, 166
Height (cm), n=51, 165
Body Mass Index (BMI), n=50, 164
Age at Menarche (years), n=51, 158
Age at Birth of First Child (years), n=41, 127
Age at Menopause (years), n=10, 38
MPD Correlated With:
USTPD, n=51, 166
Volume of Dense Tissue (cm3), n=51, 166
Volume of Non-Dense Tissue (cm3), n=51, 166
Total Breast Volume (cm3), n=51, 166
SS of Dense Tissue (km/s), n=51, 166
SS of Non-Dense Tissue (km/s), n=51, 166
Area of Dense Tissue (cm2), n=50, 169
Area of Non-Dense Tissue (cm2), n=52, 169
Total Breast Area (cm2), n=52, 169
Age (years), n=52, 169
Weight (kg), n=51, 166
Height (cm), n=51, 165
Body Mass Index (BMI), n=50, 164
Age at Menarche (years), n=51, 158
Age at Birth of First Child (years), n=41, 127
Age at Menopause (years), n=10, 38

Spearman Correlation Coefficient
(p-value)
Family History
No History
0.603 (< 0.001)
0.769 (< 0.001)
0.567 (< 0.001)
0.707 (< 0.001)
0.021 (0.884)
0.104 (0.183)
-0.530 (< 0.001)
-0.602 (< 0.001)
-0.474 (< 0.001)
-0.543 (< 0.001)
0.656 (< 0.001)
0.792 (< 0.001)
0.712 (< 0.001)
0.900 (< 0.001)
0.256 (0.073)
0.484 (< 0.001)
-0.652 (< 0.001)
-0.671 (< 0.001)
-0.509 (< 0.001)
-0.507 (< 0.001)
-0.246 (0.079)
-0.339 (< 0.001)
-0.388 (0.005)
-0.463 (< 0.001)
-0.198 (0.163)
0.019 (0.813)
-0.329 (0.020)
-0.492 (< 0.001)
0.122 (0.395)
0.129 (0.106)
0.048 (0.765)
0.009 (0.919)
0.218 (0.545)
0.053 (0.751)
0.612 (< 0.001)
0.186 (0.191)
-0.460 (< 0.001)
-0.386 (0.005)
0.703 (< 0.001)
0.504 (< 0.001)
0.724 (< 0.001)
-0.763 (< 0.001)
-0.448 (< 0.001)
-0.099 (0.486)
-0.322 (0.021)
-0.190 (0.182)
-0.271 (0.057)
0.239 (0.091)
0.105 (0.514)
0.321 (0.365)

0.680 (< 0.001)
0.038 (0.623)
-0.646 (< 0.001)
-0.594 (< 0.001)
0.660 (< 0.001)
0.731 (< 0.001)
0.730 (< 0.001)
-0.785 (< 0.001)
-0.552 (< 0.001)
-0.177 (0.022)
-0.475 (< 0.001)
-0.004 (0.962)
-0.484 (< 0.001)
0.156 (0.050)
0.098 (0.271)
0.133 (0.425)
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Figure 3-8 - Sound speed versus mammographic percent density for women grouped by family history of
breast cancer. Top: Women with a family history of the disease, n = 52; Bottom: Women with no family
history of the disease, n = 169
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Table 3-12 – VASS and MPD Correlations – Parity

VASS Correlated With
MPD, n=172, 45
USTPD, n=168, 45
Volume of Dense Tissue (cm3), n=168, 45
Volume of Non-Dense Tissue (cm3), n=168, 45
Total Breast Volume (cm3), n=168, 45
SS of Dense Tissue (km/s), n=168, 45
SS of Non-Dense Tissue (km/s), n=168, 45
Area of Dense Tissue (cm2), n=170, 45
Area of Non-Dense Tissue (cm2), n=172, 45
Total Breast Area (cm2), n=172, 45
Age (years), n=172, 45
Weight (kg), n=168, 45
Height (cm), n=168, 45
Body Mass Index (BMI), n=166, 45
Age at Menarche (years), n=166, 43
Age at Birth of First Child (years), n=171
Age at Menopause (years), n=42, 6
MPD Correlated With
USTPD, n=168, 45
Volume of Dense Tissue (cm3), n=168, 45
Volume of Non-Dense Tissue (cm3), n=168, 45
Total Breast Volume (cm3), n=168, 45
SS of Dense Tissue (km/s), n=168, 45
SS of Non-Dense Tissue (km/s), n=168, 45
Area of Dense Tissue (cm2), n=170, 45
Area of Non-Dense Tissue (cm2), n=172, 45
Total Breast Area (cm2), n=172, 45
Age (years), n=172, 45
Weight (kg), n=168, 45
Height (cm), n=168, 45
Body Mass Index (BMI), n=166, 45
Age at Menarche (years), n=166, 43
Age at Birth of First Child (years), n=171
Age at Menopause (years), n=42, 6

Spearman Correlation Coefficient
(p-value)
Parous
Nulliparous
0.711 (< 0.001)
0.792 (< 0.001)
0.644 (< 0.001)
0.779 (< 0.001)
0.127 (0.101)
-0.076 (0.619)
-0.524 (< 0.001)
-0.738 (< 0.001)
-0.463 (< 0.001)
-0.683 (< 0.001)
0.751 (< 0.001)
0.871 (< 0.001)
0.873 (< 0.001)
0.833 (< 0.001)
0.427 (< 0.001)
0.450 (0.002)
-0.658 (< 0.001)
-0.670 (< 0.001)
-0.501 (< 0.001)
-0.504 (< 0.001)
-0.314 (< 0.001)
-0.345 (0.020)
-0.427 (< 0.001)
-0.464 (< 0.001)
-0.071 (0.363)
0.138 (0.366)
-0.421 (< 0.001)
-0.504 (< 0.001)
0.130 (0.095)
0.181 (0.245)
0.013 (0.863)
N/A
0.118 (0.457)
-0.143 (0.787)
0.643 (< 0.001)
0.119 (0.125)
-0.555 (< 0.001)
-0.497 (< 0.001)
0.649 (< 0.001)
0.675 (< 0.001)
0.754 (< 0.001)
-0.775 (< 0.001)
-0.518 (< 0.001)
-0.159 (0.037)
-0.430 (< 0.001)
-0.056 (0.473)
-0.429 (< 0.001)
0.184 (0.018)
0.104 (0.176)
0.220 (0.161)

0.710 (< 0.001)
-0.106 (0.488)
-0.696 (< 0.001)
-0.671 (< 0.001)
0.802 (< 0.001)
0.639 (< 0.001)
0.627 (< 0.001)
-0.763 (< 0.001)
-0.542 (< 0.001)
-0.238 (0.115)
-0.332 (0.026)
-0.043 (0.778)
-0.304 (0.042)
0.141 (0.368)
N/A
-0.029 (0.957)
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Figure 3-9 - Sound speed versus mammographic density comparisons grouped by parity. Top: Parous
women (have given birth at least once), n = 172; Bottom: Nulliparous women (never given birth), n = 45
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3.4 UST Measurements Made with Different Ring Transducers
The sound speed is a measure that is obtained by determining the arrival times of
signals that are emitted from one portion of the transducer ring and received on another.
Since the physical parameters of the ring are determined precisely at the time of
manufacture, the sound speed can be calculated precisely. However, during the course of
collecting patient data, the UST prototype underwent several hardware revisions. This
included the use of several separate ring transducers for patients that received a film
mammogram.

Since the measure of sound speed depends on the exact physical

parameters of the device, small differences in the construction of the different rings could
manifest themselves as differences in sound speed in the finished image. The physical
differences also cause electronic delays that, if not properly calibrated for, can lead to
more uncertainties in the final sound speed.
Of the patients that received a film mammogram, 17 were imaged with the first
ring (Ring 2), 74 with the second (Ring 3) and 76 with the third transducer (Ring 4).
Figure 3-10 below shows the same VASS versus MPD results for film mammography
plotted earlier, but separated by which ring transducer was used to make the sound speed
image. Of the patients that received digital mammograms, all but 7 were imaged using
the same ring (Ring 4). The results are not replotted in a similar fashion due to the small
number of patients imaged with Ring 5.
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Figure 3-10 - The plot of sound speed versus mammographic percent density for patients that received a
film mammogram separated by the ring transducer hardware that was used to create the UST image.

Since all patients have been pulled from the same general population, we expect
no fundamental difference in overall average sound speed between different rings.
However, from Figure 3-10, we can see that there is a systematic difference in sound
speed between patients imaged with different ring transducers. The differences are most
apparent at low densities where the data appears linear and become less apparent at high
densities where the data becomes scattered. In order to remove this systematic error in
the results, a simple shift was used. The data from ring 4 was created using the most up
to date reconstruction algorithm which included properly calibrated ring geometries and
electronic delays. So this meant that the data from ring 2 and ring 3 were shifted to align
with the data from ring 4.

Breasts with mammographic densities lower than
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approximately 35% have a narrow range of possible sound speed values. Breasts with
higher densities show a larger range of potential sound speeds. The shift was therefore
only calculated using sound speed values for breasts with mammographic densities lower
than 35%, but it was then applied to all points, regardless of density. Doing this ensured
that there would be good agreement between all three rings for the patients with low
mammographic density where sound speed appears to be more uniform.
The data for each ring was plotted individually for patients with mammographic
densities lower than 35%. Linear trendlines were fitted to each ring and the equations of
these lines were calculated. Using these lines of best fit, the average sound speed value
was calculated for each ring. The difference in average sound speed between each ring
and ring 4 was then calculated. These results are shown below in Table 3-13. This
difference was then applied as a simple shift to all data collected from the specific ring,
including patients with higher densities. This new shifted patient data was plotted and is
shown below in Figure 3-11. By applying the shift, the systematic errors between each
ring disappeared.
Table 3-13 – Calculating the Shift for Different Ring Transducers
Linear Fit

Average Sound
Speed (m/s)

Shift in Sound Speed
(m/s)

Ring 2

SS = 0.3847x + 1446

1453.1

-25.3

Ring 3

SS = 0.1195x + 1444

1446.3

-18.5

Ring 4

SS = 0.3656x + 1421

1427.8

0.0
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Figure 3-11 - The VASS versus mammographic percent density for the film patients after the corrections
were applied to the data from the different ring transducers.

Correlations were measured and trendlines were fit to all the data both before and
after the shift occurred. In all situations, applying the shift improved the relationship
between sound speed and mammographic density. The results are summarized in Table
3-14. For the unshifted VASS vs MPD data, the Spearman correlation coefficient was
found to be rs = 0.701 (p < 0.001). A linear and 2nd order polynomial fit was also applied
to the unshifted data. The linear fit showed an R2 of 0.5104 while the 2nd order fit gave
an R2 of 0.5385. This suggests that there was a moderately strong correlation between
sound speed and MPD. However, after the shift was applied, the correlations grew
stronger. For the shifted data, the Spearman correlation coefficient was measured to be rs
= 0.794. The linear fit gave an R2 of 0.5422 and the 2nd order polynomial fit showed an
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R2 of 0.6055. Since the corrections improve the strength of the correlations, all plots and
correlations that involve sound speed data use this shifted sound speed.
Table 3-14 – Correlations for Raw and Shifted Transducer Rings
Spearman
Coefficient
Raw

0.701

Shifted

0.794

Linear Fit

Polynomial Fit

SS = 1.0092x + 1421
R2 = 0.5104
SS = 0.9968x + 1411
R2 = 0.5422

SS = 0.0136x2 + 0.1387x + 1431
R2 = 0.5385
SS = 0.0195x2 - 0.2539x + 1425
R2 = 0.6055

3.5 Association of VASS and MPD with USTPD
With the use of the k-means clustering algorithm, the three dimensional volume
of a UST scan can be segmented into dense and fatty subregions. This allows for the
calculation of a volumetric percent density (USTPD), which is shown in Figure 3-12
plotted against the VASS of the entire breast. The measurement of this volumetric
density does not depend on the type of mammogram received, so the figure plots all 247
patients on the same plot. The Spearman correlation coefficient is 0.647, which suggests
that there is a correlation between VASS and USTPD, but that it is not as strong as the
relationship between VASS and MPD. This is most likely because the algorithm that
segments the volumetric images chooses the regions differently and perhaps less
effectively than the Cumulus software.
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Figure 3-12 - Plot of average sound speed versus ultrasound percent density for the entire population of
patients, n = 247.

A more direct comparison between the two imaging modalities (UST and
mammography) can be made by comparing the percent density measurements. Figure
3-13 shows the relationship between the USTPD and the MPD.

The Spearman

coefficients for these plots are rs = 0.608 and rs = 0.747 for patients receiving film and
digital mammograms. The correlations are similar to those found between VASS and
MPD (rs = 0.794 and rs = 0.706 for film and digital mammograms). However, this is a
more direct comparison of the two imaging modalities as both USTPD and MPD are a
measure of the same characteristic (density), but measured in different ways. This shows
the relationship directly between a three dimensional density measurement (USTPD) and
a two dimensional density measurement (MPD). The curvilinear nature of the film
mammograms is less apparent when compared to the VASS plot (Figure 3-5).
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Figure 3-13 - Plots of the mammographic percent density versus the ultrasound percent density, grouped by
patients receiving a film mammogram (Top, n = 163) and a digital mammogram (Bottom, n = 84).

88

3.6 Subregion Analysis
The regions of dense and fatty tissues in the breast can also be used to determine
more than percent density. By separating these regions, further associations with these
subregions can be analyzed for both mammography and UST sound speed images. These
associations may provide more information about the nature of breast density.

3.6.1 Two-Dimensional Subregion Analysis
The Cumulus software can take the projected anatomy onto an x-ray and segment
dense and fatty regions of the breast. Associations of VASS with the dense, non-dense
and total areas of the breast were calculated. VASS was positively correlated with dense
areas as measured on a mammogram for both digital and film mammograms. The
Spearman correlation coefficient was rs=0.509 for film mammography, rs=0.404 for
digital mammography and rs=0.431 for all patients. VASS was negatively correlated
with fatty areas with a Spearman coefficient of rs=-0.687 for film mammograms, rs=0.589 for digital mammograms and rs=-0.649 for all patients. Also, the VASS was
negatively correlated with the total area on a mammogram. The Spearman coefficient
was rs=-0.446 for film mammography and rs=-0.461 for digital mammography and rs=0.472 for all patients. These plots are shown below in Figure 3-14 and the results which
were listed before in Table 3-7 are now summarized below in Table 3-15.
Table 3-15 – VASS and Mammography Correlations
Spearman Coefficient (p value)
Film Mammograms
(n = 165)

Digital Mammograms
(n = 84)

All Mammograms
(n = 249)

Dense Area

0.509 (< 0.001)

0.404 (< 0.001)

0.431 (< 0.001)

Non-Dense Area

-0.687 (< 0.001)

-0.589 (< 0.001)

-0.649 (< 0.001)

Total Area

-0.446 (< 0.001)

-0.461 (< 0.001)

-0.472 (< 0.001)
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Figure 3-14 - Plots of the sound speed associated with several different mammographic characteristics
grouped by mammogram type. Left: Film, n = 165; Right: Digital, n = 84.
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The same correlations were made between the dense, fat and total areas on a
mammogram and the mammographic percent density. Figure 3-15 shows the plots of the
data and Table 3-16 summarizes the correlations that were listed previously in Table 3-7.
The Spearman coefficients between MPD and dense area are rs = 0.755, rs = 0.612 and rs
= 0.731 for the film group, digital group and all patients. This indicates a strong and
positive correlation with dense area.

For MPD and non-dense area, the Spearman

coefficients are rs = -0.774, rs = -0.764 and rs = -0.757 for film, digital and all patients.
There is a strong and negative correlation between MPD and non-dense area. There is
also a moderate and negative correlation with the total area as well. The Spearman
correlation coefficients are rs = -0.436, rs = -0.576 and rs = -0.477 for film, digital and all
patients. The correlations are stronger for MPD than they are for the VASS. This is
expected since the mammographic density and areas were both measured on the same
mammogram.
Table 3-16 – MPD and Mammography Correlations
Spearman Coefficient (p value)
Film Mammograms
(n = 165)

Digital Mammograms
(n = 84)

All Mammograms
(n = 249)

Dense Area

0.755 (< 0.001)

0.612 (< 0.001)

0.731 (< 0.001)

Non-Dense Area

-0.774 (< 0.001)

-0.764 (< 0.001)

-0.757 (< 0.001)

Total Area

-0.436 (< 0.001)

-0.576 (< 0.001)

-0.477 (< 0.001)
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Figure 3-15 - Plots of the mammographic percent density associated with several different mammographic
characteristics grouped by mammogram type. Left: Film, n = 165; Right: Digital, n = 84.
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3.6.2 Three-Dimensional Subregion Analysis
The subregions that were calculated using the k-means clustering algorithm were
also plotted against the overall measurements of density to determine if any correlations
existed. Since UST is a volumetric analysis, instead of calculating mammographic areas,
dense, non-dense and total breast volumes could be calculated. Figure 3-16 shows the
plots of the VASS versus the measured dense, non-dense and total breast volumes. Since
both values were measured using the UST device, they are not dependent on
mammography type and the data are therefore not separated. The Spearman correlation
coefficients were found to be rs = 0.070 for the dense volume, rs = -0.553 for the nondense volume and rs = -0.497 for the total breast volume. Table 3-17 summarizes these
results although they were already listed before in Table 3-7. The correlations involving
the non-dense and total volumes are both moderate and negative which mirrors the
relationship with the mammographic areas. However, the correlation involving the dense
volume was near zero and statistically insignificant.

This indicates that either the

algorithm that was used to segment the volumes was unable to accurately separate the
dense volume or that dense volume manifests itself in a different manner in UST
imaging.
Table 3-17 – VASS and UST Volume Correlations
Spearman Coefficient (p-value)
Dense Breast Volume, n = 247

0.070 (0.273)

Non-Dense Breast Volume, n = 247

-0.553 (< 0.001)

Total Breast Volume, n = 247

-0.497 (<0.001)
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Figure 3-16 - Plots of sound speed versus UST imaging characteristics for all patients, n = 247.
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The same volume measurements were then plotted against the mammography
data to compare their relationships with VASS. Since the mammography data was being
used, it was split according to the type of mammogram received to observe whether or
not there were any differences. The Spearman coefficients for the dense volume were
found to be rs = 0.064, rs = 0.104 and rs = 0.085 for the film patients, digital patients and
all patients respectively. For the non-dense volume, correlations of rs = -0.549, rs = 0.642 and rs = -0.568 were found for film, digital and all patients, while for the total
volume the correlations were rs = -0.485, rs = -0.585 and rs = -0.509. These correlations
align with the results that were measured for the VASS and the non-dense and total
volume measurements align with the correlations found when examining the
corresponding mammographic areas. Table 3-18 summarizes these correlations that were
originally listed previously and Figure 3-17 shows the plots that for the film and digital
groups.
Table 3-18 – MPD and UST Volume Correlations
Spearman Coefficient (p value)
Film Mammograms
(n = 163)

Digital Mammograms
(n = 84)

All Mammograms
(n = 247)

Dense Volume

0.064 (0.416)

0.104 (0.346)

0.085 (0.185)

Non-Dense Volume

-0.549 (< 0.001)

-0.642 (< 0.001)

-0.568 (<0.001)

Total Volume

-0.485 (< 0.001)

-0.585 (< 0.001)

-0.509 (<0.001)
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Figure 3-17 - Plots of mammographic percent density associated with UST imaging characteristics
separated by mammogram type. Left: Film, n = 163; Right: Digital, n = 84.
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Due to the quantitative nature of the UST device, it is possible to extract more
information about these subregions by analyzing their sound speeds. Since each pixel
holds sound speed information about the voxel, by segmenting the breast into dense and
non-dense volumes, sound speed information, and subsequently density information can
be measured by performing calculations to the subregion volume. Figure 3-18 shows the
average sound speed of the non-dense volume as a function of the average sound speed of
the dense volume. The Spearman correlation coefficient is rs=0.674, but the plot appears
curvilinear.
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Figure 3-18 - Plot of the average sound speed for the dense and non-dense sub-regions of the breast
measured using UST, n = 247.
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Figure 3-19 - Plot of the overall average sound speed associated with the average sound speed of the dense
sub-region (Top) and the non-dense sub-region (Bottom) as measured by UST, n = 247.
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The association of VASS with both the dense and non-dense average sound
speeds is shown in Figure 3-19. The Spearman coefficients of rs=0.765 for the dense
volume and rs=0.837 for the non-dense volume indicate that the density of the sub
regions themselves can be a good indicator of overall breast density. The correlations are
much stronger when using subregion volumes than area on a mammogram. This is likely
due to the fact that areas on a mammogram are dependent on the volume of the patient’s
breast, whereas the average sound speed of the subregion is a normalized value that is not
as easily influenced by the relative volume of the breast between patients.

This

quantitative information that was obtained through UST is something that is unavailable
from mammography.

3.6.3 Comparison of Two and Three Dimensional Segmentation
To compare the effectiveness of measuring the sub-regions within the breast, the
dense, non-dense and total volumes measured by UST and dense, non-dense and total
mammographic areas were plotted against each other. Spearman correlations of rs =
0.326 for the dense tissue, rs = 0.808 for the non-dense tissue and rs = 0.769 for the entire
breast were calculated.

The correlation between the dense volume and dense

mammographic area is the weakest of the three, but still statistically significant. Density
has traditionally been determined by separating dense tissue from non-dense tissue.
However, this suggests that dense tissue is represented in different ways in UST imaging
compared to mammography. When grouped by mammogram type, as shown in Table
3-19 and Figure 3-20, all correlations were stronger between UST and digital
mammography, compared to film. This is more evidence to suggest that the difference in
x-ray response between film and digital detectors affects their ability to measure density.
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Figure 3-20 - Correlations involving the measured sub-region volumes and areas separated by
mammography type. Left: Film, n = 163; Right: Digital, n = 84.
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Table 3-19 – Area and Volume Correlations
Spearman Coefficient (p value)
Film Mammograms
(n = 163)

Digital Mammograms
(n = 84)

All Mammograms
(n = 247)

Dense Area/Volume

0.274 (< 0.001)

0.431 (< 0.001)

0.326 (< 0.001)

Non-Dense Area/Volume

0.745 (< 0.001)

0.890 (< 0.001)

0.808 (< 0.001)

Total Area/Volume

0.697 (< 0.001)

0.862 (< 0.001)

0.769 (< 0.001)

3.7 Distribution of Density within the Breast
The use of the k-means clustering algorithm was an attempt to characterize the
distribution of sound speed within the breast. To further test the sub-region results
obtained using the algorithm, visual inspection was done on several images and their
corresponding sound speed distributions.

3.7.1 Sound Speed Distributions across Different Average Densities
To further examine the nature of breast density in the sub-regions, histograms of
the voxel sound speed distributions were analyzed for several different patients. A total
of 12 patients were analyzed. They were chosen to ensure the average sound speed of
each patient was roughly spread out evenly along the entire range. The data were
grouped into three groups that represented breasts with low average sound speed, breasts
with moderate average sound speed and breasts with high average sound speed. Table
3-20 lists the patients selected for this examination, which group they were placed in and
their average sound speed. The histogram of the distribution of sound speed voxels
within each patient was plotted by group in Figure 3-21, Figure 3-22 and Figure 3-23 for
the low, moderate and high sound speed groups respectively. The histograms were
normalized relative to the volume of each breast in order to be plotted on similar scales.
The area under each curve is therefore normalized to a value of 100%. In an attempt to
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estimate the average effect seen on each group, the histogram data was averaged. Figure
3-24 shows the average distribution of sound speed voxels in each group. This can
potentially show how dense and non-dense tissues are distributed across “average”
breasts of specific density.
Table 3-20 – Patients Selected and Their Average Sound Speed
Low Sound Speed

Moderate Sound Speed

High Sound Speed

Patient

Average
SS (km/s)

Patient

Average
SS (km/s)

Patient

Average
SS (km/s)

CURE 340

1.4222

CURE 317

1.4362

CURE 301

1.4894

CURE 319

1.4223

CURE 309

1.4451

CURE 299

1.5043

CURE 302

1.4257

CURE 294

1.4453

CURE 300

1.5148

CURE 315

1.4308

CURE 298

1.4535

CURE 301

1.5196
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Figure 3-21 – The histogram of the distribution of the sound speed voxels for the low average sound speed
group. The histograms are each normalized relative to the total volume in each scan.

102

Voxel Distributions - Medium Density
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Figure 3-22 – The histogram of the distribution of the sound speed voxels for the moderate average sound
speed group. The histograms are each normalized relative to the total volume in each scan.
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Figure 3-23 – The histogram of the distribution of the sound speed voxels for the moderate average sound
speed group. The histograms are each normalized relative to the total volume in each scan.
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Figure 3-24 – The average distribution of sound speed for each group.

3.7.2 Image ROI Analysis
By averaging over the entire breast volume, differences in dense and non-dense
tissues among the different categories may be masked.

An attempt to analyze the

individual tissue types on a more independent level was made by analyzing a small
region-of-interest (ROI) that was drawn over non-dense tissue on breasts with different
average densities. Two different images were analyzed that corresponded to a fatty
breast and a heterogeneously dense breast. By ensuring that only one tissue type was
being examined in the ROI, this would allow for observations on how density affected
the non-dense tissue that composes most of the breast volume. These non-dense regions
were selected by visual inspection of the sound speed images and not with an automated
segmentation algorithm. The small ROI used allowed for only a specific small volume
of the breast to be analyzed instead of volume averaging the entire breast which could
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potentially cause small variations in density to go unnoticed. The ROI was measured in
four consecutive slices that contained visible non-dense tissue to minimize any partial
volume effects. Table 2 shows the different imaging characteristics of the two different
breasts that were analyzed. The average sound speed, mode, median, minimum and
maximum values of the ROI were calculated along with many other values. These results
are summarized in Table 3.
Table 3-21 – Overall Imaging Characteristics of Images Analyzed
Patient

Sound
Speed
(km/s)

Standard
Deviation
(km/s)

CURE275

1.4795

0.0334

45.2

CURE315

1.4308

0.0143

9.9

Dense
Mean SS
(km/s)

Non-Dense
Mean SS
(km/s)

35.3

1.5168

1.4591

2.8

1.5041

1.4287

MPD USTPD

Table 3-22 – ROI Tissue Analysis
Patient

CURE275
Heterogeneously
Dense

CURE315
Fatty

ROI
Area
(voxels)

Mean
(km/s)

Standard
Deviation
(km/s)

Mode
(km/s)

Min
(km/s)

Max
(km/s)

Median
(km/s)

Skew

2163

1.4319

0.0129

1.4322

1.3950

1.4828

1.4312

0.352

2163

1.4311

0.0151

1.4275

1.3890

1.4774

1.4299

0.302

2163

1.4316

0.0173

1.4290

1.3828

1.4909

1.4298

0.331

2163

1.4337

0.0212

1.4216

1.3855

1.5096

1.4332

0.272

2040

1.4170

0.0066

1.4154

1.3988

1.4480

1.4169

0.216

2040

1.4174

0.0064

1.4181

1.3974

1.4406

1.4174

0.062

2040

1.4178

0.0060

1.4155

1.3970

1.4398

1.4177

0.146

2040

1.4186

0.0059

1.4161

1.3996

1.4367

1.4184

0.146

3.8 Sound Speed Inter-rater Analysis
Inter-rater reliability is the degree of agreement among different raters who
measure or analyze the same data. It is used in statistical analysis to determine how
much consistency or consensus there is in the ratings given by different raters. If various
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raters get the same results using the same scale, the reading can be characterized as
highly reliable. Here, the VASS was measured for 64 images by two independent raters,
as reported by Faiz153. Each rater independently determined the number of slices that
corresponded to the majority of the breast tissue by selecting the nipple and chest wall
cutoffs. Masks were then created for the chosen slices. Figure 3-25 plots the VASS for
each image as measured by the two independent raters.

The Pearson correlation

coefficient for the relationship was rp=0.99995, which is very strong. The percent error
between each measurement was also measured with the largest error being 0.65%.
Linear regression was also performed and the best-fit straight line had an equation of y =
1.0167x – 0.0241 with an R2 = 0.9913. These results suggest that there is a very high
degree of agreement between these two independent raters. The VASS measurements
obtained using the UST device are highly reliable and consistent.

Figure 3-25 - Sound speed measurements of the same data as measured by two separate readers showing a
strong intra-rater correlation153.
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3.9 Future Studies
Currently, multiple studies have linked mammographic percent density to the risk
of developing breast cancer. There are no studies that link VASS with breast cancer risk.
The work presented above has only correlated UST breast density measurements with the
current gold standard of breast imaging, mammography. It has shown that breast density,
as measured by VASS, is at least comparable to density as measured by mammography.
Future work would involve a study to investigate the relationships between density
measured using VASS in UST imaging and the risk of developing breast cancer.
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CHAPTER 4
THE ULTRASOUND STUDY OF TAMOXIFEN
4.1 Tamoxifen Use in the Prevention of and Treatment of Breast Cancer
Tamoxifen has been shown to reduce the incidence of breast cancer in women
who have had breast cancer by up to 50%154, 155. Therefore, it is commonly used as a
breast cancer preventative agent. This indicates that tamoxifen causes a reduction in the
incidence, or risk, of invasive breast cancer. Although tamoxifen has been shown to
reduce the number of breast cancers during many studies, the term “prevention” does not
necessarily imply that all these cancers have been eliminated. Tamoxifen has been used
to treat advanced breast cancers alone and in combination with chemotherapy156-159. It
also has a proven efficacy in reducing tumor recurrence and prolonging survival when
administered as postoperative adjuvant therapy in early stage disease62, 160-162. Patients
who use tamoxifen have also shown lower incidences of contralateral breast cancer62, 162,
163

. It has also shown an ability to reduce invasive and non-invasive breast cancers in

other women who have an increased risk of the disease, including younger and premenopausal women62, 164-166. Tamoxifen is usually administered for between 2 to 5 years,
although 5 years of therapy is the recommended duration. The preventative effects of
tamoxifen are seen in patients with up to an additional 10 years of follow-up164. The use
of tamoxifen for prevention may be limited due to its side effect profile165, although the
effects are minimal. Still, tamoxifen remains a cheap and highly effective treatment.

4.1.1 Biological Effects of Tamoxifen
Tamoxifen is a selective estrogen receptor modulator (SERM) that prevents
estrogen from binding to estrogen receptors. It was approved by the Food and Drug
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Administration in 1977 for the treatment of advanced breast cancer and several years
later for adjuvant treatment of primary breast cancer167 and also as a chemopreventive
agent among high risk women62. Tamoxifen is absorbed readily after oral administration
with a usual dosage of 20 mg per day167-170. The half-life of tamoxifen in serum ranges
from 7 to 14 days, permitting once-daily administration167,

171-173

.

For long-term

treatments, the steady state concentrations of tamoxifen in serum can remain constant for
10 years. After treatment is discontinued, tamoxifen can still be detected in serum for
several weeks and in tumor tissue for several months173. Tamoxifen is one of the most
commonly used adjuvant hormonal therapy for hormone receptor-positive breast cancers,
along with aromatase inhibitors. The antitumor effects of tamoxifen are thought to be
due to its estrogen receptor antagonism. It inhibits the expression of estrogen-related
genes that include growth factors secreted by the tumor which causes a slowing of tumor
cell proliferation174. Therefore, tamoxifen prevents only estrogen receptor (ER)-positive
breast cancer and has little to no effect on ER-negative cancers175, 176. For prevention to
be successful, it is important to define and identify women at high risk of developing ERpositive breast cancer.

4.1.2 Effect of Tamoxifen on Breast Density
Most attempts at defining a high risk for breast cancer have focused on family
history, which has an attributable risk of 7%.

However, women with higher

mammographic densities (MPD > 50%) have an attributable risk of approximately 30%22,
177, 178

. Density can also be increased by menopausal hormone therapy and can be

affected by other hormonal stimuli179-183. Not only does tamoxifen reduce the risk of
breast cancer, it also decreases breast density particularly in premenopausal women19, 154,
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168-170, 176, 184-186

. Should these two effects be due to the same mechanism, the reduction in

breast cancer risk may be partially explained by tamoxifen’s effect on breast density185.
Therefore, monitoring breast density in an individual woman during an antiestrogenic
intervention such as tamoxifen may indicate whether or not the treatment will be
effective.
Many groups have performed observations on the effects of tamoxifen on breast
density as measured qualitatively or quantitatively on mammography and even breast
MRI. Son and Oh184 observed decreased breast parenchyma on mammograms in 60% of
women treated with tamoxifen for an average of 22 months, compared to 36% of
nontamoxifen patients. Brisson et al154 observed treatment with tamoxifen for almost 3.5
years. There, 44.4% of those treated showed a decrease in density as measured by
Wolfe’s patterns compared to 15.2% of women on placebo. Atkinson et al168 also
measured a change to a less dense Wolfe pattern in 31% of women on tamoxifen. The
use of a quantitative or semi-automated criteria for measuring density changes was
proposed by Chow et al170.

There, 56% of patients showed a relative decrease in

mammographic percent density of >10% relative to their pre-tamoxifen scans. They also
measured an average decrease in mammographic percent density of 4.3% per year.
Decensi et al tracked the effects of tamoxifen in combination with fenretinide186, another
drug that reduces premenopausal breast cancer risk. It was observed that the combination
of the two drugs reduced density more than either drug on its own. Density changes as
measured by MRI were observed by Chen et al169 for a small cohort of sixteen patients.
A 5.8% reduction in percent density was measured for patients that had only been taking
tamoxifen for only 2 years.
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Cuzick et al have released several studies from the International Breast Cancer
Intervention Study I (IBIS-I) that monitored almost 1000 women undergoing either
tamoxifen or placebo treatment for prevention. When observing more than 800 breast
cancer free women176, after 18 months of treatment, statistically significant differences in
the decrease in density were observed between women taking tamoxifen and those
receiving placebo. After 54 months, the average decrease in percent density for the
tamoxifen group was 13.7% compared to only a 7.3% decrease in the placebo group.
When Cuzick later also included women who later developed breast cancer185, 46% of
women in the tamoxifen arm showed a reduction in breast density of >10% at their 12-18
month scan. They found that changes in mammographic breast density at 12- to 18months were an excellent predictor of response to tamoxifen in the preventive setting.
Although the measured changes in breast density are small with tamoxifen, on the order
of a few percent, the effect on breast cancer risk is much larger. This suggests that
changes in breast density may only be a marker of tamoxifen activation and only be
causally related to decreases in breast cancer risk.

4.2 The Ultrasound Study of Tamoxifen Protocol
In collaboration with researchers at the Karmanos Cancer Institute, Henry Ford
Hospital, the University of Toronto and the National Cancer Institute, the Ultrasound
Study of Tamoxifen was launched in 2011. The protocol calls for an enrollment of 150
patients into the study. UST will be used to assess volumetric breast density within the
first year of tamoxifen for patients referred to take tamoxifen for clinical indications,
including a diagnosis of incident atypical lobular or ductal hyperplasia (ALH/ADH),
ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), or invasive breast
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cancer. Breast density will be assessed in the breast that is contralateral to the diagnosis.
To assess whether tamoxifen-related declines in mammographic density found at 12
months can be identified earlier with UST, multiple repeat exams will be performed on
the patients. An additional 150 women with negative mammographic screens will be
examined to ensure that the changes in UST density associated with tamoxifen use are
greater than changes in density we might expect over time. This control group will be
frequency matched to the cases on age, race and menopausal status. In order to assess
whether early changes in density from tamoxifen are predictive of the changes at one
year, the patients receiving tamoxifen will also undergo additional UST exams which will
occur approximately 1-3 months and 3-6 months post-tamoxifen initiation.
To be eligible for the study, all subjects must be aged 30 to 70 at the baseline visit
and they must weigh less than 250 lbs.

They may not be currently pregnant or

breastfeeding and have no breast implants. There should be no active skin infections or
wounds overlying the breast and the breast must be able to fit through the ultrasound
tomography ring. Finally, they must have no serious medical or psychiatric illness that
would prevent them from giving voluntary informed consent. The patients eligible for
the case study must also be planning to take tamoxifen for clinical indications such as a
referral from a health care professional based on a woman’s personal risk of breast cancer
or a diagnosis with invasive, estrogen receptor positive breast cancer, DCIS, LCIS or
atypical lobular or ductal hyperplasia that affects only one breast. Also, the patient must
have never been diagnosed with breast cancer in the breast contralateral to the current
diagnosis and is not receiving or planning to take chemotherapy. The patients eligible for
the screen-negative comparison group must also have a recent mammogram that resulted
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in recommendations for continued routine screening. They must not be taking oral
contraceptives, menopausal hormone therapy or medicines (such as tamoxifen or
raloxifene) to lower their breast cancer risk. They must also not have been previously
diagnosed with breast cancer or received medications or radiation for any type of cancer.

4.3 Measuring Breast Density
The methods described earlier (Section 2.5) to calculate the average breast sound
speed for the MPD patients were applied once again to calculate the VASS for the
Tamoxifen study. For this study, this density measurement was defined as the whole
volume sound speed (WVSS). Different methods of measuring the density were also
developed to deal with issues that presented themselves in regards to imaging the same
patient’s breast volume multiple times and with image artifacts that were encountered
while the images were being analyzed.

4.3.1 Measuring the Sound Speed over Time
Since this study is looking at the changes in breast density over time, different
methods of calculating the density were also investigated. Because patient positioning
between scans is not uniform, to accurately track changes in sound speed, roughly the
same volume of the breast was also analyzed for each scan. This was done by first
determining a common volume between scans. The process for this is described below.
For each UST scan, most of the breast anatomy is imaged on average. Each image
captures the patient’s breast starting with the nipple and extending as far towards the
chest wall as possible. However, due to patient positioning and breast size, the chest wall
may not be visible in the image. This means that some of the breast anatomy also may
not have been imaged, which potentially omits information about the breast’s density.
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Even as the same patient comes in and receives multiple scans, there is no guarantee that
the same patient will have the same breast volume imaged each time. By using a
common volume, changes to the same breast anatomy can be examined during the course
of Tamoxifen treatment.

4.3.2 Determining the Common Volume
In order to properly measure changes in breast density in patients between scans,
a common volume was determined. In cases where the volume of the breast from nipple
to chest wall was similar in multiple scans, no additional steps were required to obtain a
common volume. However, this situation is rare due to differences in patient positioning
between scans. When the overall volume of the breasts varied between scans, the scan
with the smaller volume was used as the cutoff. Landmarks on the first non-chest wall
slice were found on the reflection image and were matched up with similar landmarks
from the other scan (Figure 4-1). The reflection images provided more detail than either
the sound speed or attenuation images and allowed for multiple landmarks to be
visualized between scans. Multiple landmarks were used in the different images incase
changes in the parenchymal patterns occurred due to tamoxifen’s effect on breast density.
Since the landmarks were usually visible in multiple images, similar volumes between
the scans were obtained with a careful slice choice. The sections of the breasts that were
chosen using this method was known as the common volume. As patients received a
third or fourth scan, the common volume may have been recalculated for previous scans
to account for the new imaged volume. Otherwise, the common volume would just be
calculated for the new image. The new sound speed for each scan was calculated using
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only the masked slices that were chosen to be in this common volume using this method.
This measurement is known as the common volume sound speed (CVSS).

Figure 4-1 - Observing similar landmarks in the same patient scanned at two different times. In both
images, the same parenchymal patterns are apparent, indicating the slices represent the same volume is
being imaged.

115
The UST images show the breast anatomy from the chest wall to the nipple. The
anatomy is presented with the slice closest to the chest wall as the first slice. Higher
numbered slices represent anatomy that is further from the chest wall, towards the nipple.
This continues even past the nipple, where most of the highest numbered slices in the
image contain only the water bath. However, the volume measured by the common
volume essentially counts the voxels starting from the nipple and moving towards the
chest wall. The effect of the common volume is to remove slices from the entire volume
that correspond to breast anatomy that is closer to the chest wall. This ensured that
roughly the same volume of tissue, measured from the nipple towards the chest wall, was
analyzed between scans. Figure 4-2 shows an exaggerated example of the differences
between the whole volume (WV) and the common volume (CV) for the same patient as
they undergo three scans. For the scan with the smallest volume imaged, the common
volume is identical to the whole volume.

WV

CV
WV

WV

CV
CV

Scan 1

Scan 2

Scan 3

Figure 4-2 - An exaggerated example of a patient receiving three separate scans and the differences in
calculating the whole volume (WV) and common volume (CV) between them.

4.3.3 Dark Ring Artifacts
Further complicating the measurement of the sound speed was an artifact that
appeared in some sound speed images. This artifact presented itself as a dark ring or
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donut near the surface of the breast (Figure 4-3). This artifact did not appear in every
image. When it did appear, it was much more visible in slices that are nearest to the chest
wall. It disappeared completely in the slices closer towards the nipple. This dark region
on the image is of low sound speed and will cause the true sound speed of the breast to be
underestimated. This may affect the measured results, especially when a patient receives
an image with the artifact and another image without the artifact. The source of the
artifact was the transducers measuring a slow moving surface wave as it traveled across
the breast. Removal of the artifact cannot be done with a new reconstruction algorithm,
but there is a parameter in the algorithm that can be adjusted to decrease the presence of
the artifact. However, it comes at a cost of being able to identify the breast/water bath
boundary.

The dark regions were therefore removed manually from the images

themselves using ImageJ. This allowed for only the breast anatomy itself to be measured,
not any artifacts that did not physically correspond to any anatomy.

Figure 4-3 - Left: Sound speed image showing the presence of the dark ring artifact near the surface of the
breast. Right: Sound speed image without dark ring artifact.

117
Removal of the dark ring occurred after the whole breast volume was masked as
described before. On images where the artifact appeared, another mask was fitted that
covered the affected regions. The dark regions were oddly shaped, but appeared towards
the surface of the breast, away from the center. Using ImageJ, a large ellipse was fit to
the boundary between the artifact and the normal breast tissue. By selecting a large
enough ellipse, part of the dark region would lie outside this ellipse, while the rest of the
breast would lie inside the ellipse. ImageJ allowed for the pixels on the outside of this
ellipse to be cleared, or set to a value of zero. Clearing the outside of the ellipse in this
fashion eliminated the dark region, while keeping the breast anatomy untouched. This
process of carefully placing the ellipse to eliminate the dark region was repeated until the
entire artifact was removed. Figure 4-4 shows the steps in this process. This could then
be repeated for any other slice where the artifact was present. Once all slices were
cleared of the artifact, the sound speed could then be calculated from the remaining
voxels. This new mask was then saved.
The slices that were used to make this measurement were the same slices used for
the whole volume sound speed measurement. Therefore this measurement was known as
the donut removed whole volume (DRWV) sound speed. Applying these newly created
masks to the slices of the common volume allowed for the measurement of the donut
removed common volume (DRCV) sound speed. In images where there is no artifact, the
DRWV sound speed is equal to the WV sound speed and the DRCV sound speed is equal
to the CV sound speed. Since the artifact appears primarily in the slices close the chest
wall and the common volume may eliminate many of the same slices near the chest wall,
the DRCV may be very close or even equal to the CV for images with the artifact.
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Figure 4-4 - The steps involved in removing the dark ring artifact from a single slice. A The original
image with artifact. B An ellipse is fit tangent to part of the artifact. C The pixels outside the ellipse are
cleared, removing a portion of the artifact, but leaving the remaining breast volume. D The ellipse is fit
tangent to another part of the artifact where step C is repeated. E The final image with the artifact
completely removed.
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Since the artifact was a result of a surface wave moving across the breast surface,
it did not represent true breast anatomy in the final reconstruction. On the sound speed
image, the artifact appeared as a region of lower sound speed than the surrounding tissue.
Including the artifact in the analysis of the breast density could introduce a systematic
error causing the density to appear to be lower than it actually is. Removing the pixels
that are known to not correspond to the physical tissue is important to accurately
measuring the true breast density.

This exclusion of pixels does introduce some

additional uncertainty into the final measurement of the average sound speed of the
breast, but the effect is small as the volume of the artifact is small compared to the
volume of the breast.

Therefore, the best estimate of the true breast density was

accomplished by using the donut removed whole volume sound speed (DRWV). Unless
otherwise noted, this sound speed value was used for all measurements made.

4.4 Preliminary Results
A total of 52 patients have been admitted into the study so far. Of these 52
patients, 26 are case studies who will receive tamoxifen and 26 are untreated comparison
cases with negative screening mammograms. All 26 case patients have received their
baseline scan. Of these 26 case patients, 20 of them have also received a second scan (13 month follow up) and 15 of these patients have also received a third scan (3-6 month
follow up). The second scan was obtained an average of 51 days after treatment with
tamoxifen started and the third scan was obtained an average of 143 days after starting
treatment.

After enrollment, one of the case patients decided to not begin taking

tamoxifen after completing her baseline scan. All 26 comparison patients have only
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received their baseline scan. No patient has yet to receive their 12 month scan. These
results are summarized below in Table 4-1.
Table 4-1 – Summary of Patient Scans
# of Patients that Received the
Scan
Scan

Case

Comparison

Total

Average Scan Time
in Days (SD)

Earliest/Latest
Time

Baseline Scan

26

26

52

N/A

N/A

1-3 Month Scan

20

N/A

20

51 (16)

(33 – 97)

3-6 Month Scan

15

N/A

15

143 (34)

(85 – 193)

12 Month Scan

0

0

0

N/A

N/A

The overall patient characteristics can be grouped and analyzed in several different ways:
1. By status in the study (Case/Comparison group)
2. By menopausal status (Pre/Post Menopause)
3. By Race (African American/White/Other)

4.4.1 Patient Characteristics – Status in the Study
Of the 52 patients enrolled so far, 26 are case studies who will undergo treatment
with tamoxifen and 26 are controls who will not undergo treatment.

The average

baseline volume averaged sound speed for the case study patients is 1.457 km/s and 1.453
km/s for the control group. In the case group, 14 patients are pre-menopausal and 12 are
post-menopausal while in the control group, 12 patients are pre-menopausal and 14 are
post-menopausal. Sorting by race gives 16 African Americans, 8 White and 2 Others in
the case group and 15 African Americans, 10 White and 1 Other in the control group.
These results along with measured averages for age, weight, height and BMI are shown
below in Table 4-2 for the case and control groups.
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Table 4-2 – Descriptive Statistics for Case and Control Groups
Count (%) or Mean (EOM)
Menopausal Status

Pa

Case (n = 26)

Control (n = 26)

Pre-Menopausal

14 (54 %)

12 (46 %)

Post-Menopausal

12 (46 %)

14 (54 %)

African-American

16 (62 %)

15 (58 %)

White

8 (31 %)

10 (38 %)

Other

2 (8%)

1 (4 %)

1.457 (0.003)

1.453 (0.002)

0.157

Age (years)

51.0 (1.7)

52.3 (1.5)

0.571

Weight (lbs)

168.4 (5.7)

167.0 (6.3)

0.863

Height (inches)

63.9 (0.5)

64.3 (0.5)

0.567

BMI (kg/m2)

29.0 (0.9)

28.5 (1.1)

0.762

0.579

Race

0.740

Other Statistics
VASS (km/s)

a

P is a p-value from the chi-squared test for menopause status and race and from the two sample
independent t-test for VASS, age, weight, height and BMI

4.4.2 Patient Characteristics – Menopausal Status
Out of the 52 patients, 26 are pre-menopausal and 26 are post-menopausal. The
average baseline sound speed is 1.459 km/s for the pre-menopausal women and 1.451
km/s for the post-menopausal women. For the pre-menopausal women, 14 are case
studies and 12 are in the comparison group, while for post-menopausal women, 12 are
case studies and 14 are in the comparison group. In the pre-menopausal group, 15
women are African-American, 9 are white and 2 others while in the post-menopausal
group, there are 16 African-Americans women, 9 white women and 1 other. These
results along with the averaged age, weight, height and BMI are shown below in Table
4-3 for the different menopausal status.
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Table 4-3 – Descriptive Statistics for Menopausal Status
Count (%) or Mean (EOM)
Status in Study

Pa

Pre (n = 26)

Post (n = 26)

Case Group

14 (54 %)

12 (46 %)

Comparison Group

12 (46 %)

14 (54 %)

African-American

15 (58 %)

16 (62 %)

White

9 (35 %)

9 (35 %)

Other

2 (8%)

1 (4 %)

1.459 (0.003)

1.451 (0.002)

0.010

Age (years)

45.3 (1.0)

57.9 (1.1)

< 0.001

Weight (lbs)

172.9 (6.8)

162.5 (4.9)

0.220

Height (inches)

64.6 (0.4)

63.5 (0.5)

0.095

BMI (kg/m2)

29.1 (1.1)

28.4 (0.9)

0.612

0.579

Race

0.387

Other Statistics
VASS (km/s)

a

P is a p-value from the chi-squared test for status in study and race and from the two sample independent ttest for VASS, age, weight, height and BMI

4.4.3 Patient Characteristics – Race
Of the 52 patients enrolled in the study, 31 are African American, 18 are white, 2
are Asian and 1 is Native Indian. The average sound speed of the African-American
women is 1.454 km/s and the average sound speed of the white women is 1.455 km/s. 16
African-American women are case studies and 15 are in the comparison group while 8
white women are case studies and 10 are in the comparison group. There are 15 premenopausal and 16 post-menopausal African-American women and 9 pre- and postmenopausal white women. These results along with the averaged age, weight, height and
BMI are shown below in Table 4-4 for the different races.
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Table 4-4 – Descriptive Statistics for Racial Status
Count (%) or Mean (EOM)
African-American
(n = 31)

White (n = 18)

Case Group

16 (52 %)

8 (44 %)

Comparison Group

15 (48 %)

10 (56 %)

Pre-Menopause

15 (48 %)

9 (50 %)

Post-Menopause

16 (52 %)

9 (50 %)

1.454 (0.002)

1.455 (0.003)

0.597

Age (years)

51.2 (1.7)

51.7 (1.6)

0.850

Weight (lbs)

177.5 (5.1)

153.9 (7.1)

0.008

Height (inches)

64.0 (0.4)

64.4 (0.6)

0.526

BMI (kg/m2)

30.5 (0.8)

26.1 (1.2)

0.004

Status in Study

Pa
0.628

Menopausal Status
0.913

Other Statistics
VASS (km/s)

a

P is a p-value from the chi-squared test for status in the study and menopause status and from the two
sample independent t-test for VASS, age, weight, height and BMI

4.4.4 Overall Patient Characteristic Trends
Trends between the baseline volume averaged sound speed and age, weight,
height and BMI were measured. Trends were all negative and weak to moderate in
strength. The trends were calculated using all patient data, regardless of study status,
menopausal status or race. The results are summarized in Table 4-5 and plotted in Figure
4-5.
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Sound Speed and Patient Characteristics - Age

Sound Speed and Patient Characteristics - Weight
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Figure 4-5 - Correlations between volume averaged sound speed and age, weight, height and BMI for all
patients with a baseline scan (n = 52).

Table 4-5 – Sound Speed Correlations (n = 52)
Patient Characteristic

Spearman Correlation
Coefficient

p-value

Age (years)

-0.389

0.004

Weight (lbs)

-0.287

0.039

Height (inches)

0.060

0.674

BMI (kg/m2)

-0.296

0.033
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4.5 Mammographic Measurements
Digital mammograms were also obtained for each patient in the study to be used
for further analysis. All 52 patients enrolled in the study received a mammogram, but 46
had their mammographic density analyzed with Cumulus for comparative studies. To
test for reliability of the density measurements, the mammograms were randomized and
five patients had their mammograms read twice. There was one additional mammogram
that could not be analyzed due to file corruption.

4.5.1 Mammographic Percent Density and Patient Characteristic Trends
The mammographic percent density along with other mammographic imaging
characteristics were calculated using the obtained mammograms. The average MPD
stratified by the different groupings is shown below in Table 4-6.
Table 4-6 – Average MPD by Different Groupings
Grouping

First Group
Average (EOM)

Second Group
Average (EOM)

p-value

Case/Comparison

34.6 (5.0)

22.2 (4.2)

0.062

Pre/Post Menopausal

31.7 (4.7)

23.6 (4.6)

0.230

African-American/White

28.1 (4.9)

27.1 (5.0)

0.888

Correlations involving the MPD and many of the other mammographic
characteristics were also plotted. The correlations involving age, weight, BMI and height
were similar to those involving the VASS with age, weight and BMI showing modest but
negative correlations. These patient characteristics are shown below in Figure 4-6 and
the results are summarized in Table 4-7.
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Figure 4-6 - Correlations between mammographic percent density and age, weight, height and BMI for all
patients with a baseline scan (n = 46).

Table 4-7 – MPD and Patient Characteristic Correlations (n = 46)
Patient Characteristic

Spearman Correlation
Coefficient

p-value

Age (years)

-0.312

0.035

Weight (lbs)

-0.272

0.067

Height (inches)

0.114

0.452

BMI (kg/m2)

-0.308

0.037
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4.5.2 Mammographic Imaging Characteristic Trends
Along with the calculation of mammographic percent density, measurements of
the total amounts of dense, non-dense and total breast areas were also made. Correlations
involving the MPD and VASS with these imaging characteristics were made and are
shown below. Even with the smaller number of patients involved in this study, the
results that are seen are consistent with those observed with the larger population of
patients earlier (Table 3-7). The correlation between UST and mammographic density
measures showed a Spearman correlation of rs = 0.736 (Figure 4-7), which is similar in
strength to the previous study. The relationship between VASS and MPD also appears to
be linear, which is what was observed before for digital mammograms. The linear
relationship is likely due to the linear x-ray response of digital detectors.
UST and Mammographic Density Measurements
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Figure 4-7 - Plot of volume averaged sound speed versus mammographic percent density for the patients in
the UST study, n = 46.
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Figure 4-8 - Correlations involving the mammographic imaging characteristics and the mammographic
percent density (Left) and the volume averaged sound speed (Right), n = 46.
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The correlations between the sound speed and MPD with the mammographic
imaging characteristics are strong and are shown in Figure 4-8. Stronger correlations are
observed for the MPD measurements than for the VASS measurements. This is expected
as the measurement of MPD is made directly from the measurements of the dense area on
the mammogram. The results for these correlations are summarized below in Table 4-8.
Once again, these results are similar to those observed previously with more data.
Table 4-8 – Sound Speed and MPD Correlations with Mammographic Characteristics
Spearman Correlation Coefficient (p-value)
Mammographic
Factor

Correlation with
MPD (n = 46)

Correlation with
VASS (n = 46)

Dense Area

0.869 (< 0.001)

0.589 (< 0.001)

Non-Dense Area

-0.822 (< 0.001)

-0.645 (< 0.001)

Total Area

-0.520 (< 0.001)

-0.422 (0.003)

4.6 Measuring the Effects of Tamoxifen over Time
To compare their performance, all methods of sound speed measurement
(WVSS, CVSS, DRWVSS and DRCVSS) were calculated. This was done to see if
differences in the methods used in measuring sound speed produced differences in the
relative changes within them. If the uncertainties produced by not removing the artifact
or by measuring different volumes of breast tissue are uniform between scans, the extra
effort required to compensate for them may not be required if the interest is only to track
relative changes in density over time.

4.6.1 Overall Average Response
Averaging the sound speed of all the patients can give us an estimate of how
much of an effect tamoxifen has on breast density. For the 20 patients with two scans,
the baseline average sound speed was 1.4530 km/s and the second scan average was
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1.4518 km/s as measured using the donut removed whole volume sound speed
(DRWVSS). The results for the remaining methods of sound speed calculation are
shown below in Table 4-9 and plotted in Figure 4-9. A different method of viewing the
change over time is to average the difference from the baseline scan for each patient.
This essentially normalizes the changes such that the baseline scan for each different
method of calculation gives a change of zero. This plot is also shown in Figure 4-9.
Table 4-9 – Results for Tamoxifen Cases with Two Scans (n = 20)
Measurement

Baseline
Average (km/s)

Second Scan
Average (km/s)

Change from
Baseline (m/s)

p-value

WVSS

1.4514

1.4507

-0.7

0.661

CVSS

1.4518

1.4509

-0.9

0.628

DRWVSS

1.4530

1.4518

-1.2

0.366

DRCVSS

1.4523

1.4513

-1.0

0.605

WVSS – whole volume sound speed; CVSS – common volume sound speed; DRWVSS – donut removed
whole volume sound speed; DRCVSS – donut removed common volume sound speed. The p-value was
from the paired t-test between the baseline and final scan.

Of the 15 patients with three scans, when using the donut removed whole volume sound
speed, the baseline average sound speed was 1.4524 km/s, the second scan average was
1.4518 km/s and the third scan average was 1.4516 km/s. Once again, this overall change
was negligible and too small, compared to the uncertainty, to indicate any overall trend as
a result of tamoxifen treatment. These results, along with the results for the other
methods of measurement are shown below in Table 4-10 and plotted in Figure 4-10. The
difference from the baseline scan for each method was also plotted in Figure 4-10.
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Average Sound Speed of Patients with Two Scans
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Figure 4-9 - The average sound speed (Top) and the average change in sound speed from baseline
(Bottom) for patients with 2 scans (n = 20) using the different methods of measuring sound speed.
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Average Sound Speed of Patients with Three Scans
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Figure 4-10 - The average sound speed (Top) and the average change in sound speed from baseline
(Bottom) for patients with 3 scans (n = 15) using the different methods of measuring sound speed.
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Table 4-10 – Results for Patients with Three Scans
Measurement

Baseline
Average
(km/s)

Second Scan
Average
(km/s)

Third Scan
Average
(km/s)

Change from
Baseline (m/s)

p-value

WVSS

1.4510

1.4508

1.4509

-0.1

0.919

CVSS

1.4513

1.4511

1.4504

-0.9

0.638

DRWVSS

1.4524

1.4518

1.4516

-0.8

0.503

DRCVSS

1.4512

1.4511

1.4505

-0.6

0.729

WVSS – whole volume sound speed; CVSS – common volume sound speed; DRWVSS – donut removed
whole volume sound speed; DRCVSS – donut removed common volume sound speed. The p-value was
from the paired t-test between the baseline and final scan.

The changes in sound speed over this time frame are too small to draw firm
conclusions, especially when compared to the uncertainty in the measurement of the
average values. For the small number of patients used, the standard error of the average
values calculated is on the scale of 3-4 m/s, so changes on the order of the 1 m/s that were
obtained here may be lost in the noise. The uncertainty will decrease as more data are
collected. Currently there is not any statistically significant trend that can be inferred
from the overall average measurements of all the patients. However, among tamoxifen
treated patients, approximately half appear to be density responders by showing a
decrease in breast density. So analysis of changes in density per patient may be more
appropriate and may provide the basis for further study.

4.6.2 Patients Responding to Treatment
The data plotted above show the average change in sound speed of all patients
undergoing treatment with tamoxifen. The small overall change in sound speed across all
patients may mask heterogeneity in responses because change in sound speed was
averaged across patients whose density declined, remained unchanged or increased. To
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further examine the effects of tamoxifen on UST-measured breast density, the response
of the patients was grouped into two categories:
1. Those that showed a decrease in sound speed
2. Those that showed an increase in sound speed
Of the 20 patients that received two scans, 11 showed a decrease and 9 showed an
increase in sound speed, while of the 15 that received three scans, 8 showed a decrease
and 7 showed an increase in sound speed. Table 4-11 gives the results for the average
sound speed of the patients that showed a decrease while Figure 4-11 plots the
differences for the different methods used to calculate sound speed. When observing
these patients, the changes in sound speed are much more apparent than when changes
are averaged across the entire group. Also, the changes measured here are similar in size
or greater than the uncertainties in the measurements. This suggests that the trends
visible in the plots may be more statistically relevant.
Table 4-11 – Average Sound Speed of Patients Showing A Decrease

Patients
With Two
Scans
(n = 11)

Patients
With
Three
Scans
(n = 8)

Measurement

Baseline
Average
(km/s)

Second Scan
Average
(km/s)

Third Scan
Average
(km/s)

Change
(m/s)

p-value

WVSS

1.4540

1.4498

N/A

-4.2

0.016

CVSS

1.4546

1.4494

N/A

-5.2

0.037

DRWVSS

1.4560

1.4513

N/A

-4.7

0.005

DRCVSS

1.4556

1.4501

N/A

-5.4

0.045

WVSS

1.4523

1.4476

1.4482

-4.1

0.007

CVSS

1.4520

1.4471

1.4468

-5.2

0.004

DRWVSS

1.4531

1.4494

1.4489

-4.2

0.001

DRCVSS

1.4519

1.4470

1.4470

-4.9

0.001

WVSS – whole volume sound speed; CVSS – common volume sound speed; DRWVSS – donut removed
whole volume sound speed; DRCVSS – donut removed common volume sound speed. The p-value was
from the paired t-test between the baseline and final scan.
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Change in VASS for Patients Showing Decrease with Two Scans
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Figure 4-11 - Plots of the average change in sound speed measured using all separate measures of sound
speed for patients that showed a decrease for patients with two scans (Top) and patients with three scans
(Bottom).
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Average Change in Sound Speed Grouped by Response
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Figure 4-12 - The average change in sound speed grouped by response type for patients that received two
scans (Top) and three scans (Bottom).
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To make the effects of the patients whose breast density decreased with tamoxifen
treatment more evident, the average sound speed of each response group (i.e. those
showing an increase or decrease in sound speed) was plotted as a function of time. This
plot is shown above in Figure 4-12 for patients with two and three scans. From the
preliminary data shown here, the change in sound speed that occurs after the second scan,
approximately 50 days after treatment begins, resulted in the largest visible change. This
change was maintained after the third scan.

These preliminary data do not permit

definitive conclusions regarding whether serial UST examinations may enable rapid
identification of women who will show discernible declines in mammographic density at
12 months and beyond. However, it appears that it may be possible to use UST to detect
changes in breast density associated with tamoxifen treatment after only approximately
50 days of treatment, at least in some women.

4.6.3 Changes in Patient Weight
Since a patient’s weight is a factor that is known to affect breast density and can
fluctuate in a short period of time, it is important to track to ensure that any measured
changes in breast density are likely due to tamoxifen and not to a patient’s weight loss or
gain. The patient’s weight was recorded at each scan and the average values for patients
with two and three scans are shown in Table 4-12 grouped for the entire group as well as
for those patients that showed an increase and decrease in sound speed. The results show
that there was a small decrease in sound speed of no greater than a few pounds, but the
difference was not statistically significant.
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Table 4-12 – Average Changes in Patient Weight between Scans

Patients
With
Two
Scans
Patients
with
Three
Scans

Group

Weight
at First
Scan
(lbs)

Weight
at Second
Scan
(lbs)

Weight
at Third
Scan
(lbs)

Difference
(lbs)

p-value

Overall, n = 20

170.9

170.1

N/A

-0.8

0.382

Decreasing, n = 11

159.3

159.5

N/A

+0.2

0.890

Increasing, n = 9

185.0

183.1

N/A

-1.9

0.138

Overall, n = 15

164.9

164.2

162.7

-2.2

0.084

Decreasing, n = 8

160.4

159.8

158.8

-1.5

0.462

Increasing, n = 7

170.2

169.3

167.2

-3.0

0.059

The difference was calculated between the first and final scan. The p-value was from the paired t-test
between the first and final scan.

4.7 Response Grouped by Baseline Sound Speed
Since one of the presumed effects of tamoxifen is to reduce breast density, women
with higher starting densities may be more inclined to show greater decreases in sound
speed. Women with low baseline breast densities should be less likely to further reduce
their density, so tamoxifen may not produce the same changes in these patients. To test
this, the data was grouped into thirds (or tertiles) according to the baseline sound speed
and the changes in sound speed were calculated. The results for patients with two and
three scans are shown below in Table 4-13 and plotted in Figure 4-13. The average
baseline sound speed of the highest tertile was approximately 15 m/s higher than the
middle tertile, which is a large difference. The change in sound speed for the highest
tertile was almost 4 m/s while the middle and lowest tertile showed little change to a
small increase in sound speed. For the small number of patients in each group, about 5 to
7, the standard error of the average sound speed is on the order of 3-4 m/s. So the 3-4
m/s decrease in sound speed for the highest tertile may indicate a statistically significant
trend.
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Average Response Grouped by Baseline Sound Speed
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Figure 4-13 - The average sound speed (Top) and average change in sound speed (Bottom) grouped by
baseline sound speed for patients that received two scans (Left) and three scans (Right).
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Table 4-13 – Change in Sound Speed Grouped by Baseline Sound Speed

Patients
With
Two
Scans
(n = 20)
Patients
With
Three
Scans
(n = 15)

Tertile

Baseline
Average
(km/s)

Second Scan
Average
(km/s)

Third Scan
Average
(km/s)

Change From
Baseline (m/s)

p-value

Lowest

1.4436

1.4444

N/A

+0.8

0.258

Middle

1.4503

1.4498

N/A

-0.4

0.889

Highest

1.4647

1.4609

N/A

-3.8

0.163

Lowest

1.4430

1.4440

1.4429

-0.1

0.980

Middle

1.4501

1.4512

1.4506

+0.5

0.859

Highest

1.4642

1.4602

1.4613

-2.8

0.225

The p-value was from the paired t-test between the baseline and final scan.

4.8 Sound Speed Inter Rater Correlations
Since measuring the average sound speed from a UST image was semiautomated, the obtained values may be dependent on the subjectivity of the current
reader. Each reader is responsible for deciding which slices are to be included in the final
calculations, along with estimating the shape of the breast in each slice. The selection of
the common volume as well as the removal of the artifact, if present, from the images is
also dependent on the user. Therefore, the inter rater correlations were tested for the
different sound speed measurements made by several different users.

4.8.1 Whole Volume Sound Speed Inter Rater Correlation
The intra rater correlation was calculated for WVSS measurements between five
different raters (MS, SJ, BH, BR and ZM). To calculate the WVSS, each rater was
responsible for determining the first slice that contains the nipple region, the last slice
that does not contain any of the chest wall and for selecting the boundary of the breast
that is to be masked. Since the WVSS is the first measurement made for each scan
regardless of the patient’s status in the study, a total of 64 scans over 43 patients were
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analyzed and correlations between different pairs of raters were calculated. For five
raters, a total of 10 Spearman’s correlation coefficients were measured. The results are
shown below in Table 4-14. The average correlation coefficient was found to be rs =
0.960. This strong correlation between raters shows that the selection of start and end
slices is not that critical. This is most likely due to the large volumes measured for each
scan which reduce the effects of the small differences in pixels that the choice of slices
and mask creation produces. The Intraclass correlation coefficient is ICC = 0.966, which
indicates a very strong correlation between raters.
Table 4-14 – Spearman Correlation Coefficients for Inter-Rater WVSS Measurements

Raters

MS

SJ

BH

BR

SJ

0.951

N/A

N/A

N/A

BH

0.983

0.949

N/A

N/A

BR

0.963

0.955

0.947

N/A

ZM

0.974

0.948

0.977

0.952

All p-values for all correlations were found to be p < 0.001

4.8.2 Common Volume Inter Rater Correlation
Of the 5 raters that calculated the WVSS, 4 then went to calculate the CVSS for
the patients with multiple scans. The raters were responsible for determining which
slices corresponded to the common volume in these scans using the methods described
earlier. Each rater would first calculate the WVSS over the entire volume and then
individually choose the common volume between the scans. Once the common volume
was selected, the average sound speed over this volume was calculated. The ability to
identify common landmarks between scans was the greatest source of uncertainty
between each rater. The raters examined the images for 15 patients with multiple scans,
giving a total of 36 scans. Spearman coefficients for the different pairs were calculated
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and are shown below in Table 4-15. The average correlation coefficient was found to be
rs = 0.970. The correlation between the different raters for the common volume is just as
strong as the correlation for the whole volume despite the additional uncertainty of
selecting the common volume between raters. The Intraclass correlation coefficient
between the three raters was found to be ICC = 0.962, which indicates a very strong
correlation.
Table 4-15 – Correlation Coefficients for Inter-Rater CVSS Measurements

Raters

MS

SJ

BH

SJ

0.986

N/A

N/A

BH

0.979

0.971

N/A

BR

0.964

0.963

0.958

All p-values for all correlations were found to be p < 0.001

4.8.3 Artifact Removed Inter Rater Correlation
Two different raters then went on to remove the ring artifacts for the whole
volume calculations (DRWVSS). Choosing the slices with the artifact and the removal of
the artifact introduce a new potential source of error. The measurements were made on a
total of 13 patients that received 31 separate scans. The Spearman coefficient was found
to be rs = 0.948. The Intraclass correlation coefficient between the three raters was found
to be ICC = 0.907, which indicates a very strong correlation.
Three raters then also measured the common volume sound speed with the artifact
removed. A total of 31 scans were compared over 13 patients. The Spearman correlation
coefficient for each pairing was calculated and shown below in Table 4-16. The average
coefficient was rs = 0.921. The intraclass correlation coefficient was calculated to be ICC
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= 0.921. These strong correlations indicate that the removal of the artifact could be done
in a similar fashion by different raters.
Table 4-16 – Correlation Coefficients for Inter-Rater DRCVSS Measurements

Raters

MS

SJ

SJ

0.940

N/A

BH

0.907

0.917

All p-values for all correlations were found to be p < 0.001

Table 4-17 summarizes the calculated ICC values from the different inter-rater
measurements.
Table 4-17 – Intraclass Correlation Coefficients

Measurement

# of Raters

# of Scans

ICC

WVSS

5

64

0.966

CVSS

4

36

0.962

DRWVSS

2

31

0.907

DRCVSS

3

31

0.921

4.9 Estimating the Uncertainty in the Sound Speed Measurements
Estimating the uncertainty in the sound speed measurements requires careful
consideration. The average sound speed is on the order of 1.4 – 1.5 km/s. Since the
sound speed is the average of a distribution of values, the standard error of the mean, a
value calculated from the statistics of the distribution, should describe the uncertainty
adequately. However, the standard error was calculated by taking the standard deviation
of the distribution, which for any single measurement was on the order of 15 – 40 m/s,
and dividing by the square root of the number of counts, which was between a hundred
thousand and one million. This gave a standard error that was usually less than 10 cm/s.
However, this value underestimates the true uncertainty in the measurement.
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A more accurate estimate of the uncertainty was obtained from the inter-rater
measurements. The different readers will provide a range of values for each individual
measurement. These differences arise from the subjective decisions made by each reader
to choose the start/end slices and to separate the breast tissue from the water bath. By
averaging the deviations in each of these measurements, an estimate of the rater
uncertainty can be made.

The 5 raters that were used to assess the 64 WVSS

measurements caused an average deviation in the measured value of 1.8 m/s. With an
effective range of potential sound speed measurements of about 100 m/s, this calculated
uncertainty is a much more reasonable estimate of the actual uncertainty associated with
an individual sound speed measurement.
To estimate the uncertainty in values that average several individual sound speed
measurements involves simply calculating the standard error. This uncertainty applies to
the average sound speed grouped by response type and grouped by baseline sound speed.
Since there are a limited number of patients enrolled in the study, grouping the data into
further subsets causes this uncertainty to vary strongly based on the actual number of
patients in each group.

Depending on which group is being examined, it contains

between 5 and 20 averaged values. The uncertainty in these values ranges on the order of
3-4 m/s. The uncertainty will decrease with the inverse of the square root of the number
of values. Upon completion of the study, these groups may contain up to 10 times the
current number of patients. This will cause the uncertainty to fall below that of the
individual measurement, making smaller changes more readily apparent and statistically
meaningful.
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4.10 Future Studies
The data presented here are only preliminary based on approximately 50 total
patients. The study is not a completed study yet. The proposed study called for a total of
300 patients to be examined, 150 case and 150 comparison patients. The next course of
action would be to continue the study and collect the full set of results from the entire
cohort of patients. This includes collecting the full set of four scans from the case group
(baseline, 1-3 month scan, 3-6 month scan and 12 month scan) and the pair of scans from
the comparison group (baseline, 12 month scan). Collecting this entire set of data will
allow for trends involving the effects of tamoxifen and VASS to be fully understood and
analyzed.

Despite the incomplete data set, these preliminary results are promising.

Although the full 12-month measurements are necessary to draw complete conclusions of
the effects of tamoxifen, large changes in breast density can be measured after only 1-3
months of treatment. The change after 1-3 months may also be indicative of the overall
effectiveness of the treatment, but this cannot be concluded for certainty from this study
as patient outcomes will not be followed. The percentage of women who have shown a
decrease in breast density falls in line with the results of other studies. UST therefore
shows promise to be an effective tool to track changes in breast density. It can be used to
frequently and accurately monitor breast density in women with higher densities and
greater risk. The degree of its effectiveness is still yet to be fully determined, but the
preliminary results shown here reflect that there is some value to UST breast density
measurements.
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CHAPTER 5
DISCUSSION
The inclusion of mammography, menopausal, race, family history and parity data
allows for the unique opportunity to compare and analyze differences in breast density
measurements relative to each group and relative to the sound speed measurements.

5.1 Factors that Affect Breast Density
Table 3-2 summarizes the characteristics of the digital and film data sets. The
statistically significant differences between the two groups include the mean values of
mammographic percent density, dense area on the mammogram, age, weight and BMI.
There is no reason why the average weight and BMI should be higher for the women who
received a film mammogram, so the differences are likely due to random chance. One
possible explanation for the lower age of the digital group is that younger women, who
are more likely to have denser breasts, may be more likely to be referred to digital
mammography.

However, without knowing the exact reason for the choice of

mammogram type, the difference could also simple be due to random chance.
Based on known correlations involving increased age and weight [Table 1-2], the
breast density of the film group should therefore be lower than that of the digital group
since the average age and weight in the film group is higher. However, the opposite is
true. For the film group, the MPD and the dense area are actually greater than that of the
digital group. When comparing the density measurements made on these two groups
using UST, the density, as measured by the VASS, was higher for the group that received
digital mammograms, yet statistically insignificant. Groups of women chosen randomly
from a larger population should have a similar average breast density regardless of the
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imaging modality used to measure the density. This should be true unless there is a
systematic bias in patient referrals.

Also, when comparing density measurements

between the other groups, even when there was no statistical significance between them,
the group with the higher VASS also had the larger MPD.
Therefore, these results suggest that the way digital and film mammography
create images are fundamentally different.

It appears that digital mammography

underemphasizes dense tissue relative to film. Other studies have shown mixed results
when comparing film and digital mammography.

One study shows similar results

presented here, that film mammograms give higher percent density measurements than
digital mammograms187. Another study shows comparable measurements, but between
screen-film mammography and the digitized versions of the film188. However, since the
digital mammograms in this study were actually performed using digital detectors, the
results of this study are not applicable here.

Still, other studies show little to no

difference between the two different modalities in regards to cancer detection rates63, 64,
189, 190

. Because of these inconsistencies, it is therefore justifiable to separate the two data

sets for purposes of comparison with overall patient characteristics and with
mammographic and UST-related imaging characteristics.
Menopausal status is a well known risk factor for breast cancer and the results
shown in Table 3-3 indicate that it also has a great effect on breast density as well.
Menopause is known to lead to a decrease in breast density. Density measurements made
using both imaging modalities show higher breast densities in pre-menopausal women,
exactly as expected. When using MPD, VASS or even USTPD, the results are consistent
and statistically significant.

Most other imaging characteristics show statistically
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significant differences depending on menopausal status. In particular, the amount of fatty
tissue is greater in post-menopausal women and while the amount of dense tissue is lower
in post-menopausal women, the difference is not statistically significant. This seems to
indicate that the amount of fatty tissue is the key change in breast anatomy as women
proceed through menopause. However, this conclusion can not be definitively drawn
since these women were drawn from two separate groups and not followed through the
menopausal transition.
Boyd et al36 did perform such a longitudinal study on the effect of menopause on
mammographic density and concluded that menopause has effects on mammographic
properties that are greater than those due to age alone. In line with the results shown here
for mammography and UST, it was determined that breast density decreased and the
amount of non-dense tissue increased as women passed through menopause. In addition,
Boyd et al also found that the amount of dense tissue shows a statistically significant
decrease during menopause, which conflicts with the behavior observed here. This can
likely be explained because in the data presented here, the average size of the breast of
the post-menopausal group is greater than the size in the pre-menopausal group. In the
longitudinal study, the overall sizes of the different groups were very similar. Larger
breasts are more likely to contain more dense and non-dense tissue which can potentially
skew the results. If the measured areas in the data presented here are normalized, the
decrease in dense tissue in post-menopausal women would be more apparent.
Menopause is an important stage in a woman’s life and has great effects on breast
anatomy, breast cancer risk and even cancer treatment. However, even though the overall
effects of menopause on breast density are well understood, UST can be a useful tool to
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characterize the changes associated with menopause and effects of the menopausal
transition on density.
Associations between race and breast density have been inconsistent. Previous
results have found that breast density in African-American women can be higher or lower
than breast density in white women48-50. The results presented here in Table 3-4 provide
little consensus. There were few statistical significant differences in imaging or patient
characteristics between the two different races. However, both mammographic and UST
breast density were greater on average for African-American women. These differences
were not statistically significant though. Age, weight and BMI are factors that are known
to affect breast density and can cause discrepancies when comparing between two
different groups. However, these variables are consistent between the two groups and
should therefore not cause the breast density to appear greater in African-American
women.
The only statistically significant differences between the two races involved the
dense UST volume, dense mammographic area, total UST breast volume and non-dense
UST volume. All were larger for the African-American women. Despite the average
height and weight being similar, the average breast size was much larger for the AfricanAmerican women. This caused a corresponding increase in the amount of dense and nondense breast tissue. Had breast size been similar between the two groups, it is likely that
the volume of the sub-regions of the breast would also have been similar. The effect this
would have on breast density is uncertain. It is possible that the sub-regions would have
decreased with in the same proportion, which likely would have left the percent density
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and average sound speed measurements mostly unaffected. Therefore firm conclusions
regarding differences in breast density among race can not be reached.
Family history of breast cancer is a well known risk factor for the disease. The
results shown in Table 3-5 indicate that all measures of breast density, MPD and VASS,
were higher for the higher risk group, which are those women with a family history of
disease. However, these relationships were not statistically significant. There were also
no other significant relationships when stratifying by family history. This suggests that
family history does have some effect on breast density, but that it is not as pronounced as
other factors, such as menopausal status. The elevated breast cancer risk as a result of
family history of breast is likely not only caused by breast density. The additional risk is
likely also due in part to genetic mutations, notably the BRCA1 or BRCA2 mutations, and
lifestyle factors that may be shared by women within the same family.
Women who have not carried a full-term pregnancy do show an increased risk of
developing breast cancer as well. The results shown in Table 3-6 do show an increased
density measurement for nulliparous women, but once again, the relationship is not
statistically significant. There are no other statistically relevant relationships involving
parity and imaging or patient characteristics. Again, this suggests that the difference in
hormones between these groups affect cancer risk by more than just affecting breast
density.
UST has shown its ability to be able to potentially identify small changes in
density among different subsets of women. However, in order to use UST to fully
examine how these factors affect breast density, much larger studies are required. The
results presented here show patterns similar to the ones observed when using
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mammographic density measurements. These studies benefited from the widespread use
of mammography which easily allowed for thousands of women to be examined. This
large amount of data is required to be able to obtain statistically significant results. The
small number of commercial UST devices means that acquiring enough data to draw firm
conclusions will be time consuming. Yet, the results presented here show that UST
density measurements have the potential to be as valid as mammographic density
measurements. UST can easily be used to classify density according to known densityrelated risk factors in a safe and reliable way.

5.2 Correlations Involving Breast Density
The correlations between density measurements and many of the imaging and
patient characteristics are strong. The results for all patients grouped together were
shown in Table 3-7. The correlation between VASS and MPD was very strong with a
Spearman coefficient of rs = 0.726. This value was of similar strength to correlations
found between other forms of volumetric density measurements and mammography.
When the VASS versus MPD data was plotted in Figure 3-4, it appears to be slightly
curvilinear. The MPD was then sorted by mammogram type to analyze the source of this
curvilinear nature and Table 3-8 shows these correlations. The correlation is stronger for
film than it is for digital, but in the plots shown in Figure 3-5, the film plot appears to be
much more curvilinear than the digital plot. When using regression to fit equations to the
data, the film plot showed a greater increase in the R2 value when going from a linear fit
to a polynomial fit. Other groups152 have suggested that this polynomial fit is more
appropriate since VASS is a volumetric measurement of the breast while mammography
is a two-dimensional analysis of the projected area. However, when examining the
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USTPD, another three dimensional density measurement, versus mammography in
Figure 3-13, the data appear more linear and less curvilinear. This once again suggests
that the linear and sigmoidal detector response characteristics of digital and film
mammography cause slight but fundamental differences in the measurement of breast
density.
As expected, both the VASS and MPD were moderately and inversely correlated
with age, weight and BMI. These results are consistent with the expectations that women
develop fattier breasts naturally as they age (tissue replacement) and add fat content to
breast tissue as they gain weight (obesity). The measurements made using VASS tend to
be slightly stronger and more statistically relevant when compared to the MPD
measurements. This is likely due to the fact that because of the differences between film
and digital mammography, there is an additional variability in the MPD measurements
that is not present in the VASS measurements.
When comparing the correlations involving the different imaging characteristics,
the general trend was that the VASS correlated more strongly with UST characteristics
than MPD and that mammographic characteristics correlated better with MPD than
VASS. MPD showed strong to moderate associations with dense, non-dense and total
areas on a mammogram whereas VASS only showed moderate to weak associations. The
dense area showed a positive correlation with the density measurements while the nondense and total areas showed a negative correlation. VASS showed strong and positive
correlations with the average sound speed of the dense and non-dense tissues whereas
MPD only showed moderate correlations. However, when comparing the volume of
dense, non-dense and total tissue, the correlations were of a similar strength.

In
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particular, there was no statistically relevant correlation with the volume of dense tissue
for either VASS or MPD. The lack of a correlation for dense volume indicates that the
clustering algorithm used on the volumetric data experienced difficulty separating dense
tissue. In mammography, dense tissue is separated based on its appearance on the
detector and the threshold between dense and fat is subjective. Therefore, the density that
is observed on the mammogram may not directly correspond to dense tissue in the breast.
Because of the volumetric and quantitative nature of the UST device, dense tissue may be
represented in a different way. Defining density based on a binary interpretation of tissue
may not be the most ideal method. Two regions of the breast may be very close in
density, but on a mammogram they are labeled as entirely dense or entirely fat. The
density of breast tissue likely changes gradually across the breast and UST is sensitive to
these subtle changes. Even if the breast volume cannot be easily separated into different
categories, the information each voxel of tissue contains is still available in the VASS
measurement. The lack of a correlation involving the dense volume is therefore not
critical to the usefulness of UST measurements.
The correlations involving the density measurements with the non-dense and total
areas and volumes behave just as expected.

The correlations were negative which

indicates that as the amount of non-dense and overall tissue increases, the density
decreases. This can be explained by noting that larger breasts are more likely to be fattier
than small breasts. This is reflected in the measurements. The non-dense and total areas
on the mammogram have a range that is more than twice that of the dense area, while the
non-dense and total volumes have a range that is 3-4 times that of the dense volume. In
general, it appears that the larger the breast volume, the more fatty tissue it will contain
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and therefore, the lower the density will be. This is consistent with the known negative
correlation of MPD and VASS with weight and BMI. Obesity is a driver of breast size
and breast fat content and likely accounts for the bulk of the observed negative
association of VASS and breast volume.
All correlations that involved VASS show an interesting behavior. The sound
speed measurements do not fall below a value of approximately 1.42 km/s, regardless of
what the corresponding MPD is. This effect is more pronounced when MPD is measured
using film. Conversely, there is no such limit for the higher densities which seems to
indicate there is a gradation of sound speeds for the denser tissues. This observation
suggests that the methods the two imaging systems use to determine density are
fundamentally different. The quantitative nature of the UST system indicates that for
women with low breast density, the difference in density is small. A change in the MPD
or many of the other imaging characteristics is not likely to have a large effect on the
measured VASS for women with low breast density. The UST device is much more
sensitive to women with higher breast densities, where small changes in breast
composition may have larger effects on the measured VASS. Since most of the breast
volume is made up of fatty tissue, as previously discussed, small changes to the amount
of dense tissue will have small effects on the overall UST density measurement. The
amount of dense tissue in the breast relative to the total volume is smaller than the
amount of dense area on a mammogram relative to the total area.

It is therefore

unsurprising that the average sound speed is similar for many patients while there is more
variability in the mammography. Since most breasts are mostly composed of lower
density fatty tissue, the overall UST density measurement will be much more dependent
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on this tissue. This suggests that fatty tissue is of a similar average density and sound
speed from woman to woman.

The quantitative measurements obtained from UST

imaging may in fact be better at identifying the subtle variations in breast anatomy,
especially for those women with elevated densities.
Another difference between mammography and UST shows up in the plots
involving the USTPD (Figure 3-12 and Figure 3-13). The range of USTPD does not
exceed 50%, which is lower than the MPD, which ranges up to 80% in this population.
Since the percent density is defined as the ratio of dense volume or area to total volume
or area, this result implies that there is a difference in how both imaging modalities
interpret density. The projected area of dense tissue on the mammogram should be
closely related to the dense volume of the breast, since breast compression preserves
breast volume. The same should be true for the total breast area and breast volume which
should leave the ratio of the two relatively unaffected. Since the ratios do not span the
same range, the two imaging modalities define dense breast tissue differently.
One possible explanation is that the algorithm used for either modality to separate
between dense and non-dense regions is unable to accurately make this selection
properly. Separation of the dense and non-dense tissue on the UST images was done
using a k-means clustering algorithm. The ability to separate dense tissue from nondense tissue is highly dependent on the algorithm used. It is possible that the algorithm
was not efficient at delineating between the two tissue types.

This would raise

uncertainties in the associations measured using these sub regions. It may be difficult in
general to separate breast tissue, which is composed of tissues with a wide spectrum of
densities, into just two separate density categories. There is no universal standard that
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defines the characteristics of dense tissue and fatty tissue. There is also no clear point
that separates dense tissue from fatty tissue. Until such criteria are developed across
multiple imaging modalities, if that is even possible, the separation of these tissue types
will be a subjective process.
Alternately, the discrepancy may in fact be due to the differences in imaging 2-D
projection images versus 3-D volumetric images. Depending on the amount of dense
tissue present in the breast, the compression used in mammography can distort the
distribution of the dense regions. This is thought to cause one of two effects: (i) regions
of dense tissue can overlap each other on a mammogram, which shrinks the visible area
of dense tissue and therefore underestimates the MPD or (ii) regions of dense tissue can
overlap fatty tissue which increases the amount of visible dense tissue therefore leading
to an overestimate of MPD. Although these two effects should effectively cancel each
other out, they do introduce a greater variance in the measurement of the MPD. This
likely explains why, in the association of VASS and MPD, the scatter is least at low
values and increases steadily toward higher values. However, since breast compression,
breast positioning and even the projection angle of the mammogram can be
uncontrollable factors in mammography, there are some that argue80 that density
measurements made from mammography do not accurately reflect the amount of dense
volume in the breast.
A study191 analyzed a group of UST sound speed images and applied a finite
element model to deform the volumetric images into a form similar to that of a
mammographic image. This allowed for a more direct comparison of UST imaging and
mammographic imaging by directly registering them together. However, the study only
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analyzed the displacement of visible lesions and did not attempt to measure density with
this new sound speed image. Although the mean lesion displacement was 7.1 mm and
the lesion overlap was 91%, these results suggest that the anatomy does align itself
slightly differently when it is compressed in mammography. It is therefore possible, that
dense regions in the breast are oversampled in mammography. This could lead to more
white regions on the mammogram, which is then interpreted as higher density.
The plot of the dense mammographic area against the dense volume measured by
UST shows a weak, but positive correlation, Figure 3-20. This could be a result of the
discrepancies between the two different segmentation algorithms used in mammography
and UST. However, it could also suggest that the methods used to measure density are
fundamentally different and do not necessarily align between the two imaging modalities.
Since the physics of ultrasound and x-ray interactions with breast tissue is fundamentally
different, density, as measured by both imaging modalities, refers to separate physical
characteristics. Without full knowledge of the x-ray technique that was used for the
mammogram along with many other physical characteristics of the mammography
system, the images that are produced provide a qualitative evaluation of the relative
density throughout the breast. Also, the reconstruction algorithm used to create the sound
speed images can produce uncertainties in identifying the sound speed of certain tissues.
It is possible, especially for tissues with intermediate density values, that some fattier
tissues are presented as denser than they actually are and that some denser tissues are
shown as fattier than they are. This can lead to additional discrepancies when separating
the tissues into the subregions. However, since measurement of the overall average
sound speed of the breast does not depend on these separations, it is likely a more
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accurate measure of the overall breast properties as the net effect of these uncertainties
will likely cancel each other out. The quantitative nature of the UST system therefore
provides a much more robust method of measuring and visualizing the distribution of
densities within the breast.
The plots of the sub-region sound speeds in Figure 3-18 and Figure 3-19 give a
further analysis of how density is manifested throughout the breast. By calculating the
average sound speed of the sub-regions, a more in-depth inspection of breast tissue than
is possible with mammography was performed. There were strong correlations between
the average sound speed of the dense tissue and the average sound speed of the non-dense
tissue and with the VASS and both sub-region sound speeds. This seems to indicate that
density changes in the breast affect the entire breast somewhat uniformly. As the average
sound speed and breast density increase, there is also an increase in the average speed of
the dense and non-dense tissue as well. This result suggests that separating breast tissue
into two categories, dense and fatty, is not straightforward representation of the anatomy.
The tissue that is defined as either dense or fat may vary from patient to patient. The
average sound speed of the fat regions in some of the denser breasts is actually higher
than the dense regions in some of the fattier breasts. However, much like how there was
a large peak in the distribution of VASS around 1.44 km/s, most of the non-dense and
dense average sound speed show a similar distribution towards the lower values. Fatty
breast tissue regions and dense breast tissue regions appear to be relatively uniform
across most of the population, except for the minority of patients who show higher breast
density. UST can be used as a tool to identify women with higher densities as this
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suggests that UST imaging is more sensitive to small variations in density at higher sound
speeds.
The analysis on the distribution of sound speeds on breasts of different densities
give a visual interpretation of how dense tissue manifests itself throughout the breast. It
appears that increases in breast density occur due to a combination of two reasons. First,
increases in overall average breast density are due to a systematic increase in sound speed
of all breast tissue. As the density of the breast increases, the distributions shift toward
higher sound speeds systematically. All breast tissue increases its sound speed as the
breast becomes denser. This is especially notable in Figure 3-24 as the mean, median and
mode of the average distributions all shift toward higher sound speed values as the
density of the group increases. Increases in density are therefore not solely due to an
increase in the volume of dense tissue in the breast. The non-dense tissue in breast is not
uniform in composition across different women.

If non-dense tissue was uniform

between women, then all the distributions would display a large peak in values near the
same low sound speed value. This characteristic was not seen in these distributions, so
the density of breast tissue does not act in this manner. As density increases, the average
density of the dense tissue increases in much the same way as the density of the nondense tissue. Since the sound speed increases systematically across the breast, it must
also affect the sound speed of the dense tissue as well.

From inspection of the

distributions, it can be seen that dense breasts are uniformly denser than fatty breast.
This suggests that it is possible for fatty tissue in dense breasts to be denser than the
dense tissue in fatty breasts.
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Although the dense and non-dense breast tissue changes in density as average
breast density increases, it is not the only effect that is likely occurring. The other effect
is that as density increases, the volume of dense breast tissue also increases. This can be
seen by inspecting the shape of the distributions in each group. All distributions are
positively skewed, which means that most sound speeds have low values, but there is a
longer tail leading to the high sound speed values. However, as the overall density of
each group is increased, the high sound speed tails become longer at the expense of the
low sound speed majority. This can be seen the best in Figure 3-24. The mode of the
low density group occurs at approximately 4% of the volume. However, as the density is
increased, the mode decreases, which corresponds to a decrease in the amount of nondense tissue. There is therefore an increase in the amount of dense tissue in the breast
and this is visualized as the high sound speed tail growing longer and larger.
When the breast becomes significantly dense, it appears that this volume of dense
tissue becomes comparable in size to the non-dense volume in the breast. For the highdensity group, the dense-tissue occupies enough volume to cause a second peak to occur
in the distribution. It is very clear in these patients that there are two distinct breast
tissues with two distinct sets of tissue characteristics. These peaks are not as readily
visible for the moderately dense breasts, although some individual patients do seem to
show some small peaks. Women with dense breasts may therefore benefit the most from
UST imaging as UST is able to identify dense breast tissue in a quantifiable fashion.
This means that UST is likely much more sensitive to changes in their breast density as
well. The differences in breast tissue in women with fatty or moderately dense breasts
may be small. However, there appears to be much more variation in breast composition
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among women with dense breasts. UST can be used to identify these variations and
potentially quantify them.
When examining the small ROI’s for the non-dense tissue in the different density
patients, similar results were observed. It appears that as the overall density of the breast
increases, the density of the non-dense tissue increases accordingly. The non-dense
tissue of the heterogeneously dense breast does have a higher average sound speed than
non-dense tissue in the fatty breast. When examining the values found in Table 3-22, the
mean, median, mode and max values were all greater in the denser breast. This shows
that density changes affect the entire breast. The distribution of density values also
changes as the density increases. The skewness of the distribution was more positive for
the denser breast than for the fatty breast and the standard deviation was larger as well.
This indicates that there is a larger spread in sound speed values and that there are more
high sound speed values for the denser breast. The wider range of values is likely why
the minimum value is lower for the denser breast. In mammography, density is modeled
a binary distribution of uniform dense and non-dense tissue. These results with UST
show that the distribution of density in breast tissue is much more complex.
By examining the smaller regions, any averaging that was occurring when the
entire breast was examined could be avoided. It allowed for potentially small differences
in density to be examined on a more microscopic level and not be lost when
macroscopically examining the whole breast. However, it was critical to be able to find
regions of the breast that corresponded to mostly non-dense tissue. This is difficult as
variations in the breast anatomy are likely subtle across the breast.

The patients

examined had no visible masses, so changes in density occur gradually across the volume
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and not abruptly. Therefore each ROI still does contain tissue that is likely identified as
both dense and non-dense. This is especially true for breasts that are very low or very
high in density. However, despite the amount of tissue present in the breast, the regions
are not necessarily well separated. This means that the non-dense ROI is simply more
likely to contain non-dense tissue, but could still include dense tissue as well. This can
be seen when comparing the mean value calculated within the ROI against the mean nondense tissue sound speed that was measured using the k-means clustering algorithm. The
values measured in the ROI were lower in sound speed than those measured using the
clustering algorithm. This likely indicates that separating dense tissue from non-dense
tissue is difficult and that the algorithm used will place some moderately dense tissue into
the non-dense category. Doing this would cause the average value of each tissue type to
be increased. There is no clear definition for what sound speed value should mark the
transition from non-dense to dense tissue. These results, which show that density affects
the entire breast volume instead of just certain tissues within the breast, indicate that
more study is required to determine the true nature of UST breast density.
The dense tissue in the breast is not the sole driver of overall breast density. It is
also affected by the fatty tissue. The association of VASS and non-dense sound speed is
greater than the dense sound speed. Since the volume of fatty tissue is greater than the
volume of dense tissue, it is not surprising that the larger volume has more of an effect on
the whole breast’s properties and characteristics. Mammographic density was originally
determined using a visual inspection of the mammogram to gauge the relative amounts of
dense tissue. Greater amounts of dense tissue lead to greater densities. However, these
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results show that it may be important to include an analysis of the fatty tissue as well
when discussing density.

5.3 Frequency Distributions
The frequency distributions of sound speed and mammographic percent density
are significantly different, as shown in Figure 3-1. Although all the distributions are
positively skewed, the VASS distributions are more heavily skewed than either the filmbased or digital-based MPD measurements. There are several possible explanations for
this behavior.

Most likely, the most important factor is the fact that VASS is a

volumetric measurement whereas MPD is an area measurement.

Since MPD is

essentially a projection of the volume, there is less intrinsic spread of the independent
variable (MPD) compared to the VASS and therefore less stratification of density. It is
important to recognize that MPD is a measurement of ratios of areas and is therefore
subject to confounding effects such as the overlap of tissues. This overlap can act as a
volume averaging phenomenon which can smooth density differences between subjects.
A secondary factor may be the need for setting thresholds in MPD measurements.
This introduces subjective differences between measurements which adds to
measurement error and also acts to smooth density differences. The difference in the
distributions between film and digital density measurements is similar, but not as marked
as the one between MPD and VASS. It suggests that digital MPDs peak somewhat more
and to lower values compared to film MPDs. Due to film’s sigmoidal response, it is
plausible that for a given threshold, film measurements lead to higher estimates of MPD
when compared to digital. This would cause a shift of the histogram peak to higher MPD
values. It is likely the combination of the volumetric and threshold effects that cause the
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significant difference between the VASS and MPD histograms.

This difference is

significant because it appears that the VASS measurements better isolate the highest
densities, and therefore the women at highest risk, from the rest of the distribution. It is
therefore possible that VASS may better stratify breast cancer risk in future risk studies.
The distributions for the mammographic factors of dense area, non-dense area and
total area show slight differences when separated by type. The differences support the
argument that the differences are attributable to the different ways in which digital and
film images are created and analyzed. Once again, all distributions are positively skewed
which leaves a greater percentage of lower values. The dense area is more skewed on
film than it was for digital, which the non-dense and total areas are more skewed for
digital mammograms. The dense volume measured by UST is much more strongly
skewed. This suggests that the two different imaging modalities interpret density in
different ways. The volumetric measures seem to indicate that more women tend to have
a smaller amount of dense tissue while the mammographic measures seem to distribute
the density more evenly. This may be due to the deformation of the anatomy that occurs
during mammography as a result of compression. Mammography may therefore slightly
overestimate the breast density relative to UST related density measurements.

5.4 The Ultrasound Study of Tamoxifen
The sample of patients involved in the Ultrasound Study of Tamoxifen is much
smaller than the population involved in the sound speed study. However, even in this
limited group, many of the same generalizations involving how density and other patient
characteristics are associated with each other can be identified. In particular, the VASS
measured in this population shows similar correlations to the previous results.
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Associations between the VASS and age, weight and BMI are moderate and negative.
Once again, these correlations behave exactly as expected. Breast density is expected to
decrease with increasing age and increased weight causes breasts to become fattier. The
relationships involving the mammographic quantities (MPD, dense, non-dense and total
areas) behaved just as they did before. Once again, the relationship between VASS and
MPD suggests that the x-ray response of digital detectors plays an important role. Since
the digital detectors have a linear response to x-rays, a linear relationship between VASS
and MPD also exists, as measured before.

The mammographic area measurements

correlate much more strongly with MPD than with VASS. This is unsurprising since
MPD is determined by using the same area measurements. Measurement of the VASS is
not dependent on the knowledge of the total amount of dense and non-dense tissue in the
breast, so the subsequent correlations are therefore noisier and not as strong. Overall,
although the correlations are not as strong as measured before in the VASS vs MPD
study (Chapter 3), they are still statistically significant. This is likely due to the fact that
the smaller number of patients in this cohort naturally leads to greater statistical
uncertainty.
When comparing the differences in characteristics amongst the different groups,
the first groups to compare are the case and comparison groups. There is no statistically
significant difference between the two groups for almost all of the characteristics studied.
The comparison population was specifically chosen to frequency match the cases on age,
race and menopausal status. Doing so would allow for effects of tamoxifen for one
patient be compared to the changes that occur naturally in a similar patient. Since there
are no statistically relevant differences between the two groups, the patients enrolled so
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far have been selected in a manner that will ultimately allow for the effects of tamoxifen
to be studied.
Although the difference was not statistically significant, the UST and
mammographically measured density was higher on average for the case group. The
difference was much more pronounced for MPD measurements than for VASS
measurements. This result is not unexpected as the case group is comprised of patients
with confirmed breast cancers while the comparison group is comprised of healthy
patients that have shown a screen negative mammogram. The women who were already
diagnosed with breast cancer were more likely to be women with an already increased
risk of developing breast cancer. Since increased breast density is one factor that leads to
an increased risk, it is not surprising that, on average, the women in the case group show
greater densities in the breast contralateral to the diagnosed breast than the women in the
comparison group. The lack of statistical significance is likely due to the low statistics
collected so far. As enrollment in the study grows, the statistical significance will likely
appear. However, breast density is only one of many different factors that could have
contributed to the diagnosed breast cancer, so the statistical uncertainty requires more
data to overcome.
The only other group separation that provides meaningful differences is the
separation by menopausal status.

Once again, the average age and VASS show

statistically significant differences between pre-menopausal and post-menopausal
women. The average age is lower and the VASS is higher for pre-menopausal women
while the average age is greater and the VASS is lower for post-menopausal women.
This is the exact result that was observed before and it is exactly what is expected to
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occur. All other groupings provide no statistically significant differences in any other
patient characteristic.
A previous study185 done on the effects of tamoxifen on breast density showed
that after 12-18 months of tamoxifen treatment, 46% of women had a 10% or greater
reduction in breast density as measured by mammogram. Since density in this study was
measured by using VASS, there exists a difference in the scales used to describe the
change. The VASS ranges from approximately 1.42 km/s to 1.52 km/s, giving a window
of about 100 m/s to allow for relative variations in breast density. Therefore, a 10%
change in mammographic breast density corresponds to a change in VASS of 10 m/s.
Should similar results be seen in this study, approximately half of the patients undergoing
tamoxifen treatment should show a decrease in VASS of at least 10 m/s after 18 months.
When averaging the net change for all the patients in the trial, the average change in
sound speed was found to be at most, approximately 1 m/s after 140 days (4-5 months).
However, since this average includes the patients who have shown no change or even an
increase in sound speed, it does not account for the effect of tamoxifen on those patients
it is affecting. It may be more effective to track the changes in density for those patients
who have shown a decrease in sound speed since the start of treatment. Figure 4-11 and
Figure 4-12 show these results and when examining these results, the effect of tamoxifen
is much more pronounced. The change in sound speed in these patients is on the order of
approximately 4-5 m/s after 5 months.
The preliminary results presented here also show an interesting characteristic of
the change in breast density. When the limited data are grouped according to the amount
of change in density, the average change after approximately 50 days is almost identical
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to the change in density after 3-6 months of treatment. Therefore, this may indicate that
early screening of patients undergoing tamoxifen treatment can potentially predict with
patients will respond positively and negatively to the treatment. Knowledge of this
information early can then be used to optimize the treatment strategy for patients on a
case by case basis. However, the full set of patients needs to be analyzed throughout the
entire 12-month period before these conclusions can be fully developed, but the
preliminary results are promising.
Weight is a factor that is known to be inversely related to breast density. This
was also shown to be true for sound speed measurements (Table 3-7 and Figure 4-5).
When attempting to measure changes in breast density over time, changes in the patient’s
weight must also be monitored as it is one factor that can fluctuate relatively easily.
Should a patient show a large increase or decrease in weight between scans, this may
result in a respective decrease or increase in breast density. This could mask or enhance
the effect that tamoxifen is having on breast density.

Therefore it is important to

carefully monitor a patient’s fluctuations in weight whenever density is measured and
then account for the changes it produces. Fortunately, the results that were presented in
Table 4-12 show that there was no statistically significant average change in weight
during the course of treatment so far. Depending on how the patients are grouped, the
average weight shows only a small decrease of a few pounds. Since weight and average
sound speed show only a moderate correlation, it is very likely that the small decreases in
weight between scans that were measured here have little effect on the measured breast
densities.
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When the baseline data is grouped into tertiles, it is apparent that the tertile with
the greatest initial sound speed showed the greatest decrease in sound speed (Figure
4-13). This suggests that the density-decreasing effects of tamoxifen are most beneficial
to women who initially have high density breasts. This makes logical sense as it is easier
to lower a higher baseline sound speed than it is to lower a smaller baseline sound speed.
This result may ultimately be useful in designing cancer treatments. Measuring breast
density with UST is simple and fast. If women with higher UST breast densities respond
better to tamoxifen treatment, these changes in these women can be better assessed by
using UST. However, it should be noted that until all case and control patient data is
collected, the true effect of tamoxifen cannot be inferred.

The changes to the

composition of the breast over the one year period being studied are a combination from
the effects of tamoxifen and the natural changes expected due to aging along with other
patient characteristics. Without the matched control data, it is therefore impossible to
isolate the effects that tamoxifen has on its own. The results and conclusions presented
here for this study are therefore preliminary. More data are necessary to be able to make
fully formed conclusions about the true effects of tamoxifen. However, despite being
unable to make full conclusions, UST imaging has shown its effectiveness in being able
to measure small changes in breast density. It is an inexpensive and safe method that can
be used to obtain repeated measurements of breast density over time.

5.5 Measurement Uncertainty
An advantage of measuring sound speed using UST is its high inter-rater
agreement. Qualitative mammographic density measurements are highly subjective and
significant differences between raters can be observed. The inherent quantitative nature
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of the UST measurements is what provides the strong inter-rater agreement as it makes
sound seed measurements less sensitive to the input of different raters. When examining
a sound speed image, there are only two factors the rater has control over: i) the selection
of the nipple and chest wall slices ii) the separation of the breast from the water bath in
each slice. Once these two criteria are selected, the calculation of the average sound
speed and average density is performed automatically on the remaining image pixels.
The variation between each rater in their selection of these factors will be on the order of
several thousand pixels. Since the UST device creates images of the breast with up to
hundreds of thousands of pixels, even if different raters vary widely in their assessment
of the two factors, it is still very likely that a large majority of the exact same data will be
analyzed between the different raters. Therefore, the final measurement each rater makes
will be far less subjective and this leads to a much stronger inter-rater agreement.
The calculation of standard error of the mean relies on the assumption that sound
speed is normally distributed around a single value. This may not in fact be the case,
especially for patients with visible tumors. Some voxel distributions seem to indicate
there being a two-peaked distribution (Figure 2-9), with a large group of voxels
distributed around one sound speed and a smaller group of voxels distributed around a
higher mean sound speed. This seems to suggest that there may be more than one type of
tissue present in the breast. A visible tumor or mass may be able to explain such results.
Although, the results presented in Section 3.7 also seem to indicate that these two peaks
may correspond to non-dense and dense tissue. Regardless of what is the cause, as a
result, the calculation of the standard error may not be accurate. However, since UST
generates images with a large number of pixels, the uncertainties calculated were on the
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order of several cm/s. The measurement error between different users was on the order
of approximately 1 m/s, so the standard error does not greatly impact the overall
uncertainty of the final measurement. Further analysis of the individual distributions
likely will not lead to better uncertainty estimates. However, it may lead to a greater
understanding of density distribution throughout the entire breast.

5.6 Limitations and Future Direction
There are several limitations to the methods presented here that could not be
overcome due to either time constraints or technological constraints. The measurement
of the USTPD appeared to be weaker than all the other methods used to determine
density. This is likely because only one k-means clustering algorithm was used to
segment regions of dense and non-dense tissue from the UST images. The algorithm was
not necessarily optimized for use with UST images and an improved segmentation may
have produced better results. However, any modifications to the algorithm were limited
to the amount of time and effort that could be devoted to creating it.

The UST

segmentation algorithm was likely less efficient than the segmentation used for the
CUMULUS measurements made on the mammography. More time to develop a more
robust segmentation algorithm for UST would likely have produced stronger associations
with these subregions. However, the associations and trends that were seen here were
promising and show that further investigation into the density structure of the breast may
be required. Fortunately, the effectiveness of separating dense breast tissue from nondense tissue has no consequence on determining the overall average breast density, unlike
in mammography. The use of the volume average sound speed removes the need to
segment the breast as the density is considered over the whole of the breast.
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The dark ring artifacts that were present during the tamoxifen study also posed a
limitation on the effectiveness on the results. Ideally, an imaging system will produce
images that accurately depict the true anatomy with no artifacts. Realistically, this is an
impossible technological task as sacrifices in image quality must be made in order to
produce acceptable images in real time. Since the source of the artifact was identified as
slow moving surface waves, the dark regions do not physically correspond to actual
breast anatomy.

The signal strength of the surface wave overwhelmed the normal

transmission signal for the rays that correspond to the edge of the breast. The signal that
corresponds to the ultrasound transmission through the center of each image was not
affected by the surface wave.

The algorithm was able to properly select the true

transmission signals and distinguish them from the surface wave for these rays. This
means that the portion of the image without the visible artifact should represent the true
breast anatomy and the solution to manually remove the artifact is acceptable.
Due to the presence of the artifact, the calculation of the absolute average sound
speed may be difficult and depend highly on how the artifact is handled. As expected,
when the artifact was removed, the average sound speed of the breast increases.
However, measuring relative changes in sound speed appear to be fairly accurate whether
or not the artifact is removed as the different methods (WV, CV, DRWV, DRCV)
showed similar changes in sound speed (Figure 4-11). As long as the same method is
employed for all scans, the relative changes in density should be fairly accurate. While
not the most elegant solution, manual removal of the artifact is required to obtain the
most accurate measure of the breast density.
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The hardware that was used to obtain the sound speed images was only a
prototype and was limited by its technological constraints. While the images it provided
were still acceptable, improvements to the UST device itself will lead to higher quality
images and stronger data. SoftVue is the first UST commercial device that was designed
using the clinical prototype discussed here192. It has recently been installed in place of
the prototype and begun scanning patients. SoftVue is a massive upgrade over the
prototype in terms of artifact suppression, image processing, image resolution and image
quality. By using a ring transducer with more elements and transmit/receive channels,
the SoftVue system produces images with much higher quality and resolution from the
greater amounts of raw data that can be collected. The greater amount of information
present in these images can potentially allow for the methods described here to produce
better results without further modification. The better resolution may allow for dense and
non-dense tissue to be defined more clearly, allowing the k-means clustering algorithm to
segment them more effectively. Measurements of the average sound speed can improve
with more well defined breast volume as well. The dark ring artifact is less prevalent
when using SoftVue, which also improves the sound speed measurements. The technical
limitations of the current prototype were addressed as well as possible, but they could
only be addressed up to a certain point. As the hardware continues to improve and
becomes more widespread, the analysis that can be done using UST will improve along
with it.
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CHAPTER 6
CONCLUSIONS
Ultrasound tomography imaging has been shown to be an effective tool for the
measurement of breast density. Volume averaged sound speed, as measured by UST,
was positively associated with mammographic percent density, as measured by
mammography. The association between VASS and MPD was found to be very strong
for both film (p < 0.001) and digital mammography (p < 0.001) which suggests that
breast sound speed could be a viable marker of breast density. VASS was shown to
associate with many other mammographic imaging properties such as the dense and nondense areas for both film and digital mammography.

Many other UST imaging

properties also correlated with VASS. These included volume and sub-region sound
speed measurements.
Factors that are known to affect breast density were tracked using VASS
measurements made by UST imaging.

Associations of VASS were measured that

matched the expected negative correlations with age, weight and BMI. UST imaging was
able to identify differences in density in groups of women that are the result of their
menopausal status, which is a known factor of breast cancer risk. The distributions of the
density measurements made by both UST and mammography indicate that the way film
mammography measures density may be skewed toward overproducing higher densities.
VASS may therefore be a more sensitive and accurate measure of density for women
with higher densities. These results support the findings made previously193 for UST that
were based on smaller studies.
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VASS measurements made using UST have also shown the ability to track small
changes in density over time for women undergoing tamoxifen therapy. Changes on the
order of several meters per second have been observed after only a few months of
treatment. However, these are preliminary results as data relating to control patients was
not yet collected and full information regarding the effects of tamoxifen on density could
not be determined. Despite this, these preliminary results fall in line with results that
were obtained using mammography in previous studies. Nevertheless, UST showed itself
as capable of monitoring changes in breast density as early as 1-3 months post-tamoxifen
initiation through the use of VASS as a marker.
Although the calculation of VASS is still user dependent and rather laborious, the
results that are obtained by different users are strongly correlated to each other. Strong
ICC’s were calculated between different users on the same sets of patient images. The
large breast volumes measured make the differences in calculations that each reader
imposes very small. Therefore, VASS measurements made using UST are less subjective
than MPD measurements.
Since sound speed is more directly linked to physical density of breast tissue than
mammography, it has the potential to be more accurate and more relevant than MPD as a
measure of breast density. Furthermore, since UST imaging does not require ionizing
radiation or physical compression of the breast, it has the potential to become a safe and
more accurate surrogate marker for breast cancer. Women with high breast densities are
at an elevated risk of developing breast cancer; yet conventional screening
mammography presents greater risks to this group of women. UST imaging can be used
to safely and frequently screen this group and may in fact be more sensitive to changes in
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their breast density. Future work will focus directly on testing the associations of VASS
and breast cancer risk, but for now UST imaging shows promise as a safe and costeffective imaging modality.
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APPENDIX A
IMAGE J MACROS USED
A.1 Masked Sound Speed Image Creator
The code for the macro that was used in ImageJ to create the masks that removed
the water background from the sound speed images is shown below.
//This macro is based on a macro originally written by Jason Shen
//This macro is used to manually create and save elliptical masks of the sound speed
images
//This prompts user to select the slice that corresponds to the nipple region
//Also obtains file names and directory names
path = File.openDialog("Select a File");
dir = File.getParent(path);
name = File.getName(path);
list_all = getFileList(dir);
L_name = lengthOf(name);
//Selects the patient number and slice number from the filename automatically
TAM=substring(name,3,6);
ind_end=indexOf(name, ".ss");
sli=substring(name,ind_end-3,ind_end);
//Filter out the files in the directory that are not sound speed images
temparray=newArray(list_all.length);
ki=0;
for (i=0;i<list_all.length; i++)
{
if (endsWith(list_all[i], ".ss"))
{
temparray[ki]=list_all[i];
ki=ki+1;
}
}
list=newArray(ki);
for (i=0;i<ki; i++)
{
list[i]=temparray[i]; //Only sound speed images remain now
}
newlist=newArray(ki);
//End selecting sound speed images
//Creation of elliptical mask begins now
nk=10; //Defines how many points for ellipse polygon.
xx=newArray(nk);
yy=newArray(nk);
k=0;
do
{

//The first slice to be segmented.

//Close unwanted windows
if (k != 0)
{
selectWindow(name2);
close();
selectWindow(name1);
close();
}

path1 = dir+"\\"+name;
run("ASC TextReader", "open="+path1); //Open first image
setLocation(10,100);
name1= "sound speed "+TAM+"_"+sli;
rename(name1);
//Check if working on the first image (k=0), if yes, then need an initial input
for ellipse
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//Don't need input if not working on first image (k>0)
if (k == 0)
{
//Here is the first time segment, you need select some initial ROI points.
waitForUser("Interactive Input Window", "For the first slice \n Select the
initial ROI points,\n then click OK");
getSelectionCoordinates(x, y); //Ellipse points selected
run("ASC TextReader", "open="+path1);
setLocation(10,400);
name2="ROI selection";
rename(name2);
//Adjust the initial input to have the same angle interval.
//Find x,y mean of ROI.
xmean=0.;
ymean=0.;
ni=x.length;
for (i=0; i<ni; i++)
{
xmean=xmean+x[i];
ymean=ymean+y[i];
}
xmean=xmean/ni;
ymean=ymean/ni;
//End find mean of ROI.
radius=newArray(ni);
angle=newArray(ni);
for (i=0; i<ni; i++)
{
xpri=x[i]-xmean;
ypri=y[i]-ymean;
radius[i]=sqrt(xpri*xpri+ypri*ypri);
angle[i]=atan2(ypri, xpri);
}
//Find max and min angle.
kimin=0;
kimax=0;
anglemin=angle[kimin];
anglemax=angle[kimax];
for (ii=1; ii< ni; ii++)
{
if (anglemin > angle[ii])
{
anglemin=angle[ii];
kimin=ii;
}
if (anglemax < angle[ii])
{
anglemax=angle[ii];
kimax=ii;
}
}
for (ik=0; ik<nk; ik++)
{
theta=3.1415926+2*3.1415926*((ik-nk)/nk);
if ((theta < anglemax) && (theta > anglemin))
{
kamin=0;
fmin=abs(theta-angle[kamin]);
for (mi=1;mi<ni;mi++)
{
if (fmin > abs(theta-angle[mi]))
{
kamin=mi;
fmin =abs(theta-angle[mi]);
}
}
ra=radius[kamin];
}
else
{
ra=0.5*(radius[kimax]+radius[kimin]);
}
xx[ik]=round(xmean+ra*cos(theta));
yy[ik]=round(ymean+ra*sin(theta));
}
//Polygon is fit to points selected, can still be adjusted if not good fit
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makeSelection("polygon",xx,yy);
waitForUser("Interactive Input Window","If Automatic selection
good,\n Adjust the ROI points, then click OK");
getSelectionCoordinates(xx, yy); //Adjust still made here
selectWindow(name1);
makeSelection("polygon",xx,yy);
run("Fit Ellipse"); //Ellipse is fit to selected points

is

not

}
//If not the first slice, not as many steps required.
else
{
selectWindow(name1);
makeSelection("points",xx,yy);
run("ASC TextReader", "open="+path1);
setLocation(10,400);
name2="ROI selection";
rename(name2);
xmean=0.;
ymean=0.;
for (i=0; i<nk; i++)
{
xmean=xmean+xx[i];
ymean=ymean+yy[i];
}
xmean=xmean/nk;
ymean=ymean/nk;
for (ik=0; ik<nk; ik++)
{
xpri=xx[ik]-xmean;
ypri=yy[ik]-ymean;
ra=0.8+sqrt(xpri*xpri+ypri*ypri);
theta=atan2(ypri, xpri);
xx[ik]=round(xmean+ra*cos(theta));
yy[ik]=round(ymean+ra*sin(theta));
}
//Polygon can be adjusted to fit the image and ellipse will be fit to selecting
makeSelection("polygon",xx,yy);
waitForUser("Interactive Input Window","If Automatic selection is not
good,\n Adjust the ROI points, then click OK");
getSelectionCoordinates(xx, yy);
selectWindow(name1);
makeSelection("polygon",xx,yy);
run("Fit Ellipse");
//Ellipse has been fit to user selected data
}
//Sort the file, so the first file in the newlist is automatically the next slice
to be segmented.
ki=0;
while(name!=list[ki])
{
ki=ki+1;
}
kk=ki;
for (ii=kk;ii<list.length;ii++)
{
newlist[ii]=list[ii];
}
nn=list.length-kk;
for (ii=0;ii<kk;ii++)
{
newlist[kk-ii-1]=list[ii];
}
//End sort file.
//Popup window askes for final judgement before creating mask
Dialog.create("Final Judgement");
Dialog.addChoice("Good and Continue", newArray("YES","NO"));
Dialog.addChoice("SAVE MASK:", newArray("YES","NO"));
Dialog.addString("The current slice:", TAM+"_"+sli);
Dialog.addChoice("Input New Slice:", newlist);
Dialog.show();
Sta = Dialog.getChoice();
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SAVE = Dialog.getChoice();
Cur = Dialog.getString();
run("Clear Outside");
//End window popup
//Make the appropriate directories only once to store image masks and masked sound
speed images
if (k==0)
{
savedir="C:\\ROI_NoWater\\TAM"+TAM+"_ALLSLICES\\";
File.makeDirectory(savedir);
savedir1="C:\\ROI_NoWater\\TAM"+TAM+"_ALLSLICES\\Ascii\\";
File.makeDirectory(savedir1);
savedir2="C:\\ROI_NoWater\\TAM"+TAM+"_ALLSLICES\\Mask\\";
File.makeDirectory(savedir2);
}
//End making directories
//Create and save masked sound speed images and masks
savepath1="save=C:\\ROI_NoWater\\TAM"+TAM+"_ALLSLICES\\Ascii\\TAM"+TAM+"_"+sli+".a
sc";
run("ASC TextWriter", savepath1); //Masked sound speed image created
savepath2="save=C:\\ROI_NoWater\\TAM"+TAM+"_ALLSLICES\\Mask\\TAM"+TAM+"_"+sli+"_ma
sk.asc";
run("ASC MaskWriter", savepath2); //Mask created
name = Dialog.getChoice();
sli=substring(name,ind_end-3,ind_end); //Increment to next slice number
k=k+1; //Increment slice counter
}
while (Sta == "YES");
//End Mask Creator

A.2 Sound Speed Statistics Calculator Macro
The code for the macro used in ImageJ to calculate the mean, standard deviation,
total pixel count and standard error of the mean for the sound speed images is shown
below.
// Macro to open and then find statistics for masked breast sound speed images
setBatchMode(1);
run("Clear Results");
//Select the first masked sound speed image
ASC_Path = File.openDialog("Select the Image");
//Obtains information about the file names and directory of the images
ASC_dir = File.getParent(ASC_Path);
ASC_files = getFileList(ASC_dir);
ASC_length = lengthOf(ASC_files);
ASC_Name = File.getName(ASC_Path);
setBatchMode(0);
//Open and stack the masked sound speed images
run ("ASC TextReader Stack NoBuffer","open="+ASC_Path);
run("Images to Stack");
strt = ASC_length + 1; //Number of images
//Calculate the mean sound speed by summing over each pixel
mn=0;
cnt=0;
for (n=1; n< strt; n++)
{
setSlice(n);
//Set current slice
h = getHeight();
w = getWidth();
//Measure over each pixel in image
for (x=1; x<w+1; x++)
{
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for (y=1; y<h+1; y++)
{
//Only measure pixels with sound speeds between 1.3 and 1.6 km/s
//This ensures masked background, with values of 0, aren't included
if (getPixel(x,y) > 1.3 && getPixel(x,y) < 1.6)
{
cnt++;
//Running pixel count
mn += getPixel(x,y); //Running sum
}
}
}

}

//Mean calculated here
mean = mn/cnt;
avg = d2s(mean, 8);
//Calculate standard deviation by summing over each pixel
std = 0;
for (n=1; n< strt; n++)
{
setSlice(n);
//Set current slice
h = getHeight();
w = getWidth();
//Measure over each pixel in image
for (x=1; x<w+1; x++)
{
for (y=1; y<h+1; y++)
{
//Only measure pixels with sound speeds between 1.3 and 1.6 km/s
//This ensures masked background, with values of 0, aren't included
if (getPixel(x,y) > 1.3 && getPixel(x,y) < 1.6)
{
std += pow((getPixel(x,y)-mean),2);
}
}
}
}
//Standard deviation calculated here
stdev = sqrt(std/(cnt-1))*1000;
//Calculate the error of the mean
eom=100*stdev/sqrt(cnt);
//Run a histogram to make sure values agree
run("Histogram", "bins=256 x_min=1.3 x_max=1.6 y_max=Auto stack");
//Close the images to not clutter up screen
selectWindow("Stack");
close();
setBatchMode("exit and display");
//Display final
spreadsheet.
print (avg);
print (stdev);
print (cnt);
print (eom);
print (mn);

calculated

values

in

form

to

allow

them

to

easily

be

copied

to
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ABSTRACT
THE ROLE OF TISSUE SOUND SPEED AS A SURROGATE MARKER OF
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Breast density is one of the strongest predictors of breast cancer risk as women
with the densest breasts have a three- to five-fold increase in risk compared to women
with the least dense breasts.

Breast density is currently measured by using

mammography, the current gold standard for breast imaging.

There are many

shortcomings to using mammography to measure breast density, including the use of
ionizing radiation. Ultrasound tomography (UST) does not use ionizing radiation and
can create tomographic breast sound speed images. These sound speed images are useful
because breast density is proportional to sound speed. The purpose of this work was to
assess the ability of UST to measure breast density and its ability to measure changes in
breast density over short periods of time.
A cohort of 251 patients was examined using both UST and mammography.
Many different associations were found between the UST density measurement, the
volume averaged sound speed, and the mammographic percent density.

Additional

associations were found between many other UST and mammographic imaging
characteristics. UST density was found to correlate with various patient characteristics in
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a similar manner to mammographic density. Additionally, UST was used to examine the
effects of tamoxifen on breast density.

Tamoxifen has been shown to reduce

mammographic density and breast cancer risk for some women. Preliminary data for 52
patients has shown promising results so far.

UST density has decreased for

approximately a similar percentage of patients as has been measured for mammographic
density. These changes have been measured over short time frames that could not be
achieved using mammography.
These results show that UST’s ability to measure breast density is consistent with
mammography, the current standard of care. UST has the potential to become a safe and
effective device that can be used to reliably assess breast density and serial changes in
breast density.
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